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Abstract 
Virus-based expression systems have been widely exploited for the production of 
recombinant proteins in plants during the last three decades. Advances in technology have 
boosted scale-up manufacturing of plant-made pharmaceuticals to high levels, via the 
complementation of transient expression and viral vectors. This combination allows proteins 
of interest to be produced in plants within a matter of days and thus, is well suited for the 
development of plant-made vaccines or therapeutics against emerging infectious diseases and 
potential bioterrorism agents. Several plant-based products are currently in varying stages of 
clinical development. To investigate the viability of virus-based expression systems for plant-
made subunit vaccines against Porcine reproductive and respiratory syndrome virus 
(PRRSV), I have developed several viral vectors which express partial PRRSV glycoprotein 
5 (GP5). 
In this thesis, I demonstrated that viral vectors can increase the expression of proteins for 
vaccine development in a variety of host plants. Green fluorescent protein (GFP) and the C-
terminus of GP5 fused with GFP (GP5C-GFP) were expressed at up to 37.29 mg/kg and 4.36 
mg/kg fresh weight of leaf tissue, respectively, in soybean plants via biolistic bombardment, 
using viral vectors derived from Bean pod mottle virus (BPMV). A Cucumber green mottle 
mosaic virus (CGMMV)-based vector was employed to display chimeric virus particles, 
presenting the neutralizing epitope (NE) of GP5, at levels as high as 35.84 mg/kg of 
cucumber leaf fresh weight, via agroinfiltration. In addition, GFP and the ectodomain of GP5 
fused with GFP (GP5e-GFP) were successfully produced at up to 2.03 g/kg and 36.53 mg/kg 
fresh weight of leaf tissue, respectively, in Nicotiana benthamiana using transient expression 
of Pepino mosaic virus (PepMV)-based vectors. Co-infiltration of viral vectors with p19, a 
silencing suppressor, can help to mitigate the toxicity of GP5e to plant tissue and enhance the 
accumulation of this protein. These plant-made products may be tested as oral subunit 
vaccines against PRRSV in pigs during future experimental trials. Overall, the results 
demonstrate that viral systems can produce low-cost, versatile and robust vaccines that have 
a great impact in the fight against viral diseases, especially in developing countries.  
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Chapter 1: General Introduction 
1.1 Porcine reproductive and respiratory syndrome virus (PRRSV) 
1.1.1 PRRSV and economic impacts 
Worldwide, pork is the most popular meat. Based on information from the USDA Foreign 
Agriculture Service in 2008, pork accounts for 40% of meat consumption, and is followed by 
poultry and beef (US National Pork Board 2012). China was the leader of the top ten pork-
producing countries from 2012-2016, while Canada stood in seventh place (USDA 2016). 
Canada was also one of the largest pork exporters, having exported $2.9 billion worth of pork 
to over 80 countries in 2011 (Brisson 2014). The three main Canadian pork producing 
provinces are Quebec, Manitoba, and Ontario (Farm Credit Canada 2012). Ontario 
contributed 24.7% of national pork production in 2015 (Honey 2016). These statistics 
emphasize that the swine industry plays a major role in contributing to national and regional 
profits. Biosecurity and disease control are key issues in maintaining the health of livestock 
and ensuring a profitable on-going business. Some diseases, especially those caused by 
viruses, usually emerge quickly and can lead to outbreaks, which kill pigs at all ages and 
decrease breeding efficiency. Such outbreaks require increased information, resources and 
procedures in place in order to act in a short time and avoid catastrophic losses.  
Porcine reproductive and respiratory syndrome (PRRS) is the most devastating threat to this 
industry and has drawn concern of pork producers across the world for over three decades. 
The first outbreaks were recorded in the late 1980s in the United States, with the antibody to 
PRRS virus (PRRSV) having been collected in Iowa and Minnesota (Keffaber 1989; Loula 
1991). The symptoms were incremental, with reproductive and respiratory failure that led to 
herd mortality. Almost simultaneously, PRRS was also observed in Europe and Asia 
(Wensvoort et al. 1991). In Canada, samples showing seropositivity to PRRSV confirmed 
that Ontario herds were first infected between 1979 and 1982 by the first Canadian isolate of 
the virus (Carman et al. 1995). To date, the virus is endemic in almost all pork producing 
countries except Australia, New Zealand, Norway, Switzerland, Finland, and Sweden 
(Niederwerder and Rowland 2017). Clinical signs can include anorexia, fever, dyspnea and 
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cyanosis, which will turn pig’s ears blue and, hence, the disease is also known as “blue-ear 
pig disease.”   
As mentioned, the causal agent of the disease is PRRSV- an enveloped, positive-strand RNA 
virus belonging to the genus Arterivirus in the family Arteriviridae. Besides PRRSV, the 
genus includes Equine arteritis virus (EAV), Lactate dehydrogenase-elevating virus (LDV) 
and Simian hemorrhagic fever virus (SHFV) (Benfield et al. 1992; Cavanagh 1997). The 
predicted spherical or oval-shaped envelope of this virus is approximately 50-65 nm in 
diameter. The 15-kb genome is capped at the 5’ terminus and polyadenylated at the 3’ end, 
encoding 11 known open reading frames (ORFs). ORFs 1a and 1b encode two large replicase 
polyproteins (pp), i.e., pp1a and pp1ab, respectively (Allende et al. 1999). Subsequently, 
pp1a and pp1ab are proteolytically cleaved into 14 non-structural proteins (nsps), the first of 
which produces ten nsps: nsp1a, nsp1b, nsp2-nsp6, nsp7, nsp7 and nsp8, while the latter 
creates nsp9-12. Interestingly, the proteolytic cleavage is processed by nsp1a, nsp1b, nsp2 
and nsp4. The nsp9-12 are believed to be involved in virus replication (Snijder 1998; Snijder 
and Meulenberg 1998). Recently, a short transframe (TF) ORF was discovered. It overlaps 
the nsp2-coding sequence in ORF 1a and expresses nsp2TF and nsp2N via -1/-2 programmed 
ribosomal frameshifting (Fang et al. 2012; Li et al. 2014). These two new proteins contain 
domains of papain-like cysteine proteinase. The 3’ terminus of the PRRSV genome consists 
of a compact area of gene coding for five minor and three major structural proteins expressed 
by subgenomic mRNAs (sg mRNAs). The minor structural proteins are glycoprotein (GP) 
2a, GP3, GP4, and un-glycosylated envelope proteins (ORF5a and E), all of which associate 
with the membrane. Three major structural proteins are GP5, an un-glycosylated membrane 
protein (M), and a nucleocapsid protein (N). 
PRRSV strains discovered in the late 1980s - early1990s in two distant continents, Western 
Europe and North America) were classified into EU-genotype 1 and NA-genotype 2, 
respectively (Keffaber 1989; Wensvoort et al. 1991). Lelystad virus (LV) and ATCC VR-
2332 are prototypes of genotypes 1 and 2, respectively. These virus strains are remarkably 
distinct in their nucleotide sequences, sharing only 55-70% sequence identity (Allende et al.  
1999; Nelsen et al. 1999). PRRSV has evolved quickly, with many strains and varying 
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degrees of virulence. A highly pathogenic PRRSV (HP-PRRSV) strain has been detected in 
China and Southeast Asia since 2006 and is characterized by fast spreading outbreaks. This 
strain is associated with high fever and severe damage to pig’s lungs, leading to high 
mortality in pigs (Tian et al. 2007). A new PRRSV subtype 3, designated as Lena strain, has 
also been isolated in Eastern Europe (Belarus), with both reproductive and respiratory failure 
and severe pulmonary lesions (Karniychuk et al. 2010). In general, there are two main 
genotypes, type 1 (EU) and type 2 (NA). Type 1 is divided into three subtypes, a pan-
European subtype 1 (LV) and East European subtypes 2 and 3, to which Lena strain belongs 
(Stadejek et al. 2008). Type 2 contains NA (ATTC VR-2332) and Asian HP-PRRSV 
(Wernike et al. 2012). 
Clinical cases have shown that PRRSV is the most common virus associated with the porcine 
respiratory disease complex (PRDC) (Brockmeier et al. 2002). PRRSV is able to suppress the 
host immune system, which consequently allows for secondary pathogens to attack the host, 
resulting in more severe and chronic diseases. In many cases, PRRSV can establish a mixed 
infection with Mycoplasma hyopneumoniae, Bordetella bronchiseptica, Porcine circovirus, 
Porcine respiratory coronavirus, Swine influenza virus, and Haemophilus parasuis, causing 
a complex of swine respiratory diseases. Due to this complexity, it's difficult to control these  
infections and recover the host. PRRSV infection can be classified into at least three 
prominent stages: acute infection, persistence, and extinction. In the final stage, the virus can 
be maintained in a host up to 250 days after infection. Thus , PRRSV can establish a “life-
long” infection in swine production (Wills et al. 2003). Moreover, the disease is highly 
contagious, as PRRSV can quickly infect its host through mucosal and percutaneous 
surfaces, via respiratory and oral routes. Routes of transmission include either direct or 
indirect contact with fomites, e.g. aerial exposure, coitus/insemination, ingestion, inoculation, 
ear notching, tail docking, teeth clipping, and injection of drugs or vaccines (Baker et al.  
2012; Hermann et al. 2009; Nathues et al. 2016; Otake et al. 2002). Moreover, fighting 
between pigs during sickness can also give rise to infection through bites, cuts, scrapes, and 
abrasions. Sick pigs may show aggressive behaviour by fighting healthy ones, resulting in 
virus transmission (Bierk et al. 2001).  
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PRRS is one of the most economically costly swine diseases around the world. Based on data 
from 2005-2010, PRRS caused an annual loss of $664 million dollars in pork production 
(Holtkamp et al. 2013). Breeding herds accounted for 45% of this loss, which increased 33% 
in comparison to the previous report in 2005 (Holtkamp et al. 2013; Neumann et al. 2005). 
The high economic impact of this disease was also described for nine sow herds during and 
after outbreaks in the Netherlands (Nieuwenhuis et al. 2012). The average loss per sow was 
€126 during this 18-week outbreak, whereas, the cost was variable, from €3-160 per sow, 
after the epidemic. As these nine herds included between 250-1200 sows each, the total cost 
incurred by PRRS could potentially cause a massive negative impact on the national pork 
industry. In China, a fatal outbreak associated with a highly pathogenic PRRSV (HP -
PRRSV) strain, emerged in 2006 and quickly spread out to 10 provinces (Li et al. 2007; Tian 
et al. 2007). This outbreak infected over 2,000,000 pigs and caused death in 400,000 cases. 
Moreover, the long-term persistence of this highly virulent and contagious disease drastically 
disrupted pork production in infected areas, causing significant economic loss to farmers. 
HP-PRRSV also disseminated from China into Southeast Asia, including Vietnam, Laos, 
Cambodia, Myanmar, The Philippines, Thailand, and Singapore. South Korea and Russia 
were also affected by this epidemic (An et al. 2010; Zhang et al. 2014). Disease outbreaks 
recurred several times during 2006-2010, with high infection and mortality rates in Vietnam, 
one of the major pork producing countries in Asia. Following these outbreaks, the market 
price for pork declined by 29% in 2008. Since pork production accounted for 58% of total 
agricultural gross domestic product (GDP) and 80% of total meat production, PRRS not only 
devastated pig farming, but also created a tremendous economic loss in Vietnam (Zhang et 
al. 2012). In Canada, it was estimated in 2010 that PRRS cost the national pork industry $130 
million dollars per year (The Pig Site 2010), and approximately $37-$75 million dollars per 
annum in Ontario, as reported recently (Mussell et al. 2011; Rosendal et al. 2014). These data 
show that PRRS is a devastating epidemic worldwide and causes a massive impact on the 
pork industry, as well as national economies. Thus, a solution is desperately needed to 
eradicate this disease. However, due to the complexity of this disease, it remains a 
challenging puzzle for scientists and veterinarians. Control of PRRSV outbreaks relies 
mainly on four important aspects: early diagnosis and monitoring, biocontainment, herd 
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management and vaccination (P ileri and Mateu 2016). Therefore, intense research has been 
conducted to develop effective vaccines against PRRSV. 
1.1.2 Vaccines against PRRSV 
Currently, commercial PRRSV vaccines are divided into two categories: killed-virus 
vaccines (inactivated vaccines) and attenuated or modified-live virus (MLV) vaccines. 
Inactivated vaccines are reported as being ineffective, or having limited efficacy (Kim et al.  
2011; Meng 2000; Zuckermann et al. 2007). MLV vaccines are considered as an efficient 
method to control outbreaks, as they can establish protection against homologous re-infection 
and reduce viral shedding (Cano et al. 2007b; Linhares et al. 2012; Zuckermann et al. 2007). 
However, MLV possess some drawbacks, such as incomplete cross-protection (Cano et al.  
2007a; Martelli et al. 2009; Murtaugh et al. 2002; Okuda et al. 2008) , reversion to virulence 
under farm conditions (Bøtner et al. 1997; Storgaard et al. 1999) , and immunosuppression in 
pigs (Key et al. 2003; Opriessnig et al. 2002). Therefore, a new generation of vaccines which 
are safe and efficient in the inhibition of virus infection, transmission, immunosuppression, 
and disease onsets, are definitely in need. Subunit vaccines are composed only of specific 
components (proteins or peptides) from a pathogen and are able to elicit a protective immune 
response when delivered into a host. These components are called antigens. Unlike 
inactivated or attenuated vaccines, subunit vaccines do not contain live components of the 
pathogen and, thus, reduce the risk of side effects, but still maintain the selectivity, 
specificity, safety and ability to activate immune protection (Rappuoli 2007). GP5 was 
specifically chosen as a candidate to develop PRRSV subunit vaccines, due to several 
advantages. As mentioned above, GP5 is a major glycoprotein, which is exposed on the 
surface of PRRSV and epitopes involved in virus neutralization are found on GP5 (Gonin et 
al. 1999; P irzadeh and Dea 1997; P irzadeh and Dea 1998; Wissink et al. 2003). Many 
experiments have shown that GP5 is able to induce neutralizing antibodies against PRRSV in 
pigs, and that vaccinated pigs were partially protected from the development of viremia and 
lung lesions, following PRRSV challenge (Jiang et al. 2006; Pirzadeh and Dea 1998; Qiu et 
al. 2005). It was also proposed that the ectodomain of GP5 may interact with the macrophage 
receptor, Cluster of Differentiation (CD) 169, which mediates the entry of the virus into host 
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cells (Delputte and Nauwynck 2004; Van Breedam et al. 2010). Taken together, GP5, an 
antigen of PRRSV, is a promising trigger for immune system protection, as a component of a 
PRRSV subunit vaccine. 
GP5 of the NA type 2 (VR-2332) virus is composed of 200 amino acids (aa), approximately 
25 kDa in size, and divided into variable regions: (1) a N-terminal signal sequence (residues 
1-32), which can direct the protein to the rough endoplasmic reticulum (ER) (Mardassi et al. 
1995; Meng et al. 1995; Murtaugh et al. 1995); (2) an ectodomain (residues 33-63) 
containing N-glycosylation sites (N33, N44 and N51), in which N44 and N51 are highly 
conserved among different strains; (3) an extended hydrophobic region (residues 64-134) 
known as the transmembrane region; (4) a hydrophilic C-terminal section (residues 135-200), 
known as the endodomain, which is located in the matrix of the virus (Dea et al. 2000; 
Stadejek et al. 2002; Thaa et al. 2013) (Figure 1.1). The N-terminal part of GP5 contains two 
epitopes, epitope A (residues 27-31) and epitope B (residues 37-45) (Figure 1.1A). Epitope A 
is believed to work as a “decoy epitope”, one that is non-neutralizing, hypervariable and 
immunodominant, while epitope B is neutralizing and conservative among PRRSV isolates, 
but less immunodominant. Evidence has demonstrated that epitope A induces a strong non-
neutralizing antibody response in the early stages of infection, whereas, epitope B elicits 
neutralizing antibodies against PRRSV much later, at more than four weeks post infection 
(Ostrowski et al. 2002; Yoon et al. 1994). Somehow, the decoy epitope A decreases or delays 
the induction of neutralizing antibodies against the nearby neutralizing epitope B, which is a 
common virus strategy to defeat host immune systems (Cleveland et al. 2000; Lopez and 
Osorio 2004; Ostrowski et al. 2002). Further elucidating the underlying mechanism would 
help to design a better subunit vaccine based on GP5.  
1.2 Using plants as a biofactory to produce a subunit vaccine based on GP5 
GP5-based subunit vaccines have been produced in different host systems, such as bacteria 
(Bastos et al. 2002; Hu et al. 2016; Hu et al. 2012; Park et al. 2016; Prieto et al. 2011), yeast 
(Zhao et al. 2014), insect cells (Binjawadagi et al. 2016; Duran et al. 1997; Nam et al. 2013; 
Wang et al. 2012), mammalian cells (Eck et al. 2016; Gao et al. 2014; Jung et al. 2002; 
Matanin et al. 2008) and plants (Table 1.1). 
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Figure 1.1 Characterization of PRRSV GP5 (adapted from Thaa et al. 2013).                       
A. Schematic representation of GP5. The numbers under the bar indicate the position of 
amino acids in this protein, relative to the coding regions; signal peptide (in orange), 
ectodomain (in red), transmembrane domain (in brown) and endodomain (in blue). “N” and 
“C” are abbreviated for N-terminus and C-terminus of GP5. The N-glycosylation sites (N33, 
N44 and N51) are shown in green. The “decoy epitope” A includes residues 27-31, whereas 
the neutralizing epitope B is composed of residues 37-45. B. Putative topology of 
unprocessed GP5 on the virus membrane. Virus membrane is shown in purple. The signal 
peptide is cleaved, thus separated from the ectodomain, which presents on the outer 
membrane. The transmembrane region is hydrophobic and embedded in the membrane, while 
the endodomain is assumed to locate to the virus interior. 
  
A. 
B. 
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Since the late 1980s, the use of plants for the synthesis of recombinant proteins has been 
proposed as an alternative way to reduce the costs, while increasing biosafety and stability of 
products (Barta et al. 1986; Gutiérrez and Menassa 2014; Ma et al. 2003; Twyman et al.  
2003). The word “molecular farming or pharming” describes the production of 
biopharmaceuticals, e.g. drugs, vaccines, etc. in plants using molecular biological techniques 
(Twyman et al. 2003). P lant platforms for the production of vaccines offer numerous 
advantages over the other systems mentioned above (Lomonossoff and D'Aoust 2016). 
Firstly, the production of plant-made vaccines is cost-effective, at as much as 1000 times 
lower than the cost of mammalian cell systems, and up to 50 times lower than Escherichia 
coli bioreactors, based on relative protein yields (Giddings et al. 2000; Mett et al. 2008). 
Plants have the ability to use natural resources, such as sunlight, CO2, water and nutrients to 
synthesize materials and energy, via photosynthesis, which reduces the cost and enhances the 
versatility to scale-up production, by increasing the cultivation area. Secondly, plants do not 
carry animal pathogens, e.g. microbes or prions, as opposed to mammalian cell systems and 
are, therefore, safer for human and animal use (Mason et al. 2002). Thirdly, plant systems 
can perform eukaryotic post-translational modifications (e.g. glycosylation or disulfide bond 
formation) which retain the desired structural properties of vaccines. Bacterial systems do not 
glycosylate peptides, while yeast and insect glycosylation are inconsistent, with high 
mannose glycoforms that can affect the immunogenicity of antigens (Chen and Lai 2013; Ma 
et al. 2003). Fourthly, plant platforms possess the flexibility for scaling-up production and, 
therefore, minimize the timeline of manufacturing. This can play a critical role when 
combatting infectious diseases or controlling outbreaks (Lomonossoff and D'Aoust 2016; 
Marsian and Lomonossoff 2016). Last, but not least, plant-made vaccines can also be 
produced in various edible parts of the plant, e.g. fruits, leaves, seeds, tubers, vegetables, etc. 
and are termed “edible vaccines”. Such vaccines have the potential for oral administration in 
hosts, without the use of needles and cold chains regularly required in vaccine delivery. 
Consequently, this makes edible vaccines more efficiently delivered, affordable, and 
accessible worldwide, particularly in developing countries (Mason et al. 2002; Rybicki 
2014). Therefore, plants have become an attractive system for vaccine production. Stable 
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transformation and transient expression are often used for vaccine production in plants. With 
stable transformation, the gene of interest is incorporated into the plant genome and inherited 
by subsequent transgenic generations. Hence, all stable transgenic lines contain the gene and 
will be able to express the same protein of interest as their parents. However, stable 
transformation is labour-intensive and time-consuming for generating transgenic plants, and 
this is inappropriate for the required quick and large-scale production of vaccines against 
epidemics or bioterrorism attacks. Furthermore, recombinant proteins may be produced at 
inefficient yields in these transgenic plants, especially if they hinder plant development. GP5 
has been expressed in various transgenic plants, including tobacco, potato, banana and 
Arabidopsis (Table 1.1). Aside from potato and Arabidopsis, the other plants gave low yields 
of protein expression at approximately 110-257 ng/g of leaf tissue fresh weight (Chan et al.  
2013; Chia et al. 2010; Chia et al. 2011). Interestingly, this leaf tissue was able to induce 
specific mucosal, systemic humoral and cellular responses, when fed to PRRSV-challenged 
pigs. The viral load also decreased after inoculation. To circumvent the drawbacks of stable 
transformation, transient expression, in combination with viral vectors, was used to optimize 
protein expression levels, as well as reduce time and labour investments in this study. 
Transient expression is a conventional method for delivering a gene of interest into the 
somatic cells of leaf tissue, where the gene will be transcribed and translated into a protein of 
interest. In contrast to transgenic plants, the heterologous gene does not become a part of the 
plant genome and, thus, will not be inherited by the next generation. Proteins of interest can 
be produced within a week, when using this method. The desired gene may be introduced 
into plant cells by either agroinfiltration or biolistic bombardment. Agroinfiltration involves 
the pressurized saturation of leaves with an Agrobacterium tumefaciens culture harboring the 
gene of interest, whereas, biolistic bombardment delivers gene-coated gold/tungsten particles 
into cells via compressed helium. Therefore, the combination of transient expression and 
viral vector systems is considered as a potentially robust tool for overcoming low protein 
expression levels achieved using stable transformation systems (Pogue and Holzberg 2012; 
Salazar-Gonzalez et al. 2015). Many virus-based expression systems have been developed to 
serve as potent tools for the manufacture of plant-derived biopharmaceuticals (Gleba et al. 
2007; Hefferon 2014). 
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1.3 Plant virus-based expression system 
Tobacco mosaic virus (TMV) is the pioneer who started the first chapter of virology and has 
also become an important player in modern day science. Since its discovery, TMV has 
contributed enormously into not only its own field of plant virology, but also other 
interdisciplinary subjects, such as biotechnology, evolution, and nanotechnology (Alonso et 
al. 2013; Scholthof 2004). The use of plant viruses for the production of recombinant 
proteins in plants has been demonstrated, with many good examples to support this 
statement. Beginning from a proof-of-concept idea, plant viral vectors have developed into a 
powerful tool in the industrial production of heterologous proteins, especially traditionally 
expensive ones such as antibodies and vaccines. As cellular parasites, plant viruses possess 
certain characteristics: (1) upon infection, they can exploit host machinery to produce a large 
amount of viral proteins as well as the viral genome; (2) they have the ability to suppress 
post-transcriptional gene silencing (PTGS) and protein degradation, by evolved mechanisms; 
(3) they can also establish systemic infection throughout the plant. These characteristics 
make plant viral vectors an alternative expression system to the traditional transgenic or 
transplastomic systems, with some remarkable advantages: (1) increase in expression speed 
and yield production; (2) reductions in cost and time; (3) a high throughput, flexible and 
scalable system. Many expression strategies have been employed for the development of 
powerful viral vectors during the last 30 years (Lico et al. 2008). These can be divided into 
four main categories, including gene insertion vectors, gene replacement vectors, modular or 
deconstructed vectors and peptide display vectors, in addition to a minor category, viral 
elements and combinations of different viral vectors. 
1.3.1 Gene insertion vectors 
In this expression strategy, the heterologous sequence encoding the protein of interest is  
inserted into the viral genome at a certain site, e.g. coat protein (CP). The protein of interest 
is expressed as a fusion product, with viral CP, by the CP (subgenomic) promoter, or as an 
individual protein by a duplicated CP (subgenomic) promoter. A typical example is a vector 
derived from Cowpea mosaic virus (CPMV) (Gopinath et al. 2000). A jellyfish green 
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fluorescent protein (GFP) was fused to the last aa of the CPMV small CP in RNA2, via a 2A-
cleavage sequence from Foot-and-mouth disease virus (FMDV), called F2A, to create the 
CPMV/S-2A-GFP construct. Following inoculation into cowpea, GFP expression was 
estimated at 1% of total soluble protein (TSP). In addition, systemic infection was detected at 
10 days post inoculation (dpi) and the stability of the construct was maintained through five 
passages. A similar viral expression vector based on Potato virus X (PVX) has also been 
developed (Chapman et al. 1992). In this case, a bacterial β-glucuronidase (GUS) gene was 
inserted between a duplicated (artificial) CP subgenomic promoter (SGP) and the CP SGP to 
form pGC3. Transcripts of pGC3 were used to infect Nicotiana clevelandii and N. tabacum 
cv. Samsun NN. After infection, histochemical analysis results confirmed the expression of 
GUS in both inoculated and systemic leaves. Nevertheless, northern blot analysis showed 
that there were sequence deletions of GC3 RNA due to homologous recombination. 
Along with the aforementioned achievements, some problems have also been identified from 
the first generation of viral vectors. Firstly, as the viral genome is kept integral, complete 
viruses are also expressed and able to spread systemically in host plants. This fact may raise 
some concerns in terms of biosafety and biosecurity. Secondly, large exogenous inserts 
(more than 1 kb) may hinder virus assembly, thus limiting the infection area and subsequent 
protein expression. Thirdly, the introduction of a cleavage site may result in a mixture of 
products (e.g. free proteins and fused proteins). Last, duplication of promoters often leads to 
homologous recombination of repeating sequences, resulting in the instability of these 
constructs. Extensive efforts have been made to obviate these problems. 
1.3.2 Gene replacement vectors 
An endogenous viral sequence is substituted by that of a heterologous gene of interest (GOI) 
to form a gene replacement vector. In the viral genome, not all viral elements are required for 
protein expression (e.g. CP). CP is essential for the systemic movement of most of viruses. 
However, advances in technology, such as vacuum infiltration, allow viral vectors to be 
dispersed throughout entire plants. Therefore, with systemic movement no longer necessary, 
removal of CP helps to eliminate bio-contamination threats. Also, with the exchange of viral 
CP to a gene of interest, viral vectors can bear a much larger insert when compared to gene 
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insertion vectors. Musiychuk et al. have created a “launch vector”, called pBID4, based on 
CP-depleted TMV (Musiychuk et al. 2007). pBID4 was engineered to express not only 
modified lichenase, but also its fusion products with other proteins of interest, e.g. plague, 
anthrax, influenza, etc. Lichenase is -1,3-1,4-glucanase, a thermostable enzyme derived 
from Clostridium thermocellum. This enzyme was expressed as a carrier in fusions with 
different target proteins, in order to promote their expression, stability, and immunogenicity. 
In addition, lichenase remains stable at high temperatures (65°C), which is also adopted by 
the fusion products, facilitating fast and economical purification by heat, in downstream 
processes. Modified lichenase (LicKM), which is approximately 27 kDa, and proteins of 
interest (up to 100 kDa) were successfully produced using pBID4. For instance, antigen 
hemagglutinin (HA) of influenza type A/Vietnam/04 (H5N1) virus was expressed in two 
forms: (1) the globular domain (H5GD) fused with LicKM (LicKM-H5GD) and (2) the stem 
domain (H5SD) fused with LicKM (LicKM-H5SD). Both target proteins were extracted from 
Nicotiana benthamiana at 4-7 dpi and purified to over 80% purity using affinity 
chromatography. These plant-made vaccines also formed specific bindings to antibodies in 
sheep sera raised against HA of the influenza type A/Vietnam/04 virus. 
The rise of agroinfiltration, using A. tumefaciens, has paved a novel way for the delivery of 
viral vectors into desired areas in plants, without the need for systemic virus movement. In 
addition, it has facilitated the design of viral vectors by giving an enhanced capacity for 
creativity and simplification. The ultimate result of this progress is modular systems based on 
deconstructed vectors. 
1.3.3 Modular or deconstructed vectors 
Accumulated evidence has shown that the gene insertion strategy has some flaws, as 
mentioned earlier. Moreover, a vector with the entire viral genome and GOI can result in a 
large-sized plasmid and thus, reduce the efficiency and flexibility of either genetic 
engineering, or cell expression machineries. In the modular system, the viral genome is 
divided into different genetic components, referred to as provectors or minimal vectors, 
which contain only the essential viral elements in favour of protein expression, e.g. RNA-
dependent RNA polymerase (RdRp) (Giritch et al. 2006; Larsen and Curtis 2012). To form 
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an integrated system, these provectors must be delivered into one cell, via agroinfiltration, 
and subsequently co-expressed in order to function as a complete expression system. The 
most well-known deconstructed vectors are the MagniCON system, which is based on TMV. 
This system will later be described in detail in section 1.5 of this thesis. Here, I would like to 
give some details of others which are less well-known, but still successful enough.  
Larsen and Curtis have demonstrated the comparisons between different viral expression 
vectors based on PVX, in cell suspension and hairy root systems (Larsen and Curtis 2012). 
PVX-GUS contains GUS inserted between the triple gene block (TGB) and CP, and driven 
by the CP SGP. The deconstructed vectors are PVXΔCP-GUS and PVXΔCPΔTGB-GUS, in 
which the first vector lacks PVX CP, while the second has had both the CP and TGB deleted. 
Strikingly, PVXΔCPΔTGB-GUS (called a “minimal vector”) could yield GUS expression 
6.6 fold higher than that of PVX-GUS. Co-expression of the minimal vector with a 
suppressor of PTGS from Tomato bushy stunt virus (TBSV), p19, in the pPSP19 vector, 
could further increase GUS expression by 44% and 990% in cell-suspension and infiltrated 
leaves, respectively. Furthermore, GUS expression increased dramatically, by 83%, in cell 
suspension when co-transformation with HC-Pro, a silencing suppressor of Tobacco etch 
virus (TEV), in place of p19. These experiments have shown that a minimal vector can 
produce an efficient infection and boost protein expression to higher levels. 
In another example, Liu and Kearney designed a deconstructed vector, known as 
FET40/GFP, based on Foxtail mosaic virus (FoMV) (Liu and Kearney 2010). Like PVX, 
FoMV is also a member of the Potexvirus genus, whose characteristics will be described in 
more detail in section 1.6. Interestingly, this virus has a broad host range, which includes 
species in both the Poaceae family of monocots, and some dicotyledonous species. 
FET40/GFP contains only a partial viral genome, including the viral replicase, a putative 
SGP of subgenomic RNA1 (sg RNA1), GFP and the 3’ end of the CP gene. The GFP 
sequence was driven by the SGP, which has 40 nucleotide (nt) of TGB1, with the ATG 
mutated to ATC. Co-expression of FET40/GFP and p19 could produce GFP as high as 1.7 
mg/g of leaf tissue fresh weight.  This yield was comparable with that of TRBO, a TMV 
based vector (Lindbo 2007).  Notably, all of the above examples have highlighted not only 
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the importance of modular systems in protein expression, but also implicated the crucial role 
of agroinfiltration as an efficient method for the delivery of multiple constructs into plants 
(Peyret and Lomonossoff 2015). 
1.3.4 Peptide display vectors 
In this strategy, the gene of interest is fused with the viral CP sequence in order to produce 
chimeric virus particles (CVPs), which are able to display the peptide of interest on their 
surface. Using the direct fusion method, the foreign peptide can be fused to CP at either its 
N- or C-terminus. Also, with the indirect method, the gene of interest is joined with CP via 
an extra sequence, e.g. a readthrough translational context (Sugiyama et al. 1995) or an F2A 
sequence (Uhde-Holzem et al. 2010). The top priority of gene fusion is to preserve viability 
of the chimeric virus. This means that the chimeric virus must be able to maintain replication, 
RNA and protein production, assembly into viral particles, and cell-to-cell or systemic 
movement, if required. These requirements sometimes restrict the size of inserts. Despite this 
drawback, peptide display vectors have been employed since 1986 (Haynes et al. 1986) and 
become a popular tool in the production of plant-made vaccines, benefitting from their many 
advantages. Subunit vaccines are formulated from epitopes, which are usually small peptides 
or proteins. Due to their small size, free epitopes are not easily recognized by antigen 
presenting cells and are unable to induce complete immune responses (Bachmann and 
Jennings 2010). CVPs have the ability to act as efficient carriers, by increasing the size of the 
antigen when presenting the epitopes to the host immune system and, hence, stimulate innate, 
antibody, and cell-mediated responses (Marconi et al. 2006; Marusic et al. 2001). In addition, 
CVPs are restricted within their host-plant range and thus, cannot replicate using their own 
molecular machinery and induce diseases in animal hosts. Lico et al. incorporated the 
nucleoprotein (NP) sequence of the influenza A virus strain A/PR/8/24/Mount Sinai (H1N1) 
to the N-terminus sequence of PVX, in order to generate NP-CVPs (Lico et al. 2009). The 
foreign peptide (Ala-Ser-Asn-Glu-Asn-Met-Glu-Thr-Met) was expressed together with PVX 
CP, by the CP SGP, and presented on the surface of NP-CVPs. Purified NP-CVPs from N. 
benthamiana were recovered at approximately 1.1 mg/g of fresh leaf weight. Mice 
immunized by the resulting CVPs, without adjuvants, were stimulated to produce interferon  
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secreting antigen-specific CD8+ T cells. Both CD8+ and CD4+ T lymphocytes play crucial 
roles in immune responses to intracellular infections and tumors. Therefore, epitope-
displaying CVPs can be used as vaccines to activate cell-mediated immune responses. 
In addition to vaccine technologies, the peptide-display virus system has been widely used in 
a variety of new fields, including nanotechnology and nanomedicine (Lico et al. 2015; 
Steinmetz et al. 2009a). More applications will be described thoroughly in section 1.4, 1.5 
and 1.6, specific to Comovirus, Tobamovirus and Potexvirus genera. 
1.3.5 Viral elements and combination of different viral systems 
Many plant viral sequences have been working as essential elements in expression vectors. 
These include promoter sequences, translational enhancement sequences and gene-silencing 
suppressor sequences.  
The Cauliflower mosaic virus (CaMV) 35S promoter was one of the first plant virus elements 
which have been extensively studied. CaMV belongs to the genus Caulimovirus in the 
Caulimoviridae family of para-retroviruses. It infects plants of the Brassicaceae family and 
some strains are able to infect species in the Solanaceae family. This promoter has been 
greatly used in transgene expression vectors to help secure strong expression of genes of 
interest. It is noteworthy that most transgenic plants, especially commercialised genetically 
modified plants, contain the CaMV 35S sequence, as a stable and long-term activating 
promoter. CaMV 35S is a strong constitutive promoter and able to drive high levels of RNA 
synthesis not only in viruses and plants, but also in a wide variety of prokaryotes, e.g. 
Escherichia coli, or other eukaryotes, yeast, mushroom, cell lines of human embryonic 
kidney cells, Chinese hamster ovary, and fishes like the Atlantic salmon (Assaad and Signer 
1990; Rüth et al. 1992; Seternes et al. 2016; Sun et al. 2002; Tepfer et al. 2004).  
When entering host cells and uncoating their capsids, positive-sense, single-stranded RNA 
viruses hijack the host machinery to produce the necessary proteins involved in virus 
replication, such as RdRp. Evidence has shown that viruses are able to recruit host ribosomes 
to efficiently translate their RNA, owing to specific sequences in the 5’ or 3’ un translational 
region (UTR) of viral genome. The TMV 5’ omega (Ω) leader sequence and the Tobacco 
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etch virus (TEV) 5’ leader sequence are examples (Gallie 2001; Gallie et al. 1987). Ofoghi et 
al. employed these leader sequences to enhance human calcitonin production in transgenic 
potato plants (Ofoghi et al. 2005). The TMV enhancer efficiency was 2-3 fold higher than 
that of TEV, when comparing the levels of human calcitonin in leaves, roots and tubers of 
transgenic potato plants. 
Like humans, plants also possess defence mechanisms, and RNA silencing is a key 
component of the plant immune system against viruses. This mechanism is involved with 
post-transcriptional control of gene expression, in which the target transcripts go through a 
specific degradative pathway, recruiting small interfering RNA (siRNA, 21-23 nt) as 
mediators and indicators (Voinnet 2001). To counteract this mechanism, plant viruses have 
evolved the ability to suppress RNA silencing using their own specialized proteins, named 
silencing suppressors. Viral silencing suppressors include HC-Pro, p19, and 2b proteins, 
which are derived from potyviruses, tombusviruses and Cucumber mosaic virus (CMV), 
respectively. Each protein has its own mechanism for interference at different stages of RNA 
silencing pathways in plants. The suppressor p19 is well characterized and has a distinct 
mode of action. It is able to sequester viral small RNAs and inhibit t heir incorporation into 
the plants RNA-induced silencing complex (RISC) (Scholthof 2006). Furthermore, p19 also 
prevents the accumulation of Agronaut-1 (AGO1), by increasing the expression level of 
microRNA 168 while AGO1 is an essential component of anti-viral RISCs (Várallyay et al.  
2010). Induction of mRNA accumulation is one step closer to high yields of protein 
expression. When co-infiltrated with other viral constructs, p19 was able to significantly 
enhance the expression levels of proteins of interest (Voinnet et al. 2003). Thus, the use of 
silencing suppressors is usually a primary consideration in the design of protein expression 
constructs. 
In addition, the aforementioned viral elements and viral constructs also co-operated in a 
unique system to empower the competency, flexibility and scalability of virus-based 
constructs for the expression of specific peptides and proteins. It is noteworthy that the 
synergism of TMV and PVX has been exploited to create a viral system which expresses a 
full sized, functional immunoglobulin G (IgG) (Giritch et al. 2006) and hybrid chimeric PVX 
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particles (Dickmeis et al. 2015). In the first example, TMV and PVX-based expression 
vectors were co-infected into N. benthamiana, via agroinfiltration. TMV and PVX vectors 
carried the heavy chain and light chain sequences of monoclonal antibody (mAb) A5, 
respectively, in place of viral CPs. When PVX CP was introduced by another vector, the 
expression level of mAb was maximized at up to 0.5 g/kg of leaf tissue fresh weight. Also, 
TMV MP was able to rescue cell-to-cell movement of CP-deleted PVX to certain levels, 
albeit less efficiently than PVX CP, itself. Together, the combination of two different, non-
competing viruses has facilitated the production of a full size mAb A5, subclass IgG1, which 
could not be achieved when using vectors based on the same virus, due to the dramatic 
reduction in expression. This research has built up a versatile platform which can express 
seven other functional mAbs of IgG1 and IgG2 classes in less than 14 dpi (Gleba et al. 2007). 
Recently, the same concept has been applied to co-express hybrid chimeric PVX vectors 
harbouring GFP and mCherry. The pPVX-GFP-2A-CP vector contained the full viral 
genome of PVX, GFP fused with F2A (GFP-2A) and flanked by the SGP of CP, and CP. The 
pTMV-mCherry-2A-CP PVX vector was constructed with the full genome of TMV, a fusion 
of mCherry, F2A and PVX CP flanked by duplicate TMV CP SGPs. Interestingly, PVX 
showed enhancement when co-infected with PVX and TMV, as documented previously 
(Goodman and Ross 1974). More than that, two large proteins (GFP and mCherry) were 
displayed on the hybrid chimeric PVX, as confirmed by fluorescence microscopy, electron 
microscopy and western blot analysis. 
Taken together, all these examples remarkably demonstrate the capacities and opportunities 
to manipulate the viral genome for expression purposes. Positive-sense RNA viruses 
constitute the vast majority of plant viruses (approximately 80%) and this fact drives the need 
for more intensive studies to help understand these viruses for beneficial uses in 
biotechnology (Mandahar 2006). The following description of three prominent virus genera 
will give us insights into their contribution to virus expression systems in plants. 
1.4 Comovirus 
The genus Comovirus belongs to the family Comoviridae, in the order Piconavirales. This 
genus has 15 species, including Bean pod mottle virus (BPMV), and the type species Cowpea 
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mosaic virus (CPMV). CPMV was first isolated from cowpeas (Vigna unguiculata) fifty-
eight years ago in Nigeria (Chant 1959). It can infect not only legume species, e.g. cowpea, 
bean, and soybean, but also the experimental plant, N. benthamiana. The virus genome is 
comprised of two positive-stranded RNAs, including RNA1 (5.9 kb) and RNA2 (3.5 kb), and 
encapsulated by an icosahedral-shaped capsid. Both RNAs are polyadenylated at the 3’ 
termini and have a small protein (Vpg) covalently linked to their 5’ ends. Both of the RNAs 
are translated as a single protein precursor and then proteolytically processed by viral 
protease to release mature proteins. RNA1 encodes five mature proteins: a proteinase 
cofactor (Co-pro), a helicase (Hel), a viral genome-linked protein, a proteinase (Pro), and the 
RNA-dependent RNA polymerase (RdRp), all of which are requisite to the replication of 
viral RNAs and polyprotein processing. Meanwhile, RNA2 codes for a replication cofactor 
(CR), a movement protein (MP), and two CPs, large CP (L-CP) and small CP (S-CP). As 
mentioned, the virus particle has an icosahedral shape, consisting of sixty copies each of the 
L-CP and S-CP. It has been shown that virus particles are involved in both local and systemic 
viral movement in plants and also in transmission by insect vectors (Wellink and van 
Kammen 1989). 
The development of CPMV-based expression vectors started with its first use, as a peptide 
display system in the 1990s (Porta et al. 1994; Usha et al. 1993). In this system, the virus was 
modified to carry short antigenic peptides, known as epitopes, on the surface of its capsids. 
Due to its three-dimensionally symmetric structure, CPMV became a successful carrier, as it 
could present multiple copies of epitopes to the immune system, and thus, enhance the 
immunogenicity of these vectors to work effectively as vaccines. In addition to its structure, 
the high titer of CPMV particles in plants (1-2 mg/g of leaf tissue fresh weight), and its non-
pathogenicity in mammalian cells, made CPMV a perfect candidate for an epitope 
presentation platform in terms of yield and biosafety. There are three sites where the epitope 
has been inserted into the CPMV coat protein, including the B-C loop of the S-CP (the 
predominant insert site) (Langeveld et al. 2001; McLain et al. 1996; Rennermalm et al.  
2001), the C’-C’’ loop of the S-CP (Taylor et al. 2000) and the E-B loop of the L-CP 
(Brennan et al. 1999). The first successful example of this system, in which no wild-type 
reversion was observed, was designed with the insertion at an optimal position in the B-C 
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loop of the S-CP between alanine 22 and proline 23, to maximize the exposure of epitopes on 
the virus surface and eliminate the recombination of repeating sequences (Porta et al. 1994). 
The virions displaying the NIm1A site from VP1 of the Human rhinovirus 14 (HRV-14) 
could provoke a response against the presenting epitope and showed the capability of 
modified CPMV chimeras as a novel vaccine. To date, accumulated experiments have 
confirmed that peptides containing less than 40 aa and having a pI lower than 9.0 could be 
successfully expressed by CPMV, with titres as high as that of wild-type viruses (Porta et al.  
2003). In addition to plant-made vaccines, CPMV can be decorated with inorganic 
compounds, e.g. silica or an iron-platinum alloy, which serve for applications in 
nanotechnology (Steinmetz et al. 2006; Steinmetz et al. 2009b).  
A variety of approaches, including gene substitution, gene insertion, deconstructed vectors 
and transgene combined virus vectors, have been used to modify CPMV as a gene expression 
system (Cañizares et al. 2006; Liu et al. 2005; Sainsbury et al. 2008a; Sainsbury et al.  
2008b). As a result, a powerful CPMV-based expression system, pEAQ-HT, which is widely 
used today, has been developed (Sainsbury et al. 2009). The pEAQ-HT system was designed 
based on the hyper-translatable (HT) elements of CPMV RNA2 and a modified 5’ UTR and 
3’ UTR. Deletion of the AUG codon at position 161, upstream of the AUG codon at position 
512, which is the main translational initiation site, enhanced the level of translation of the 
insert gene, e.g. GFP, at up to 25% of the total soluble protein (TSP), which was equivalent 
to 1.2 g/kg of leaf tissue fresh weight in transiently transformed N. benthamiana. The CPMV 
5’ UTR, which is lacking AUG 161, or both AUG 161 and AUG 115, was named the hyper-
translatable leader (HT leader) (Sainsbury and Lomonossoff 2008). The pEAQ-HT 
expression vector consists of an expression cassette which contains a region of insert genes 
and is flanked by the HT leader and the CPMV 3’UTR, and a p19 cassette. This single vector 
was then delivered into N. benthamiana by A. tumefaciens. Using this system, transient 
expression could produce a high level of proteins of interests in a matter of days, without the 
need for viral replication. Many series of this system have been created to achieve 
compatibility with both Gateway and traditional restriction enzyme-based cloning. This 
facilitates high-throughput cloning and protein expression within a short time frame. 
Moreover, this system was exploited to specifically express virus-like particles (VLPs) in N. 
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benthamiana for vaccine plants at up to 70 mg/kg of leaf biomass. For example, Bluetongue 
virus (BTV)-like particles were transiently expressed at 70 mg/kg leaf wet weight after two 
rounds of gradient centrifugation, when using pEAQ-HT combined with CPMV-HT 
(Thuenemann et al. 2013). BTV is the causal agent of bluetongue disease in ruminants, 
especially sheep and cattle. The symptoms include high fever, swelling face and tongue, 
cyanosis of the tongue, lameness, and infertility, all resulting in high morbidity and mortality. 
When tested in sheep, the plant-made BTV VLPs were able to elicit a strong immune 
response and provide protective immunity against a South African BTV-8 field isolate. These 
results showed that the pEAQ-HT system can efficiently produce VLPs for use as plant-made 
veterinary vaccines. This state-of-art system also provides a versatile tool for the production 
of CPMV capsids, without the RNA genome and this removes  concerns of biocontainment. 
These capsids may also work as templates for synthetic biology purposes. Since CPMV 
possesses an icosahedral shaped nanostructure, its outer surface can be modified to 
incorporate different functional moieties, e.g. biotin, redox-active compound, gold 
nanoparticles, etc., by chemical modification. The application of the resulting molecules 
could lead to highly beneficial advances in bio-nanotechnology (Saunders and Lomonossoff 
2013). For instance, gold nanoparticles anchored to a cysteine-substituted CPMV particle 
could be interconnected into a precise three-dimensional scaffold in order to generate 
nanoscale conductive networks (Blum et al. 2005). Together with other components, these 
particles could then form molecular electric circuits for nano-devices (Blum et al. 2007). 
More strikingly, even the empty CPMV, as nanoparticles alone, can contribute to cancer 
immunotherapy. A recent study demonstrated that CPMV inhalation could induce an 
antitumor response by activating neutrophils (Lizotte et al. 2016). Altogether, the pEAQ-HT 
system, which is based on the modified 5’ UTR of CPMV, has proven its efficacy in the high 
yield production of not only heterologous proteins, but also virus-like particles for multiple 
purposes in interdisciplinary applications. 
1.5 Tobamovirus 
The genus Tobamovirus is classified into the family Virgaviridae. This is the only genus of 
plant virus which has rigid, rod-shaped particles and a monopartite, positive-stranded RNA 
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genome. This genus includes approximately 35 species, such as Cucumber green mottle 
mosaic virus (CGMMV), and the type member Tobacco mosaic virus (TMV). The discovery 
of TMV, when Martinus W. Beijerinck proved that “contagium vivum fixum” (virus) was a 
new infectious agent involved in the mosaic disease of tobacco (Beijerinck 1898), has 
become a milestone, which marked the beginnings of virology. TMV has been the subject of 
intensive research for over a century. It has been a popular tool and model for plant biology, 
virology, plant virus disease studies, biochemistry, structural biology, and genetics, etc. 
(Scholthof 2004). Here, I will focus on its utility in molecular farming and nanotechnology.  
TMV possesses a wide host range, with at least 199 species from 30 plant families (Shew and 
Lucas 1991), including N. tabacum, N. glutinosa, and N. benthamiana, etc. The virus is 
transmitted mainly via the mechanical inoculation of sap from infected plants. The RNA 
genome of this virus is composed of approximately 6400 nucleotides (nt) (Goelet and Karn 
1982). It encodes two replicases, including a 126-kDa protein and a 186-kDa protein, a 30-
kDa movement protein (MP) and a 17.6-kDa coat protein (CP). The 186-kDa protein is 
produced by a translational readthrough past the amber stop codon (UAG), at the end of the 
126-kDa protein (Pelham 1978). The 126-kDa protein has methyltransferase and helicase 
motifs, whereas, the 186 kDa contains the RdRp. The MP and CP are translated from co-
terminal sg RNAs, sg RNA1 and sg RNA2, respectively. The 3’ end of the 186-kDa protein 
sequence overlaps the open reading frame (ORF) of the MP by 15 nt. The 5’ UTR of this 
genome is capped by a methyl guanine and contains a leader sequence, called the Ω 
sequence, which is believed to enhance translation of the downstream sequence (Gallie et al.  
1987). The 3’ UTR can form a tRNA-like structure. TMV was the first virus that had been 
visualized by electron microscopy (Kausche et al. 1939) and studied by X-ray 
crystallography (Watson 1954). A novel self- assembly between RNA and capsid protein was 
also revealed and this became a model for virus structure research. The virus particle has a 
hollow cylindrical shape that is approximately 300 nm long, 18 nm in diameter, contains a 4 
nm channel, and is composed of approximately 2130 subunits of coat protein (Caspar 1956; 
Franklin 1955; Watson 1954). Research has shown that the N-terminus, C-terminus and a 60s 
loop (between aa 55-60) are exposed on the viral surface and able to tolerate insertions. 
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However, the residues of aa 155-158 of the coat protein are somehow disordered (Namba and 
Stubbs 1986). These characteristics make TMV an attractive peptide display particle. 
TMV was the first plant virus to be engineered for molecular farming. It was modified to 
display an epitope of a type 3 poliovirus (Haynes et al. 1986). The epitope, which contains 
eight aa (Glu-Gln-Pro-Thr-Thr-Arg-Ala-Gln), plus two glycine residues, serving as a spacer, 
were inserted into the C-terminus of TMV CP and expressed in E. coli. Purified TMV-polio 
3 particles could induce anti-polio virus neutralizing antibodies when injected into rats. This 
success facilitated research for the improvement of TMV display system in plants, especially 
tobacco (N. tabacum). Turpen et al. successfully placed different epitopes of Plasmodium 
spp. into the surface loop region and at the C-terminus of the TMV CP, to produce malarial 
subunit vaccines in tobacco (Turpen et al. 1995). Epitopes of Plasmodium vivax, consisting 
of either four (BGC246) or 12 aa (BGC291), replaced two aa (Asp64 and Ser65), following 
Pro63, in the surface loop region of CP, by site-direct mutagenesis. Another epitope of P. 
yoelii (BGC261) was fused to the C-terminus of CP, after the readthrough stop codon 
context, “CARYYA”. The virus particles exhibiting BGC291 and BCG261 reacted with their 
specific monoclonal antibodies, whereas, the BGC246 did not. Virus particles were 
recovered in high yields from infected tobacco (var. Xanthi), at 0. 4 mg/g and 1.2 mg/g of leaf 
tissue fresh weight for BGC291 and BGC261, respectively. These examples demonstrate 
TMV as a competent epitope carrier for subunit vaccines. Simultaneous to the development 
of TMV peptide presentation system, the exploitation of TMV as a viral vector has also been 
rigorously investigated. 
The first TMV-based vector for heterologous protein expression in plants was developed by 
Takamatsu et al. (Takamatsu et al. 1990). They created a gene substitution vector in which 
the CP gene was substituted by a bacterial chloramphenicol acetyltransferase gene (CAT). 
Although initially CAT expression was low (1 g/g of leaf tissue), the low expression 
problem was later overcome through construct improvements. One of these was the modular 
system, MagnICON, which was based on TMV-deconstructed viral vectors developed by 
Icon Genetics (Halle, Germany). In this system, a series of constructs were made which 
contained different and separate modular genes, e.g. controlling elements, signal peptides, 
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gene of interest, purification tags, and cleavage motifs. These modules were delivered into 
plant cells by agroinfiltration, using different bacterial cultures containing each module of 
interest. For example, the 5’ module included the viral RdRp, MP, and sequences for the CP 
SGP and a recombination site. The 3’ module contained a recombination site sequence, the 
gene of interest (e.g. GFP), and the 3’ end of the viral vector (Marillonnet et al. 2004). When 
entering into plant cells together, these modules would assemble into a fully functional 
infective replicon of interest, via site-specific recombination. This approach provided a basis 
for the fast development and optimization of viral expression vectors. Moreover, removal of 
putative cryptic sites in the 5’ end of RdRp and the addition of introns in the RdRp and MP 
resulted in a 1000-fold increase in GFP expression (Marillonnet et al. 2005). This system was 
also competent when applied to whole plant transfection, named “magnifection”, by vacuum 
infiltration, which is being widely used in large-scale production of plant-made recombinant 
proteins. As the CP was completely omitted in MagnICON vectors, long distance movement 
of viruses was disabled, preventing systemic spread throughout plants and into t he 
environment, which is safer in terms of biosafety concerns.  As such, the MagnICON system 
has gained a reputation as a robust, versatile, time-saving and efficient modular viral 
platform to produce high yields of proteins of interest on an industrial scale. For example, the 
maximum yield of small Hepatitis B virus (HBV) surface antigen (S-HBsAg) was 
approximately 300 mg/kg of leaf tissue fresh weight in N. benthamiana, when using this 
platform in conjunction with vacuum infiltration (Huang et al. 2008). Interestingly, this 
protein was able to form VLPs displaying the correct conformation of the “a” antigenic 
determinant and used as an HBV vaccine. Similar to CPMV, the nanostructure of TMV has 
recently been manipulated for bio-nanotechnology. TMV has been used as a scaffold, where 
a variety of metals (e.g. gold, silver, nickel, etc.), glass, silicon wafers or biotin adhere to its 
interior or outer surfaces, resulting in the large-scale assembly of molecules which can form 
nanowires, thin film coatings, order fibers and labeling particles. Moreover, Czapar et al.  
have reported the use of TMV as a drug delivery system for cancer therapy (Czapar et al. 
2016). Essentially, phenanthriplatin, which is a platinum-based anticancer agent, was 
chemically conjugated into the 4 nm wide central channel of TMV to generate TMV-
encapsulated phenanthriplatin (PhenPt-TMV). Subsequently, the resulting PhenPt-TMV was 
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injected into mice with breast cancer. Mice treated with PhenPt-TMV showed up to a 
fourfold increase in tumor reduction when compared to control mice.  
1.6 Potexvirus 
As a genus of the family Alphaflexiviridae, Potexvirus includes more than 47 species, e.g. 
Pepino mosaic virus (PepMV), Foxtail mosaic virus (FoMV), Bamboo mosaic virus 
(BaMV), and Potato virus X (PVX). The type member of this genus is PVX, which mainly 
infects herbaceous plants, especially the Solanaceace family. PVX is characterized by a non-
enveloped and flexible filamentous virion, approximately 470- 580 nm in length and 13 nm 
in diameter, which consists of 1270 CP subunits (Tollin and Wilson 1988). The genome is a 
monopartite, single stranded and positive-sense RNA that is 6.4 kb (Huisman et al. 1988), 
which encodes five open reading frames (ORFs): the RdRp, the triple gene block (TGB), 
which is formed by three overlapping ORFs (TGBp1-3), and the CP. The mature proteins of 
TGB and CP are translated from subgenomic RNAs (sg RNAs) in which the sg RNA1 
encodes TGBp1, sg RNA2 for TGBp2-3, and sg RNA3 for CP, respectively. The genome 
and sg RNAs are capped with methyl-guanosine at the 5’ end and polyadenylated at the 3’ 
end. The RdRp is involved in viral replication and RNA capping (Huisman et al. 1988), 
whereas, the TGB has multiple functions, the ma jority of which involve virus replication, 
virus movement, translational activation, and gene silencing in plants (Angell et al. 1996; 
Davenport and Baulcombe 1997; Howard et al. 2004; Kalinina et al. 2002; Karpova et al.  
2006; Voinnet et al. 2000). The CP is an essential requirement for long-distance viral 
movement, but is dispensable for cell-to-cell movement (Betti et al. 2012).  
In contrast to CPMV and TMV, crystallographic data on the exposed regions of PVX CP, 
which display on the surface of virus particles, has yet to be fully detailed (Steinmetz et al.  
2010). However, previous studies have shown that the N-terminus of CP was exposed on the 
external surface of PVX virions (Baratova et al. 1992). Thus, several epitopes have been 
fused to this region of the CP in order to form chimeric particles for vaccine production. For 
example, a neutralizing epitope (Glu-Leu-Asp-Lys-Trp-Ala), derived from glycoprotein 41 
of the Human immunodeficiency virus type 1 (HIV-1), was presented on PVX virions, via 
this method (Marusic et al. 2001). Mice immunized with the resulting chimeric virus 
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particles (CVPs) showed a neutralizing activity against HIV-1. Moreover, CVPs were able to 
evoke the mucosa-associated immune system into production of antigen-specific antibodies, 
when delivered intranasally without adjuvants. In the other words, chimeric PVX presenting 
a neutralizing epitope is a potential novel candidate in the fight against HIV. 
The development of viral expression vectors based on PVX has drawn scientist’s attention, 
not only as a tool for plant-made recombinant proteins, but also for studies of virus 
movement (Baulcombe et al. 1995; Chapman et al. 1992; Cruz et al. 1996). There have been 
two main strategies to generate PVX-based vectors: (1) Addition of an extra SGP of CP 
upstream of the gene of interest (GOI), both of which are then inserted between the MP 
sequence and the SGP of CP; (2) Introduction of the F2A between the GOI and CP, which 
are then placed downstream of the subgenomic promoter of CP. Both formats have been 
widely used. The first method is freely accessible for researchers through The Sainsbury 
Laboratory (http://www.ayeaye.tsl.ac.uk/) and serves as a valuable experimental tool for both 
over-expression and virus-induced gene silencing (VIGS). More interestingly, the second 
strategy, called the OVERCOAT system, has been exploited to produce chimeric virus 
particles presenting peptides and proteins of interest, the size of which can be as large as GFP 
(25 kDa) (Cruz et al. 1996). One obstacle to the virus presentation system is size limitations 
of the insert in order to maintain the correct virus assembly and prevent wild-type reversion 
(Bendahmane et al. 2000). The OVERCOAT system has been adapted to overcome this 
obstacle. In this system, F2A sequence has been introduced between the GOI and the CP. 
During translation, F2A- mediated cleavage help the detachment of foreign proteins from the 
CP. However, incomplete cleavage also happens at a low rate, and results in a fusion of the 
CP and a foreign protein, called heterologous CP. Subsequently, the heterologous CPs 
assemble with the CP to form fully functional CVPs. This allows foreign proteins to be 
presented at the outer surface of CVPs without steric hindrance. O’Brien et al. have 
successfully produced a PVX decorated with viral protein 6 (VP6) of rotavirus, using this 
system (O'Brien et al. 2000). The size of the VP6 in this study was approximately 46 kDa. In 
addition to chimeric PVX, unfused VP6 also formed icosahedral virus-like particles (VLPs), 
in a ratio of 1:50, when compared to the recombinant PVX. Another adapted system was also 
employed to express a long peptide (70 residues) of E2, the most immunogenic envelope 
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glycoprotein of Classic swine fever virus (CSFV), on the surface of PVX, based on F2A 
cleavage (Marconi et al. 2006). Partially purified chimeric PVX showed the capability to 
induce anti-E2 antibodies when rabbits were immunized. These two examples have shown 
the vast potential of PVX-based expression systems as a platform to facilitate the production 
of VLPs and chimeric PVX in plants for vaccine development. 
The PVX-based system has also been explored for cancer vaccine development. The system 
has been shown with capacity to deliver both tumor antigen sequences and activating genes 
to enhance immune responses against tumor cells. Savelyeva et al. reported that p.scFv-
PVXCP, in which single-chain Fv (scFv), a weak tumor antigen of B-cell malignancies, was 
fused with the PVX CP sequence (Savelyeva et al. 2001). The p.scFv-PVXCP was able to 
promote a distinct CD4+ T-cell-mediated protective immunity, by attacking B-cell tumors in 
mice, whereas, p.scFv, containing only scFv, failed to generate a significant immune 
response. PVX has also been applied into biomedicines, as a prophylactic vaccine against 
breast cancer. Human epidermal growth factor receptor 2 (HER2) is an antigen associated 
with tumors found in HER2-breast cancer, which has been traditionally associated with poor 
prognoses and a high rate of metastasis. Passive immunotherapy with Trastuzumab, a 
monoclonal antibody which binds to HER2, cannot protect patients from metastasis or 
recurrence, whereas, a cancer vaccine has the potential to do this. Successful administration 
of prophylactic vaccines in high risk groups may also lighten the financial burden of 
intensive treatments (chemotherapy, hormone replacement therapy, etc.). Shukla et al. have 
developed a PVX-based HER2 platform for a breast cancer vaccine (Shukla et al. 2014). A 
B-cell epitope of HER2, called P4 (containing 21 residues), was coupled to the external 
surface of PVX, via chemical ligation, to create the chimeric PVX-P4. Mice immunized with 
purified PVX-P4 demonstrated the generation of HER2-specific antibodies and different 
IgGs (e.g. IgG2a, IgG2b and IgG1), in which IgG2a and IgG2b were believed to inhibit 
tumors and IgG1 could be involved in triggering immune responses. Through these studies, 
the PVX-derived system proves as powerful as its peers (e.g. CPMV, TMV) in the 
development of vaccines, giving promise for the development of efficient vaccines in the 
fight against a variety of diseases.  
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1.7 Research goals and objectives 
As discussed briefly above, the costs associated with PRRS have been devastating the swine 
industry worldwide, and an effective therapy against this disease is highly demanded. In view 
of the advantages of plant-made vaccines and viral vectors, I proposed to develop a plant 
virus-based expression system for plant-made vaccine against PRRSV. In this thesis, 
different approaches were investigated for the construction of viral vectors expressing GP5-
based subunit vaccines in several plant species, such as soybean, cucumber and N. 
benthamiana. The vaccine products from soybean and cucumber may be directly 
administered to pigs by oral route. The specific objectives of this project include: 
1. Construction of BPMV-based expression vectors for GP5 production in soybean. This 
study aimed to produce and characterize the expression of GP5 in two moieties, GP5N 
and GP5C, using viral vectors. 
2. Construction of a CGMMV-based expression vector for neutralizing epitope 
production in cucumber and N. benthamiana. This study aimed to investigate the 
characterization of chimeric CGMMV presenting GP5 neutralizing epitopes in 
cucumber and N. benthamiana. 
3. Construction of a PepMV-based expression vector for GP5 expression in N. 
benthamiana. In this study, the modified GP5 was co-expressed with GFP in N. 
benthamiana. 
4. Evaluation of recombinant protein expression in soybean, N. benthamiana and 
cucumber.
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Type  System Vector Protein Level Model Dose  Response Reference 
Transgenic 
plant 
Tobacco  
N. tabacum 
pGKU-
35PRRSV 
GP5 0.011% TSP 
 (~110 ng/g 
fresh weight 
of leaf 
tissue). 
pigs Feed 50 g 
leaves/pig for 
4 times.  
- Serum NA 
was detected 
at 48 DPIOV 
(3/6 pigs). 
 
- Specific 
mucosal and 
systemic 
humoral and 
cellular 
responses 
were 
induced. 
Chia et al. 
2010 
Transgenic 
plant 
Tobacco  
N. tabacum 
pGKU-
LBT-ORF5  
LTB-GP5 GP5: 155 
ng/g fresh 
weight of leaf 
tissue. 
pigs Feed 35.2 g 
leaves LTB-
GP5/pig for 3 
times. 
- NA was 
higher. 
 
- Specific 
mucosal and 
systemic 
humoral and 
cellular 
responses 
were 
induced. 
 
- Viral load 
decreased in 
3 weeks post  
inoculation. 
 
Chia et al. 
2011 
 
Table 1.1:  Plant-made vaccines based on GP5 of PRRSV 
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Transgenic 
plant 
Potato  pBI121 GP5 Leaf: 2.5-4.7 
g/g fresh 
weight. 
Tuber: 0.8-
1.2 g/g 
fresh weight. 
mice Intragastrically 
deliver 0.5ml 
transgenic 
potato tuber 
extract /pig      
(~0.3g GP5)   
for 4 times. 
- NA was 
detected (2/8 
mice). 
 
- Specific 
mucosal and 
systemic 
humoral, and 
cellular 
responses 
were 
induced. 
 
Chen and 
Liu 2011 
Transgenic 
plant 
Tobacco  
N. tabacum 
pCaMteX 
AMV  
CTB-GP5 
and 
CTB-GP5-
NEabc 
CTB-GP5: 
Not detected 
by western 
blot. 
CTB-
GP5NEabc 
0.003-
0.087% TSP. 
- - - GM1 
ELISA 
binding 
assay.  
Wang et 
al. 2011 
Transgenic 
plant 
Banana leaf, Pei 
chiao AAA 
pGKU-
35PRRSV 
GP5 0.021-
0.037% TSP 
~157-257 
ng/g fresh 
weight of leaf 
tissue. 
pigs Feed 50g 
leaves/pig      
(~ 7.7-12.9 g 
GP5) for 3 
times. 
- Specific 
mucosal and 
systemic 
humoral and 
cellular 
responses 
were 
induced. 
 
 
Chan et al. 
2013 
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- Viremia and 
tissue viral 
load was 
lower. 
Transgenic 
plant 
Arabidopsis 
seed 
pPphasGW GP5,  
GP5-Tm 
and GP5-
Tm:pFc 
GP5 or GP5-
Tm: 0.1% 
TSP. 
GP5-Tm:pFc: 
0.83% TSP 
~2.3 mg/g 
seed weight. 
 
mice Inject mice 
cocktail of 100 
g each 
GP5/GP4/GP3
-Tm:pFc 
purified  for  2 
times. 
- Antigen 
specific 
antibody but 
no 
neutralizing 
activity in 
sera was 
detected. 
Piron et al. 
2014 
Transient 
expression 
N. silvestris pICH series  GP5-M 
and GP5-T 
VLP 
qRT-PCR 
and TEM. 
mice 
and 
pigs in 
future 
- - Uribe-
Campero 
et al. 2015 
Transient 
expression 
N. benthamiana pEAQ-HT GP5synt 5 mg/kg fresh 
weight of leaf 
tissue. 
- - - CORDIS 
2015 
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“-“: Not reported 
NA: Neutralizing antibody 
LTB: Subunit B of E.coli heat-labile enterotoxin 
CTB:  Cholera toxin subunit B 
DPIOV:  Days post-initial oral vaccination 
VLP: Virus-like particle 
TEM:  Transmission electron microscopy 
qRT-PCR: Quantitative reverse transcription polymerase chain 
reaction 
  
32 
 
 
 
1.8  References 
Allende, R., Lewis, T. L., Lu, Z., Rock, D. L., Kutish, G. F., Ali, A., Doster, A. R. and 
Osorio, F. A. 1999. North American and European porcine reproductive and 
respiratory syndrome viruses differ in non-structural protein coding regions. J Gen 
Virol 80(2):307-315. 
Alonso, J. M., Górzny, M. L. and Bittner, A. M. 2013 . The physics of tobacco mosaic 
virus and virus-based devices in biotechnology. Trends Biotechnol 31(9):530-538. 
An, T. Q., Tian, Z. J., Xiao, Y., Li, R., Peng, J. M., Wei, T. C., Zhang, Y., Zhou, Y. J. 
and Tong, G. Z. 2010. Origin of highly pathogenic porcine reproductive and 
respiratory syndrome virus, China. Emerg Infect Dis 16(2):365-367. 
Angell, S. M., Davies, C. and Baulcombe, D. C. 1996 . Cell-to-cell movement of potato 
virus X is associated with a change in the size-exclusion limit of plasmodesmata in 
trichome cells of Nicotiana clevelandii. Virology 216(1):197-201. 
Assaad, F. F. and Signer, E. R. 1990. Cauliflower mosaic virus P35S promoter activity in 
Escherichia coli. Mol Gen Genet 223(3):517-520. 
Bachmann, M. F. and Jennings, G. T. 2010. Vaccine delivery: A matter of size, geometry, 
kinetics and molecular patterns. Nat Rev Immunol 10(11):787-796. 
Baker, S. R., Mondaca, E., Polson, D. and Dee, S. A. 2012 . Evaluation of a needle-free 
injection device to prevent hematogenous transmission of porcine reproductive and 
respiratory syndrome virus. J Swine Health Prod 20(3):123-128. 
Baratova, L. A., Grebenshchikov, N. I., Dobrov, E. N., Gedrovich, A. V., Kashirin, I. A., 
Shishkov, A. V., Efimov, A. V., Järvekülg, L., Radavsky, Y. L. and Saarma, M. 
1992. The organization of potato virus X coat proteins in virus particles studied by 
tritium planigraphy and model building. Virology 188(1):175-180. 
Barta, A., Sommergruber, K., Thompson, D., Hartmuth, K., Matzke, M. A. and 
Matzke, A. J. M. 1986. The expression of a nopaline synthase - human growth 
hormone chimaeric gene in transformed tobacco and sunflower callus tissue. Plant 
Mol Biol 6(5):347-357. 
Bastos, R. G., Dellagostin, O. A., Barletta, R. G., Doster, A. R., Nelson, E. and Osorio, F. 
A. 2002. Construction and immunogenicity of recombinant Mycobacterium bovis 
BCG expressing GP5 and M protein of porcine reproductive respiratory syndrome 
virus. Vaccine 21(1-2):21-29. 
Baulcombe, D. C., Chapman, S. and Santa Cruz, S. 1995. Jellyfish green fluorescent 
protein as a reporter for virus infections. Plant J 7(6):1045-1053. 
Beijerinck, M. W. 1898 [1968]. Concerning a contagium vivum fluidum as cause of the spot 
disease of tobacco leaves. In Phytopathological Classics, Number 7, ed. Johnson, J., 
pp 33-52. APS Press, St. Paul, MN, USA. 
Bendahmane, A., Querci, M., Kanyuka, K. and Baulcombe, D. C. 2000 . Agrobacterium 
transient expression system as a tool for the isolation of disease resistance genes: 
application to the Rx2 locus in potato. Plant J 21(1):73-81. 
Benfield, D. A., Nelson, E. and Robison, D. 1992. Characterization of swine infertility and 
respiratory syndrome (SIRS) virus (isolate ATCC VR-2332). J Vet Diagn Invest 
4(2):127-133. 
33 
 
 
 
Betti, C., Lico, C., Maffi, D., D'Angeli, S., Altamura, M. M., Benvenuto, E., Faoro, F. 
and Baschieri, S. 2012. Potato virus X movement in Nicotiana benthamiana: New 
details revealed by chimeric coat protein variants. Mol Plant Pathol 13(2):198-203. 
Bierk, M. D., Dee, S. A., Rossow, K. D., Otake, S., Collins, J. E. and Molitor, T. W. 
2001. Transmission of porcine reproductive and respiratory syndrome virus from 
persistently infected sows to contact controls. Can J Vet Res 65(4):261-266. 
Binjawadagi, B., Lakshmanappa, Y. S., Longchao, Z., Dhakal, S., Hiremath, J., 
Ouyang, K., Shyu, D. L., Arcos, J., Pengcheng, S., Gilbertie, A. and others. 2016 . 
Development of a porcine reproductive and respiratory syndrome virus-like-particle-
based vaccine and evaluation of its immunogenicity in pigs. Arch Virol 161(6):1579-
1589. 
Blum, A. S., Soto, C. M., Wilson, C. D., Amsinck, C., Franzon, P. and Ratna, B. R. 2007 . 
Electronic properties of molecular memory circuits on a nanoscale scaffold. IEEE 
Trans Nanobioscience 6(4):270-274. 
Blum, A. S., Soto, C. M., Wilson, C. D., Brower, T. L., Pollack, S. K., Schull, T. L., 
Chatterji, A., Lin, T., Johnson, J. E., Amsinck, C. and others. 2005 . An 
engineered virus as a scaffold for three-dimensional self-assembly on the nanoscale. 
Small 1(7):702-706. 
Bøtner, A., Strandbygaard, B., Sørensen, K. J., Have, P., Madsen, K. G., Madsen, E. S. 
and Alexandersen, S. 1997. Appearance of acute PRRS-like symptoms in sow herds 
after vaccination with a modified live PRRS vaccine. Vet Rec 141(19):497-499. 
Brennan, F. R., Jones, T. D., Gilleland, L. B., Bellaby, T., Xu, F., North, P. C., 
Thompson, A., Staczek, J., Lin, T., Johnson, J. E. and others. 1999. Pseudomonas 
aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when 
expressed on a plant virus. Microbiology 145(1):211-220. 
Brisson, Y. 2014. The changing face of the Canadian hog industry. http://www.statcan.gc.ca/ 
pub/ 96-325-x/ 2014001/article/14027-eng.htm. 
Brockmeier, S.L., Halbur, P.G. and Thacker, E.L. 2002 . Porcine respiratory disease 
complex. In Polymicrobial  Diseases, ed. Brogden, K. A.,  and Guthmiller, J. M., pp 
231–258. ASM Press, Washington (DC), USA. 
Cañizares, M. C., Liu, L., Perrin, Y., Tsakiris, E. and Lomonossoff, G. P. 2006 . A 
bipartite system for the constitutive and inducible expression of high levels of foreign 
proteins in plants. Plant Biotechnol J 4(2):183-193. 
Cano, J. P., Dee, S. A., Murtaugh, M. P. and Pijoan, C. 2007a. Impact of a modified-live 
porcine reproductive and respiratory syndrome virus vaccine intervention on a 
population of pigs infected with a heterologous isolate. Vaccine 25(22):4382-4391. 
Cano, J. P., Dee, S. A., Murtaugh, M. P., Trincado, C. A. and Pijoan, C. B. 2007b. Effect 
of vaccination with a modified-live porcine reproductive and respiratory syndrome 
virus vaccine on dynamics of homologous viral infection in pigs. Am J Vet Res 
68(5):565-571. 
Carman, S., Sanford, S. E. and Dea, S. 1995 . Assessment of seropositivity to porcine 
reproductive and respiratory syndrome (PRRS) virus in swine herds in Ontario-1978 
to 1982. Can Vet J 36(12):776-777. 
Caspar, D. L. D. 1956. Structure of tobacco mosaic virus: Radial density distribution in the 
tobacco mosaic virus particle. Nature 177(4516):928. 
34 
 
 
 
Cavanagh, D. 1997. Nidovirales: a new order comprising Coronaviridae and Arteriviridae. 
Arch Virol 142(3):629-633. 
Chan, H. T., Chia, M. Y., Pang, V. F., Jeng, C. R., Do, Y. Y. and Huang, P. L. 2013. Oral 
immunogenicity of porcine reproductive and respiratory syndrome virus antigen 
expressed in transgenic banana. Plant Biotechnol J 11(3):315-324 
Chant, S. R. 1959. Viruses of Cowpea, Vigna Unguiculata L. (Walp.), in Nigeria. Ann App 
Biol 47(3):565-572. 
Chapman, S., Kavanagh, T. and Baulcombe, D. 1992 . Potato virus X as a vector for gene 
expression in plants. Plant J 2(4):549-557. 
Chen, Q. and Lai, H. 2013. Plant-derived virus-like particles as vaccines. Hum Vaccin 
Immunother 9(1):26-49. 
Chen, X. and Liu, J. 2011. Generation and immunogenicity of transgenic potato expressing 
the GP5 protein of porcine reproductive and respiratory syndrome virus. J Virol 
Methods 173(1):153-158. 
Chia, M. Y., Hsiao, S. H., Chan, H. T., Do, Y. Y., Huang, P. L., Chang, H. W., Tsai, Y. 
C., Lin, C. M., Pang, V. F. and Jeng, C. R. 2010 . Immunogenicity of recombinant 
GP5 protein of porcine reproductive and respiratory syndrome virus expressed in 
tobacco plant. Vet Immunol Immunopathol 135(3-4):234-242. 
Chia, M. Y., Hsiao, S. H., Chan, H. T., Do, Y. Y., Huang, P. L., Chang, H. W., Tsai, Y. 
C., Lin, C. M., Pang, V. F. and Jeng, C. R. 2011 . Evaluation of the immunogenicity 
of a transgenic tobacco plant expressing the recombinant fusion protein of GP5 of 
porcine reproductive and respiratory syndrome virus and B subunit of Escherichia 
coli heat-labile enterotoxin in pigs. Vet Immunol Immunopathol 140(3-4):215-225. 
Cleveland, S. M., Buratti, E., Jones, T. D., North, P., Baralle, F., McLain, L., 
McInerney, T., Durrani, Z. and Dimmock, N. J. 2000 . Immunogenic and antigenic 
dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope 
in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: Its 
deletion leads to a strong neutralizing response. Virology 266(1):66-78. 
Community Research and Development Information Service (CORDIS). 2015. 
http://cordis. europa.eu/result/rcn/162494_en.html   
Cruz, S. S., Chapman, S., Roberts, A. G., Roberts, I. M., Prior, D. A. M. and Oparka, 
K. J. 1996. Assembly and movement of a plant virus carrying a green fluorescent 
protein overcoat. Proc Natl Acad Sci USA 93(13):6286-6290. 
Czapar, A. E., Zheng, Y. R., Riddell, I. A., Shukla, S., Awuah, S. G., Lippard, S. J. and 
Steinmetz, N. F. 2016. Tobacco Mosaic Virus Delivery of Phenanthriplatin for 
Cancer therapy. ACS Nano 10(4):4119-4126. 
Davenport, G. F. and Baulcombe, D. C. 1997. Mutation of the GKS motif of the RNA-
dependent RNA polymerase from potato virus X disables or eliminates virus 
replication. J Gen Virol 78(6):1247-1251. 
Dea, S., Gagnon, C. A., Mardassi, H., Pirzadeh, B. and Rogan, D. 2000 . Current 
knowledge on the structural proteins of porcine reproductive and respiratory 
syndrome (PRRS) virus: comparison of the North American and European isolates. 
Arch Virol 145(4):659-688. 
Delputte, P. L. and Nauwynck, H. J. 2004 . Porcine arterivirus infection of alveolar 
macrophages is mediated by sialic acid on the virus. J Virol 78(15):8094-8101. 
35 
 
 
 
Dickmeis, C., Honickel, M. M., Fischer, R. and Commandeur, U. 2015 . Production of 
Hybrid Chimeric PVX Particles Using a Combination of TMV and PVX-Based 
Expression Vectors. Front Bioeng Biotechnol 3:189. 
Duran, J. P., Climent, I., Sarraseca, J., Urniza, A., Cortés, E., Vela, C. and Casal, J. I. 
1997. Baculovirus expression of proteins of porcine reproductive and respiratory 
syndrome virus strain Olot/91. Involvement of ORF3 and ORF5 proteins in 
protection. Virus Genes 14(1):19-29. 
Eck, M., Duran, M. G., Ricklin, M. E., Locher, S., Sarraseca, J., Rodriguez, M. J., 
McCullough, K. C., Summerfield, A., Zimmer, G. and Ruggli, N. 2016 . Virus 
replicon particles expressing porcine reproductive and respiratory syndrome virus 
proteins elicit immune priming but do not confer protection from viremia in pigs. Vet 
Res 47:33. 
Fang, Y., Treffers, E. E., Li, Y., Tas, A., Sun, Z., Van Der Meer, Y., De Ru, A. H., Van 
Veelen, P. A., Atkins, J. F., Snijder, E. J. and others. 2012. Efficient - 2 
Frameshifting by mammalian ribosomes to synthesize an additional arterivirus 
protein. Proc Natl Acad Sci USA 109(43):E2920-E2928. 
Farm Credit Canada. 2012. Pork facts. https://www.fcc-fac.ca/fcc/agKnowledge/ 
publications/ag-sector-guides/pdfs/pork-facts.pdf 
Franklin, R. E. 1955. Structure of tobacco mosaic virus. Nature 175(4452):379-381. 
Gallie, D. R. 2001. Cap-independent translation conferred by the 5′ leader of tobacco etch 
virus is eukaryotic initiation factor 4G dependent. J Virol 75(24):12141-12152. 
Gallie, D. R., Sleat, D. E., Watts, J. W., Turner, P. C. and Wilson, T. A. 1987. The 5'-
leader sequence of tobacco mosaic virus RNA enhances the expression of foreign 
gene transcripts in vitro and in vivo. Nucleic Acids Res 15(8):3257-3273. 
Gao, J., Ji, P., Zhang, M., Wang, X., Li, N., Wang, C., Xiao, S., Mu, Y., Zhao, Q., Du, T. 
and others. 2014. GP5 expression in Marc-145 cells inhibits porcine reproductive 
and respiratory syndrome virus infection by inducing beta interferon activity. Vet 
Microbiol 174(3-4):409-418. 
Giddings, G., Allison, G., Brooks, D. and Carter, A. 2000 . Transgenic plants as factories 
for biopharmaceuticals. Nature Biotechnol 18(11):1151-1155. 
Giritch, A., Marillonnet, S., Engler, C., Van Eldik, G., Botterman, J., Klimyuk, V. and 
Gleba, Y. 2006. Rapid high-yield expression of full-size IgG antibodies in plants 
coinfected with noncompeting viral vectros. Proc Natl Acad Sci USA 103(40):14701-
14706. 
Gleba, Y., Klimyuk, V. and Marillonnet, S. 2007. Viral vectors for the expression of 
proteins in plants. Curr Opin Biotechnol 18(2):134-141. 
Gleba, Y., Marillonnet, S. and Klimyuk, V. 2004 . Engineering viral expression vectors for 
plants: the 'full virus' and the 'deconstructed virus' strategies. Curr Opin P lant Biol 
7(2):182-188. 
Goelet, P. and Karn, J. 1982. Tobacco mosaic virus induces the synthesis of a family of 3′ 
coterminal messenger RNAs and their complements. J Mol Biol 154(3):541-550. 
Gonin, P., Pirzadeh, B., Gagnon, C. A. and Dea, S. 1999. Seroneutralization of porcine 
reproductive and respiratory syndrome virus correlates with antibody response to the 
GP5 major envelope glycoprotein. J Vet Diagn Invest 11(1):20-26. 
36 
 
 
 
Goodman, R. M. and Ross, A. F. 1974. Independent assembly of virions in tobacco doubly 
infected by potato virus X and potato virus Y or tobacco mosaic virus. Virology 
59(1):314-318. 
Gopinath, K., Wellink, J., Porta, C., Taylor, K. M., Lomonossoff, G. P. and Van 
Kammen, A. 2000. Engineering cowpea mosaic virus RNA-2 into a vector to express 
heterologous proteins in plants. Virol J 267(2):159-173. 
Gutiérrez, S. and Menassa, R. 2014. Protein body-inducing fusions for recombinant protein 
production in plants. In Plant-derived Pharmaceuticals: Principles and Applications 
for Developing Countries, ed. Hefferon, K. L., pp 9-19. CABI International, Boston, 
MA, USA. 
Haynes, J. R., Cunningham, J., Von Seefried, A., Lennick, M., Garvin, R. T. and Shen, 
S. H. 1986. Development of a genetically-engineered, candidate polio vaccine 
employing the self-assembling properties of the tobacco mosaic virus coat protein. 
Nat Biotechnol 4(7):637-641. 
Hefferon, K. 2014. Plant virus expression vector development: new perspectives. Biomed 
Res Int 2014:785382. 
Hefferon, K. L. 2012. Plant virus expression vectors set the stage as production platforms 
for biopharmaceutical proteins. Virology 433(1):1-6. 
Hermann, J. R., Muñoz-Zanzi, C. A. and Zimmerman, J. J. 2009. A method to provide 
improved dose-response estimates for airborne pathogens in animals: An example 
using porcine reproductive and respiratory syndrome virus. Vet Microbiol 
133(3):297-302. 
Holtkamp, D. J., Kliebenstein, J. B., Neumann, E. J., Zimmerman, J. J., Rotto, H. F., 
Yoder, T. K., Wang, C., Yeske, P. E., Mowrer, C. L. and Haley, C. A. 2013 . 
Assessment of the economic impact of porcine reproductive and respiratory syndrome 
virus on United States pork producers. J Swine Health Prod 21(2):72-84. 
Honey, J. 2016. Manitoba pigs and pork profile. https://umanitoba.ca/faculties/afs/dept/ 
agribusiness/media/pdf/manitoba_pig_and_pork_profile_2015.pdf. 
Howard, A. R., Heppler, M. L., Ju, H. J., Krishnamurthy, K., Payton, M. E. and 
Verchot-Lubicz, J. 2004. Potato virus X TGBp1 induces plasmodesmata gating and 
moves between cells in several host species whereas CP moves only in N. 
benthamiana leaves. Virology 328(2):185-197. 
Hu, G., Wang, N., Yu, W., Wang, Z., Zou, Y., Zhang, Y., Wang, A., Deng, Z. and Yang, 
Y. 2016. Generation and immunogenicity of porcine circovirus type 2 chimeric virus-
like particles displaying porcine reproductive and respiratory syndrome virus GP5 
epitope B. Vaccine 34(16):1896-1903. 
Hu, J., Ni, Y., Meng, X. J. and Zhang, C. 2012 . Expression and purification of a chimeric 
protein consisting of the ectodomains of M and GP5 proteins of porcine reproductive 
and respiratory syndrome virus (PRRSV). J Chromatogr B: Analyt Technol Biomed 
Life Sci 911:43-48. 
Huang, Z., LePore, K., Elkin, G., Thanavala, Y. and Mason, H. S. 2008. High-yield rapid 
production of hepatitis B surface antigen in plant leaf by a viral expression system. 
Plant Biotechnol J 6(2):202-209. 
37 
 
 
 
Huisman, M. J., Linthorst, H. J., Bol, J. F. and Cornelissen, J. C. 1988 . The complete 
nucleotide sequence of potato virus X and its homologies at the amino acid level with 
various plus-stranded RNA viruses. J Gen Virol 69(Pt 8):1789-1798. 
Jiang, Y., Xiao, S., Fang, L., Yu, X., Song, Y., Niu, C. and Chen, H. 2006 . DNA vaccines 
co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome 
virus (PRRSV) display enhanced immunogenicity. Vaccine 24(15):2869-2879. 
Jung, H. S., Hwang, I. W., Kim, S. M., Kim, C. J., Shin, K. S. and Kim, H. S. 2002 . 
Expression of open reading frame 5 protein of porcine reproductive and respiratory 
syndrome virus using semliki forest virus expression system. J Vet Sci 3(1):13-18. 
Kalinina, N. O., Rakitina, D. V., Solovyev, A. G., Schiemann, J. and Morozov, S. Y. 
2002. RNA helicase activity of the plant virus movement proteins encoded by the first 
gene of the triple gene block. Virology 296(2):321-329. 
Karniychuk, U. U., Geldhof, M., Vanhee, M., Van Doorsselaere, J., Saveleva, T. A. and 
Nauwynck, H. J. 2010. Pathogenesis and antigenic characterization of a new East 
European subtype 3 porcine reproductive and respiratory syndrome virus isolate. 
BMC Vet Res 6:30. 
Karpova, O. V., Zayakina, O. V., Arkhipenko, M. V., Sheval, E. V., Kiselyova, O. I., 
Poljakov, V. Y., Yaminsky, I. V., Rodionova, N. P., Atabekov, J. G. and 
Atabekov, J. G. 2006. Potato virus X RNA-mediated assembly of single-tailed 
ternary 'coat protein-RNA-movement protein' complexes. J Gen Virol 87(9):2731-
2740. 
Kausche, G. A., Pfankuch, E. and Ruska, H. 1939 . Die Sichtbarmachung von pflanzlichem 
Virus im Übermikroskop. Die Naturwissenschaften 27(18):292-299. 
Keffaber, KK. 1989. Reproductive failure of unknown etiology. Am Assoc Swine Pract 
Newl 1:1-10. 
Key, K. F., Guenette, D. K., Yoon, K. J., Halbur, P. G., Toth, T. E. and Meng, X. J. 
2003. Development of a heteroduplex mobility assay to identify field isolates of 
porcine reproductive and respiratory syndrome virus with nucleotide sequences 
closely related to those of modified live-attenuated vaccines. J Clin Microbiol 
41(6):2433-2439. 
Kim, H., Kim, H. K., Jung, J. H., Choi, Y. J., Kim, J., Um, C. G., Hyun, S. B., Shin, S., 
Lee, B., Jang, G. and others. 2011. The assessment of efficacy of porcine 
reproductive respiratory syndrome virus inactivated vaccine based on the viral 
quantity and inactivation methods. Virol J 8:323-334. 
Langeveld, J. P. M., Brennan, F. R., Martínez-Torrecuadrada, J. L., Jones, T. D., 
Boshuizen, R. S., Vela, C., Casal, J. I., Kamstrup, S., Dalsgaard, K., Meloen, R. 
H. and others. 2001. Inactivated recombinant plant virus protects dogs from a lethal 
challenge with canine parvovirus. Vaccine 19(27):3661-3670. 
Larsen, J. S. and Curtis, W. R. 2012. RNA viral vectors for improved Agrobacterium-
mediated transient expression of heterologous proteins in Nicotiana benthamiana cell 
suspensions and hairy roots. BMC Biotechnol 12:21. 
Li, Y., Treffers, E. E., Napthine, S., Tas, A., Zhu, L., Sun, Z., Bell, S., Mark, B. L., Van 
Veelen, P. A., Van Hemert, M. J. and others. 2014. Transactivation of programmed 
ribosomal frameshifting by a viral protein. Proc Natl Acad Sci USA 111(21):E2172-
E2181. 
38 
 
 
 
Li, Y., Wang, X., Bo, K., Wang, X., Tang, B., Yang, B., Jiang, W. and Jiang, P. 2007 . 
Emergence of a highly pathogenic porcine reproductive and respiratory syndrome 
virus in the Mid-Eastern region of China. Vet J 174(3):577-584. 
Lico, C., Benvenuto, E. and Baschieri, S. 2015. The two-faced potato virus X: From plant 
pathogen to smart nanoparticle. Front Plant Sci 6:1009. 
Lico, C., Chen, Q. and Santi, L. 2008 . Viral vectors for production of recombinant proteins 
in plants. J Cell Physiol 216(2):366-377. 
Lico, C., Mancini, C., Italiani, P., Betti, C., Boraschi, D., Benvenuto, E. and Baschieri, 
S. 2009. Plant-produced potato virus X chimeric particles displaying an influenza 
virus-derived peptide activate specific CD8+ T cells in mice. Vaccine 27(37):5069-
5076. 
Lindbo, J. A. 2007. TRBO: A high-efficiency tobacco mosaic virus RNA-based 
overexpression vector. Plant Physiol 145(4):1232-1240. 
Linhares, D. C. L., Cano, J. P., Wetzell, T., Nerem, J., Torremorell, M. and Dee, S. A. 
2012. Effect of modified-live porcine reproductive and respiratory syndrome virus 
(PRRSv) vaccine on the shedding of wild-type virus from an infected population of 
growing pigs. Vaccine 30(2):407-413. 
Liu, L., Cañizares, M. C., Monger, W., Perrin, Y., Tsakiris, E., Porta, C., Shariat, N., 
Nicholson, L. and Lomonossoff, G. P. 2005 . Cowpea mosaic virus-based systems 
for the production of antigens and antibodies in plants. Vaccine 23(15):1788-1792. 
Liu, Z. and Kearney, C. M. 2010. An efficient Foxtail mosaic virus vector system with 
reduced environmental risk. BMC Biotechnol 10:88. 
Lizotte, P. H., Wen, A. M., Sheen, M. R., Fields, J., Rojanasopondist, P., Steinmetz, N. 
F. and Fiering, S. 2016. In situ vaccination with cowpea mosaic virus nanoparticles 
suppresses metastatic cancer. Nat Nanotechnol 11(3):295-303. 
Lomonossoff, G. P. and D'Aoust, M. A. 2016. Plant-produced biopharmaceuticals: A case 
of technical developments driving clinical deployment. Science 353(6305):1237-
1240. 
Lopez, O. J. and Osorio, F. A. 2004. Role of neutralizing antibodies in PRRSV protective 
immunity. Vet Immunol Immunopathol 102(3):155-163. 
Loula, T. 1991. Mystery pig disease. Agri-Practice 12:23-24. 
Ma, J. K. C., Drake, P. M. W. and Christou, P. 2003. The production of recombinant 
pharmaceutical proteins in plants. Nature Rev Genet 4(10):794-805. 
Mandahar, C. L. 2006. Positive-sense viral RNA. In Multiplication of RNA plant viruses, 
ed. Mandahar, C. L., pp 29-70. Springer Netherlands, Dordrecht, the Netherlands. 
Marconi, G., Albertini, E., Barone, P., De Marchis, F., Lico, C., Marusic, C., Rutili, D., 
Veronesi, F. and Porceddu, A. 2006. In planta production of two peptides of the 
Classical Swine Fever Virus (CSFV) E2 glycoprotein fused to the coat protein of 
potato virus X. BMC Biotechnol 6:29. 
Mardassi, H., Mounir, S. and Dea, S. 1995. Molecular analysis of the ORFs 3 to 7 of 
porcine reproductive and respiratory syndrome virus, Quebec reference strain. Arch 
Virol 140(8):1405-1418. 
 
 
39 
 
 
 
Marillonnet, S., Giritch, A., Gils, M., Kandzia, R., Klimyuk, V. and Gleba, Y. 2004 . In 
planta engineering of viral RNA replicons: Efficient assembly by recombination of 
DNA modules delivered by Agrobacterium. Proc Natl Acad Sci USA 101(18):6852-
6857. 
Marillonnet, S., Thoeringer, C., Kandzia, R., Klimyuk, V. and Gleba, Y. 2005 . Systemic 
Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient 
transient expression in plants. Nat Biotechnol 23(6):718-723. 
Marsian, J. and Lomonossoff, G. P. 2016. Molecular pharming - VLPs made in plants. 
Curr Opin Biotechnol 37:201-206. 
Martelli, P., Gozio, S., Ferrari, L., Rosina, S., De Angelis, E., Quintavalla, C., Bottarelli, 
E. and Borghetti, P. 2009. Efficacy of a modified live porcine reproductive and 
respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a 
heterologous European (Italian cluster) field strain: Clinical protection and cell-
mediated immunity. Vaccine 27(28):3788-3799. 
Marusic, C., Rizza, P., Lattanzi, L., Mancini, C., Spada, M., Belardelli, F., Benvenuto, 
E. and Capone, I. 2001. Chimeric plant virus particles as immunogens for inducing 
murine and human immune responses against human immunodeficiency virus type 1. 
J Virol 75(18):8434-8439. 
Mason, H. S., Warzecha, H., Mor, T. and Arntzen, C. J. 2002 . Edible plant vaccines: 
Applications for prophylactic and therapeutic molecular medicine. Trends in 
Molecular Medicine 8(7):324-329. 
Matanin, B. M., Huang, Y., Meng, X. J. and Zhang, C. 2008 . Purification of the major 
envelop protein GP5 of porcine reproductive and respiratory syndrome virus 
(PRRSV) from native virions. J Virol Methods 147(1):127-135. 
McLain, L., Durrani, Z., Wisniewski, L. A., Porta, C., Lomonossoff, G. P. and 
Dimmock, N. J. 1996. Stimulation of neutralizing antibodies to human 
immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino 
acid peptide of gp41 expressed on the surface of a plant virus. Vaccine 14(8):799-
810. 
Meng, X. J. 2000. Heterogeneity of porcine reproductive and respiratory syndrome virus : 
Implications for current vaccine efficacy and future vaccine development. Vet 
Microbiol 74(4):309-329. 
Meng, X. J., Paul, P. S., Halbur, P. G. and Morozov, I. 1995. Sequence comparison of 
open reading frames 2 to 5 of low and high virulence United States isolates of porcine 
reproductive and respiratory syndrome virus. J Gen Virol 76(12):3181-3188. 
Mett, V., Farrance, C. E., Green, B. J. and Yusibov, V. 2008. Plants as biofactories. 
Biologicals 36(6):354-358. 
Murtaugh, M. P., Elam, M. R. and Kakach, L. T. 1995 . Comparison of the structural 
protein coding sequences of the VR-2332 and Lelystad virus strains of the PRRS 
virus. Arch Virol 140(8):1451-1460. 
Murtaugh, M. P., Xiao, Z. and Zuckermann, F. 2002 . Immunological responses of swine 
to porcine reproductive and respiratory syndrome virus infection. Viral Immunol 
15(4):533-547. 
 
40 
 
 
 
Musiychuk, K., Stephenson, N., Bi, H., Farrance, C. E., Orozovic, G., Brodelius,  M., 
Brodelius, P., Horsey, A., Ugulava, N., Shamloul, A. M. and others. 2007 . A 
launch vector for the production of vaccine antigens in plants. Influenza Other Respir 
Viruses 1(1):19-25. 
Mussell, A., Oginskyy, A., Grier, K., Morin, M., Lachance, M., Whittington, L. and 
Friendship, R. 2011. A Risk, Benefit, Strength, Weakness, Opportunity and Threat 
Analysis for the Control and Possible Eradication of Porcine Reproductive and 
Respiratory Syndrome (PRRS) Virus within the Canadian Swine Herd. Guelph, ON, 
Canada. George Morris Centre. 
Nam, H. M., Chae, K. S., Song, Y. J., Lee, N. H., Lee, J. B., Park, S. Y., Song, C. S., Seo, 
K. H., Kang, S. M., Kim, M. C. and others. 2013. Immune responses in mice 
vaccinated with virus-like particles composed of the GP5 and M proteins of porcine 
reproductive and respiratory syndrome virus. Arch Virol 158(6):1275-1285. 
Namba, K. and Stubbs, G. 1986. Structure of tobacco mosaic virus at 3.6 Å resolution: 
Implications for assembly. Science 231(4744):1401-1406. 
Nathues, C., Perler, L., Bruhn, S., Suter, D., Eichhorn, L., Hofmann, M., Nathues, H., 
Baechlein, C., Ritzmann, M., Palzer, A. and others. 2016 . An Outbreak of Porcine 
Reproductive and Respiratory Syndrome Virus in Switzerland Following Import of 
Boar Semen. Transbound Emerg Dis 63(2):e251-e261. 
Nelsen, C. J., Murtaugh, M. P. and Faaberg, K. S. 1999 . Porcine reproductive and 
respiratory syndrome virus comparison: Divergent evolution on two continents. J 
Virol 73(1):270-280. 
Neumann, E. J., Kliebenstein, J. B., Johnson, C. D., Mabry, J. W., Bush, E. J., 
Seitzinger, A. H., Green, A. L. and Zimmerman, J. J. 2005 . Assessment of the 
economic impact of porcine reproductive and respiratory syndrome on swine 
production in the United States. J Am Vet Med Assoc 227(3):385-392. 
Niederwerder, M. C. and Rowland, R. R. R. 2017. Is There a Risk for Introducing Porcine 
Reproductive and Respiratory Syndrome Virus (PRRSV) Through the Legal 
Importation of Pork? Food Environ Virol 9(1):1-13. 
Nieuwenhuis, N., Duinhof, T. F. and van Nes, A. 2012. Economic analysis of outbreaks of 
porcine reproductive and respiratory syndrome virus in nine sow herds. Vet Rec 
170(9):225. 
O'Brien, G. J., Bryant, C. J., Voogd, C., Greenberg, H. B., Gardner, R. C. and Bellamy, 
A. R. 2000. Rotavirus VP6 expressed by PVX vectors in Nicotiana benthamiana 
coats PVX rods and also assembles into viruslike particles. Virology 270(2):444-53. 
Ofoghi, H., Moazami, N. and Ivanov, I. 2005 . Comparison of Tobacco Etch Virus and 
Tobacco Mosaic Virus Enhancers for Expression of Human Calcitonin Gene in 
Transgenic Potato Plant. Key Eng Mater 277-279:7-11. 
Okuda, Y., Kuroda, M., Ono, M., Chikata, S. and Shibata, I. 2008 . Efficacy of 
vaccination with porcine reproductive and respiratory syndrome virus following 
challenges with field isolates in Japan. J Vet Med Sci 70(10):1017-1025. 
 
 
 
41 
 
 
 
Opriessnig, T., Halbur, P. G., Yoon, K. J., Pogranichniy, R. M., Harmon, K. M., Evans, 
R., Key, K. F., Pallares, F. J., Thomas, P. and Meng, X. J. 2002 . Comparison of 
molecular and biological characteristics of a modified live porcine reproductive and 
respiratory syndrome virus (PRRSV) vaccine (Ingelvac PRRS MLV), the parent 
strain of the vaccine (ATCC VR2332), ATCC VR2385, and two recent field isolates 
of PRRSV. J Virol 76(23):11837-11844. 
Ostrowski, M., Galeota, J. A., Jar, A. M., Platt, K. B., Osorio, F. A. and Lopez, O. J. 
2002. Identification of neutralizing and nonneutralizing epitopes in the porcine 
reproductive and respiratory syndrome virus GP5 ectodomain. J Virol 76(9):4241-
4250. 
Otake, S., Dee, S. A., Rossow, K. D., Joo, H. S., Deen, J., Molitor, T. W. and Pijoan, C. 
2002. Transmission of porcine reproductive and respiratory syndrome virus by 
needles. Vet Rec 150(4):114-115. 
Pogue, G. P. and Holzberg, S. 2012. Transient Virus Expression Systems for Recombinant 
Protein Expression in Dicot- and Monocotyledonous Plants. In Plant Science, ed. 
Dhal, N. K., and Sahu, S. C., pp 191-216. InTech, Rijeka. 
Park, S. I., Seo, J. Y. and Kim, T. J. 2016 . Heterologous expression of porcine reproductive 
and respiratory syndrome virus glycoprotein 5 in Bordetella bronchiseptica aroA 
mutant. J Vet Med Sci 78(10):1625-1629. 
Pelham, H. R. B. 1978. Leaky UAG termination codon in tobacco mosaic virus RNA. 
Nature 272(5652):469-471. 
Peyret, H. and Lomonossoff, G. P. 2015. When plant virology met Agrobacterium: The rise 
of the deconstructed clones. Plant Biotechnol J 13(8):1121-1135. 
Pileri, E. and Mateu, E. 2016. Review on the transmission porcine reproductive and 
respiratory syndrome virus between pigs and farms and impact on vaccination. Vet 
Res 47(1):1-13. 
Piron, R., De Koker, S., De Paepe, A., Goossens, J., Grooten, J., Nauwynck, H. and 
Depicker, A. 2014. Boosting in planta production of antigens derived from the 
porcine reproductive and respiratory syndrome virus (PRRSV) and subsequent 
evaluation of their immunogenicity. PLoS One 9(3):e91386. 
Pirzadeh, B. and Dea, S. 1997. Monoclonal antibodies to the ORF5 product of porcine 
reproductive and respiratory syndrome virus define linear neutralizing determinants. J 
Gen Virol 78 ( 8):1867-1873. 
Pirzadeh, B. and Dea, S. 1998. Immune response in pigs vaccinated with plasmid DNA 
encoding ORF5 of porcine reproductive and respiratory syndrome virus. J Gen Virol 
79 (Pt 5):989-999. 
Porta, C., Spall, V. E., Findlay, K. C., Gergerich, R. C., Farrance, C. E. and 
Lomonossoff, G. P. 2003. Cowpea mosaic virus-based chimaeras: Effects of inserted 
peptides on the phenotype, host range, and transmissibility of the modified viruses. 
Virology 310(1):50-63. 
Porta, C., Spall, V. E., Loveland, J., Johnson, J. E., Barker, P. J. and Lomonossoff, G. 
P. 1994. Development of cowpea mosaic virus as a high-yielding system for the 
presentation of foreign peptides. Virology 202(2):949-955. 
 
42 
 
 
 
Prieto, C., Martínez-Lobo, F. J., Díez-Fuertes, F., Aguilar-Calvo, P., Simarro, I. and 
Castro, J. M. 2011. Immunisation of pigs with a major envelope protein sub-unit 
vaccine against porcine reproductive and respiratory syndrome virus (PRRSV) results 
in enhanced clinical disease following experimental challenge. Vet J 189(3):323-329. 
Qiu, H. J., Tian, Z. J., Tong, G. Z., Zhou, Y. J., Ni, J. Q., Luo, Y. Z. and Cai, X. H. 2005 . 
Protective immunity induced by a recombinant pseudorabies virus expressing the 
GP5 of porcine reproductive and respiratory syndrome virus in piglets. Vet Immunol 
Immunopathol 106(3-4):309-319. 
Rappuoli, R. 2007. Bridging the knowledge gaps in vaccine design. Nat Biotechnol 
25(12):1361-1366. 
Rennermalm, A., Li, Y. H., Bohaufs, L., Jarstrand, C., Brauner, A., Brennan, F. R. and 
Flock, J. I. 2001. Antibodies against a truncated Staphylococcus aureus fibronectin-
binding protein protect against dissemination of infection in the rat. Vaccine 19(25-
26):3376-3383. 
Renukaradhya, G. J., Meng, X. J., Calvert, J. G., Roof, M. and Lager, K. M. 2015 . 
Inactivated and subunit vaccines against porcine reproductive and respiratory 
syndrome: Current status and future direction. Vaccine 33(27):3065-3072. 
Rosendal, T., Dewey, C., Friendship, R., Wootton, S., Young, B. and Poljak, Z. 2014 . 
Spatial and temporal patterns of porcine reproductive and respiratory syndrome virus 
(PRRSV) genotypes in Ontario, Canada, 2004-2007. BMC Vet Res 10:83. 
Rüth, J., Hirt, H. and Schweyen, R. J. 1992 . The cauliflower mosaic virus 35S promoter is 
regulated by cAMP in Saccharomyces cerevisiae. Mol Gen Genet 235(2-3):365-372. 
Rybicki, E. P. 2014. Plant-based vaccines against viruses. Virol J 11:205-224. 
Sainsbury, F., Lavoie, P. O., D'Aoust, M. A., Vézina, L. P. and Lomonossoff, G. P. 
2008a. Expression of multiple proteins using full-length and deleted versions of 
cowpea mosaic virus RNA-2. Plant Biotechnol J6(1):82-92. 
Sainsbury, F., Liu, L. and Lomonossoff, G. P. 2008b. Cowpea mosaic virus-based 
expression of antigens and antibodies in plants. In Methods in Biotechnology: 
Recombinant Pharmaceutical Proteins from Plants, ed. Faye, L., and Gomord, V., pp 
25-39. Humana Press, NY, USA. 
Sainsbury, F. and Lomonossoff, G. P. 2008. Extremely high-level and rapid transient 
protein production in plants without the use of viral replication. Plant Physiol 
148(3):1212-1218. 
Sainsbury, F., Thuenemann, E. C. and Lomonossoff, G. P. 2009. PEAQ: Versatile 
expression vectors for easy and quick transient expression of heterologous proteins in 
plants. Plant Biotechnol J 7(7):682-693. 
Salazar-Gonzalez, J. A., Banuelos-Hernandez, B. and Rosales-Mendoza, S. 2015. 
Current status of viral expression systems in plants and perspectives for oral vaccines 
development. Plant Mol Biol 87(3):203-217. 
Saunders, K. and Lomonossoff, G. P. 2013. Exploiting plant virus-derived components to 
achieve in planta expression and for templates for synthetic biology applications. 
New Phytol 200(1):16-26. 
Savelyeva, N., Munday, R., Spellerberg, M. B., Lomonossoff, G. P. and Stevenson, F. K. 
2001. Plant viral genes in DNA idiotypic vaccines activate linked CD4+ T-cell 
mediated immunity against B-cell malignancies. Nat Biotechnol 19(8):760-764. 
43 
 
 
 
Scholthof, H. B. 2006. The Tombusvirus-encoded P19: From irrelevance to elegance. Nat 
Rev Microbiol 4(5):405-411. 
Scholthof, K. B. 2004. Tobacco mosaic virus: a model system for plant biology. Annu Rev 
Phytopathol 42:13-34. 
Seternes, T., Tonheim, T. C., Myhr, A. I. and Dalmo, R. A. 2016 . A plant 35S CaMV 
promoter induces long-term expression of luciferase in Atlantic salmon. Sci Rep 
6:25096. 
Shew, H.D. and G.B. Lucas. 1991. Compendium of Tobacco Diseases. APS Press, St. Paul, 
MN, USA. 
Shukla, S., Wen, A. M., Commandeur, U. and Steinmetz, N. F. 2014 . Presentation of 
HER2 epitopes using a filamentous plant virus-based vaccination platform. J Mater 
Chem B 2(37):6249-6258. 
Snijder, E. J. 1998. The arterivirus replicase: The road from RNA to protein(s), and back 
again. Adv Exp Med Biol 440:97-108. 
Snijder, E. J. and Meulenberg, J. J. M. 1998 . The molecular biology of arteriviruses. J  
Gen Virol 79(5):961-979. 
Stadejek, T., Oleksiewicz, M. B., Scherbakov, A. V., Timina, A. M., Krabbe, J. S., 
Chabros, K. and Potapchuk, D. 2008 . Definition of subtypes in the European 
genotype of porcine reproductive and respiratory syndrome virus: Nucleocapsid 
characteristics and geographical distribution in Europe. Arch Virol 153(8):1479-1488. 
Stadejek, T., Stankevicius, A., Storgaard, T., Oleksiewicz, M. B., Belák, S., Drew, T. W. 
and Pejsak, Z. 2002. Identification of radically different variants of porcine 
reproductive and respiratory syndrome virus in Eastern Europe: Towards a common 
ancestor for European and American viruses. J Gen Virol 83(8):1861-1873. 
Steinmetz, N. F., Lin, T., Lomonossoff, G. P. and Johnson, J. E. 2009a. Structure-based 
engineering of an icosahedral virus for nanomedicine and nanotechnology. Curr Top 
Microbiol Immunol 327:23-58. 
Steinmetz, N. F., Lomonossoff, G. P. and Evans, D. J. 2006. Decoration of cowpea mosaic 
virus with multiple, redox-active, organometallic complexes. Small 2(4):530-533. 
Steinmetz, N. F., Mertens, M. E., Taurog, R. E., Johnson, J. E., Commandeur, U., 
Fischer, R. and Manchester, M. 2010. Potato virus X as a novel platform for 
potential biomedical applications. Nano Lett 10(1):305-312. 
Steinmetz, N. F., Shah, S. N., Barclay, J. E., Rallapalli, G., Lomonossoff, G. P. and 
Evans, D. J. 2009b. Virus-templated silica nanoparticles. Small 5(7):813-816. 
Storgaard, T., Oleksiewicz, M. and Bøtner, A. 1999 . Examination of the selective 
pressures on a live PRRS vaccine virus. Arch Virol 144(12):2389-2401. 
Sugiyama, Y., Hamamoto, H., Takemoto, S., Watanabe, Y. and Okada, Y. 1995 . 
Systemic production of foreign peptides on the particle surface of tobacco mosaic 
virus. FEBS Lett 359(2-3):247-250. 
Sun, L., Cai, H., Xu, W., Hu, Y. and Lin, Z. 2002. CaMV 35S promoter directs β-
glucuronidase expression in Ganoderma lucidum and Pleurotus citrinopileatus. Appl 
Biochem Biotechnol 20(3):239-244. 
Takamatsu, N., Watanabe, Y., Yanagi, H., Meshi, T., Shiba, T. and Okada, Y. 1990. 
Production of enkephalin in tobacco protoplasts using tobacco mosaic virus RNA 
vector. FEBS Lett 269(1):73-76. 
44 
 
 
 
Taylor, K. M., Lin, T., Porta, C., Mosser, A. G., Giesing, H. A., Lomonossoff, G. P. and 
Johnson, J. E. 2000. Influence of three-dimensional structure on the immunogenicity 
of a peptide expressed on the surface of a plant virus. J Mol Recogn 13(2):71-82. 
Tepfer, M., Gaubert, S., Leroux-Coyau, M., Prince, S. and Houdebine, L. M. 2004 . 
Transient expression in mammalian cells of transgenes transcribed from the 
Cauliflower mosaic virus 35S promoter. Environ Biosafety Res 3(2):91-97. 
Thaa, B., Sinhadri, B. C., Tielesch, C., Krause, E. and Veit, M. 2013. Signal peptide 
cleavage from GP5 of PRRSV: A minor fraction of molecules retains the decoy 
epitope, a presumed molecular cause for viral persistence. PLoS ONE 8(6): e65548. 
The Pig Site. 2010. PRRS Costs Canadian Swine Industry $130M Per Year. 
http://www.thepigsite.com/swinenews/25032/prrs-costs-canadian-swine-industry-
130m-per-year/ 
Thuenemann, E. C., Meyers, A. E., Verwey, J., Rybicki, E. P. and Lomonossoff, G. P. 
2013. A method for rapid production of heteromultimeric protein complexes in 
plants: assembly of protective bluetongue virus-like particles. Plant Biotechnol J 
11(7):839-846. 
Tian, K., Yu, X., Zhao, T., Feng, Y., Cao, Z., Wang, C., Hu, Y., Chen, X., Hu, D., Tian, 
X. and others. 2007. Emergence of fatal PRRSV variants: unparalleled outbreaks of 
atypical PRRS in China and molecular dissection of the unique hallmark. PLoS One 
2(6):e526. 
Tollin, P., and Wilson, H. R. 1988. Particle structure. In The plant viruses, vol. 4: the 
filamentous plant viruses, ed. Milne, R. G., pp 51-83. Plenum, NY,USA. 
Turpen, T. H., Reinl, S. J., Charoenvit, Y., Hoffman, S. L., Fallarme, V. and Grill, L. K. 
1995. Malaria epitopes expressed on the surface of recombinant tobacco mosaic 
virus. Nat Biotechnol 13(1):53-57. 
Twyman, R. M., Stoger, E., Schillberg, S., Christou, P. and Fischer, R. 2003 . Molecular 
farming in plants: Host systems and expression technology. Trends Biotechnol 
21(12):570-578. 
Uhde-Holzem, K., Schlosser, V., Viazov, S., Fischer, R. and Commandeur, U. 2010 . 
Immunogenic properties of chimeric potato virus X particles displaying the hepatitis 
C virus hypervariable region I peptide R9. J Virol Methods 166(1-2):12-20. 
United States (US) National Pork Board. 2012. Pork quick facts. 
http://porkgateway.org/wp-content/ uploads/2015/07/quick-facts-book1.pdf 
United States Department of Agriculture (USDA)- Foreign Agricultural Services. 2016. 
Livestock and poultry: World Markets and Trade. 
https://apps.fas.usda.gov/psdonline/circulars/ livestock_poultry.pdf 
Uribe-Campero, L., Nunez-Palenius, H. G. and Gomez-Lim, M. A. 2015. Expression of 
peptide nanoparticles containing a porcine reproductive and respiratory syndrome 
(PRRS) virus epitope in plants. Afri J Microbiol Res 9(24):1600-1607. 
Usha, R., Rohll, J. B., Spall, V. E., Shanks, M., Maule, A. J., Johnson, J. E. and 
Lomonossoff, G. P. 1993. Expression of an animal virus antigenic site on the surface 
of a plant virus particle. Virology 197(1):366-374. 
 
 
45 
 
 
 
Van Breedam, W., Van Gorp, H., Zhang, J. Q., Crocker, P. R., Delputte, P. L. and 
Nauwynck, H. J. 2010. The M/GP5 glycoprotein complex of porcine reproductive 
and respiratory syndrome virus binds the sialoadhesin receptor in a sialic acid-
dependent manner. PLoS Pathog 6(1): e1000730. 
Várallyay, E., Válóczi, A., Ágyi, A., Burgyán, J. and Havelda, Z. 2010. Plant virus-
mediated induction of miR168 is associated with repression of ARGONAUTE1 
accumulation. EMBO J 29(20):3507-3519. 
Voinnet, O. 2001. RNA silencing as a plant immune system against viruses. Trends Genet 
17(8):449-459. 
Voinnet, O., Lederer, C. and Baulcombe, D. C. 2000. A viral movement protein prevents 
spread of the gene silencing signal in Nicotiana benthamiana. Cell 103(1):157-167. 
Voinnet, O., Rivas, S., Mestre, P. and Baulcombe, D. 2003. An enhanced transient 
expression system in plants based on suppression of gene silencing by the p19 protein 
of tomato bushy stunt virus. Plant J 33(5):949-956. 
Wang, A., Wang, D. J., Chowda-Reddy, R. V., Chen, H., and Ma, S. 2011 . Development 
of a Plant-based Vaccine against Porcine reproductive and respiratory syndrome 
virus: Research Progress and Future Prospects. Am J P lant Sci Biotechnol 
5(S11):127-131. 
Wang, W., Chen, X., Xue, C., Du, Y., Lv, L., Liu, Q., Li, X., Ma, Y., Shen, H. and Cao, 
Y. 2012. Production and immunogenicity of chimeric virus-like particles containing 
porcine reproductive and respiratory syndrome virus GP5 protein. Vaccine 
30(49):7072-7077. 
Watson, J. D. 1954. The structure of tobacco mosaic virus. I. X-ray evidence of a helical 
arrangement of sub-units around the longitudinal axis. BBA - Biochim Biophys Acta 
13(C):10-19. 
Wellink, J. and van Kammen, A. 1989. Cell-to-cell transport of cowpea mosaic-virus 
requires both the 58K/48K proteins and the capsid proteins. J Gen Virol 70:2279–
2286. 
Wensvoort, G., Terpstra, C., Pol, J. M., ter Laak, E. A., Bloemraad, M., de Kluyver, E. 
P., Kragten, C., van Buiten, L., den Besten, A. and Wagenaar, F. 1991 . Mystery 
swine disease in The Netherlands: the isolation of Lelystad virus. Vet Quart 
13(3):121-130. 
Wernike, K., Hoffmann, B., Dauber, M., Lange, E., Schirrmeier, H. and Beer, M. 2012. 
Detection and typing of highly pathogenic porcine reproductive and respiratory 
syndrome virus by multiplex real-time RT-PCR. PLoS ONE 7(6): e38251. 
Wills, R. W., Doster, A. R., Galeota, J. A., Sur, J. H. and Osorio, F. A. 2003. Duration of 
infection and proportion of pigs persistently infected with porcine reproductive and 
respiratory syndrome virus. J Clin Microbiol 41(1):58-62. 
Wissink, E. H., van Wijk, H. A., Kroese, M. V., Weiland, E., Meulenberg, J. J., Rottier, 
P. J. and van Rijn, P. A. 2003. The major envelope protein, GP5, of a European 
porcine reproductive and respiratory syndrome virus contains a neutralization epitope 
in its N-terminal ectodomain. J Gen Virol 84(Pt 6):1535-1543. 
Yoon, I. J., Joo, H. S., Goyal, S. M. and Molitor, T. W. 1994. A modified serum 
neutralization test for the detection of antibody to porcine reproductive and 
respiratory syndrome virus in swine sera. J Vet Diagn Invest 6(3):289-292. 
46 
 
 
 
Zhang, H. and H. Kono. 2012. Economic impacts of porcine respective and respiratory 
syndrome (PRRS) outbreak in Vietnam pig production. Trop Agric Res 23:152-159. 
Zhang, H., Kono, H. and Kubota, S. 2014 . An integrated epidemiological and economic 
analysis of vaccination against highly pathogenic porcine reproductive and 
respiratory syndrome (PRRS) in Thua Thien Hue Province, Vietnam. Asian-Australas 
J Anim Sci 27(10):1499-1512. 
Zhao, H., Wang, Y., Ma, Z., Wang, Y. and Feng, W. H. 2014 . Recombinant 
Kluyveromyces lactis expressing highly pathogenic porcine reproductive and 
respiratory syndrome virus GP5 elicits mucosal and cell-mediated immune responses 
in mice. J Vet Sci 15(2):199-208. 
Zuckermann, F. A., Garcia, E. A., Luque, I. D., Christopher-Hennings, J., Doster, A., 
Brito, M. and Osorio, F. 2007. Assessment of the efficacy of commercial porcine 
reproductive and respiratory syndrome virus (PRRSV) vaccines based on 
measurement of serologic response, frequency of gamma-IFN-producing cells and 
virological parameters of protection upon challenge. Vet Microbiol 123(1-3):69-85.  
 
 
 
 
 
 
  
47 
 
 
 
Chapter 2 
 
 
 
 
 
Developing a BPMV-based expression vector for 
production of recombinant protein in soybean 
 
 
    Hong Hanh Tran 
1, 2
, Hui Chen 
1
, Norman P.A. Hüner 
2
, Aiming Wang 
1, 2
 
 
 
1
London Research and Development Centre, Agriculture and Agri-Food Canada, 
London, Ontario, N5V 4T3, Canada 
2
Department of Biology, Western University, London, ON N6A 5B7, Canada 
   
48 
 
 
 
2.1 Introduction  
As discussed in Chapter 1, the viral protein GP5 is a promising subunit vaccine against 
PRRSV. To produce recombinant PRRSV GP5 in plants, in a previous study, my lab 
generated transgenic tobacco plants for the production of GP5 or its fusions (Wang et al.  
2008; Wang et al. 2011). The cholera toxin B (CTB) of Vibrio cholerae, an efficient 
transmucosal carrier induction of peripheral immunological tolerance, was fused with either 
GP5 or its neutralizing epitopes (GP5-NE). In this strategy, CTB worked as an adjuvant to 
facilitate either GP5, or GP5-NE, delivery into mucosal sites and to promote mucosal 
immune response. The GP5 protein or GP5-CTB fusion was not detectable in the transgenic 
plants (Wang et al. 2011). The level of GP5-NE fusion was very low in the range of 0.003 to 
0.087% of total soluble protein (TSP) and the fusion protein could bind to the mucosal GM1 
receptor effectively (Wang et al. 2011). To circumvent the low expression of target proteins 
in the production of plant recombinant proteins, I attempted to use viral vectors. P lant 
viruses have the ability to reprogram plant cells to serve as an efficient factory for viral 
genome and protein production. Once the virus carrying a gene of interest is introduced to 
plants, it will replicate and the protein of interest can be expressed in large amounts (Gleba 
et al. 2007).  
In this study, Bean pod mottle virus (BPMV), a member of the family Comoviridae, genus 
Comovirus (Lomonossoff and Ghabrial 2001), was manipulated to develop a viral-based 
expression vector for recombinant protein production in soybean plants. The genome of 
BPMV consists of two genomic RNAs including RNA1 and RNA2. Both of RNAs have a 
covalently linked protein, VPg, at the 5’ termini and a poly A tail at the 3’ termini. Viral 
proteins are expressed as a single protein precursor and subsequently proteolytically 
processed by the viral protease to release mature proteins. BPMV RNA1 (nearly 6 kb in 
length) codes for five mature proteins, protease cofactor (Co-pro), putative helicase (Hel), 
viral genome-linked protein (VPg), protease and putative RNA-dependent RNA polymerase 
(RdRp), which are necessary for viral replication. Meanwhile, BPMV RNA2 (nearly 3.6 kb) 
encodes four proteins consisting of a replication cofactor (CR), a putative movement protein 
(MP), a large coat protein (L-CP) and a small coat protein (S-CP). Cowpea mosaic virus 
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(CPMV), which is also a comovirus, has been developed as a viral vector for protein 
expression since 1998 (Gopinath et al. 2000; Verver et al. 1998) and viral elements are 
applied to enhance the expression of viral structure proteins which can form virus-like 
particles (Sainsbury et al. 2009b; Thuenemann et al. 2013a; Thuenemann 2013). In contrast, 
BPMV-based vectors has been developed mainly as a virus-induced gene silencing (VIGS) 
vector and to a much lesser extent for expression of non-therapeutics proteins (Zhang et al.  
2010; Zhang and Ghabrial 2006; Zhang et al. 2013; Zhang et al. 2009). Since BPMV is one 
of the major viruses which infect soybean (Gu et al. 2002), it has a great potential as a viral 
system for expression of edible subunit vaccines without the need of purification. Here, I 
introduce a new BPMV based-vector which can be directly inoculated on soybean plants via 
biolistic bombardment to express green fluorescent protein (GFP) and a C terminus of GP5 
fused with GFP. 
2.2 Materials and methods 
2.2.1 Plant materials 
Nicotiana benthamiana (N. benthamiana) were grown in controlled environment chambers 
under conditions of 16 hours (hr) in the light at 22°C, 8 hr in the dark at 18°C, and 70% 
relative humidity (RH). Light intensity during the 16-hr light period was approximately 100 
mol. 
Soybean (Glycine max L. Merill) cultivar, Williams 82, was grown in a greenhouse at 22°C 
under a 16/8 hr photoperiod. After 10 days post germination, seedlings were used for 
biolistic bombardment. 
2.2.2 Bacterial strains and growth conditions 
Escherichia coli (E.coli) strain DH5 was used for general plasmid propagation and 
extraction. For specific DNA manipulation required for a methylation-deficient E. coli strain, 
such as involved in the use of some restriction sites including StuI, JM101 was used. Both 
strains were cultured with Luria-Bertani (LB) liquid medium (1% tryptone, 1% NaCl, 0.5% 
yeast extract plus 1 l distilled water) or solid medium supplemented with 1.5% (w/v) agar at 
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37°C. Appropriate antibiotics such as kanamycin (50 g/ml) or ampicillin (100 g/ml) were 
added to the LB media according to selection markers of the plasmids. 
Agrobacterium tumefaciens (A. tumefaciens) strain GV3101 was grown at 28°C in LB liquid 
medium with kanamycin 50 g/ml and rifampicin 50 g/ml, or on LB solid medium 
supplemented with 1.5% (w/v) agar. 
2.2.3 Virus 
The genome of BPMV is bipartite, positive-stranded RNA genome, including RNA1 and 
RNA2. Vectors pGHoR1, pGG7R2M and pGG7R2V were obtained from Dr. Ghabrial 
(Zhang and Ghabrial 2006). pGHoR1 contains full length cDNA of BPMV RNA1 whereas, 
pGG7R2M and pGG7R2V contain BPMV RNA2 under the control of a T7 promoter (Gu et 
al. 2002). pGHoR1, pGG7R2M and pGG7R2V were subjected to Sanger DNA sequencing 
and their infectivity in soybean was confirmed via soybean bombardment. Sequencing 
results were perfectly matched to the published BPMV genome sequence (GeneBank 
accession number: AF394608, and M62738).  
2.2.4 Construction of DNA infectious clones and plant expression vectors 
Firstly, pCass4-Rz, a binary plant expression vector containing a double 35S promoter, a 
ribozyme self-cleavage site (Rz) and a terminator (T) (Annamalai and Rao 2005), was 
modified by replacing the Rz and T sites with the Nos terminator between the restriction sites 
of BamHI and PmeI to generate vector pCass4-Nos. Full length genomic DNAs of either 
BPMV RNA1 or BPMV RNA2, were amplified from pGHoR1 and pGG7R2M, 
respectively, using Phusion High-Fidelity DNA Polymerase (NEB, Pickering, Ontario, 
Canada) and primers containing indicated restriction sites such as StuI and BamHI or StuI 
and XbaI (Table 2.1). The resulting products were digested with the corresponding 
restriction enzymes and integrated into the same restriction sites (StuI/BamHI or StuI/XbaI, 
respectively) of pCass4-Nos to create the cassettes of 35S promoter::BPMV RNA1::Nos 
terminator and the cassette of 35S promoter::BPMV RNA2::Nos terminator. All the above 
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restriction enzymes were purchased from NEB (New England Biolab, Canada). The inserted 
genes were confirmed by digestion and DNA Sanger sequencing. 
To characterize the expression of GP5 in planta, the protein of interest was halved into two 
equal portions, the N-terminus (GP5N) containing the first 100 amino acid (aa) and the C-
terminus (GP5C) comprising of the remaining 100 aa. Both GP5N and GP5C were tagged 
by GFP as GP5N-GFP or GP5C-GFP fusions. GFP is the enhanced GFP, which was 
described previously (GenBank accession number: U55762.1) (Cormack et al. 1995). The 
cDNA fragment of GP5N was amplified by the primers GP5N-F and GP5N-GFPlink-R 
while the GFP fragment was created by the primers GP5N-GFPlink-F and GFPatt-R. These 
two fragments were ligated by overlapping PCR using the primers GP5N-F and GFPatt-R. 
To generate GP5C-GFP, the same steps were followed using the primers, GP5C-F and 
GP5C-GFPlink-R for the GP5C fragment, GP5C-GFPlink-F and GFPatt-R for the GFP 
fragment and GP5C-F and GFPatt-R to overlap these two fragments. The resulting PCR 
products were analyzed by gel electrophoresis and purified using gel purification kit 
(QIAGEN Inc., Toronto, Ontario, Canada). Gateway cloning was performed by applying 
Gateway Technology (Invitrogen, Burlington, Ontario, Canada) following the 
manufacturer’s protocol. GP5N-GFP or GP5C-GFP was introduced into a pDONR Zeo 
vector by a BP reaction (Hartley et al. 2000), and the resulting vector was then transformed 
into E.coli DH5α to generate an entry clone. To confirm clone identity, the plasmid was 
sequenced with M13F and M13R primers. The entry vector was mixed with pCamGate-ER 
destination vector (Pereira et al. 2013) and LR Clonase enzyme (Invitrogen) for in vitro 
recombination to construct pCamGate GP5N-GFP and pCamGate GP5C-GFP. The resulting 
plasmids were confirmed by DNA sequencing using the primers pCamGateSeq-F and 
pCamGateSeq-R. 
The pEAQ series of vectors were refined from the CPMV expression system by 
constructions of compatible systems for either traditional cloning or Gateway technology, 
combined with agroinfiltration (Sainsbury et al. 2009b). The expression cassette was 
designed to allow proteins of interest to be fused with a His-tag at their N-terminus or C-
terminus for purification. In this experiment, a pair of restriction sites, AgeI and SmaI, was 
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exploited to insert GP5N-GFP or GP5C-GFP into pEAQ-HT to generate pEAQ GP5N-GFP 
and pEAQ GP5C-GFP, respectively. GP5N-GFP was amplified from pCamGate GP5N-GFP 
using primers AgeI-GP5N-F and GFP-R while GP5C-GFP was copied from pCamGate 
GP5C-GFP using AgeI-GP5C-F and GFP-R. His-tag was also attached at the C-terminus in 
each of these constructs. The sequences were eventually verified by PCR colony screening, 
restriction enzyme digestion and DNA Sanger sequencing. 
pGG7R2V, which has the same sequence as pGG7R2M except for a multi-cloning site with 
a portion of GFP, flanked by duplicating viral proteinase sites, Glutamine-Methionine 
(QM), between coding sequences of MP and L-CP, was used for cloning of foreign genes 
(Zhang and Ghabrial 2006). Fusions of either GFP alone or GP5N and GP5C with GFP 
were created by PCR using primers containing recognition sites of BamHI and MscI 
enzymes, named BamHI-forward primers and MscI-reverse primers (Table 2.1) together 
with the templates of pCaMGate containing GP5N-GFP or GP5C-GFP, accordingly. 
Digested GFP, GP5N-GFP and GP5C-GFP were ligated into BamHI/MscI-digested 
pGG7R2V at 16°C overnight to produce pGG7R2V (GFP), pGG7R2V (GP5N-GFP) and 
pGG7R2V (GP5C-GFP) respectively. The presence of insert fragments in the resulting 
vectors was confirmed by colony PCR screening, digestion with BamHI and MscI, and DNA 
Sanger sequencing. 
In order to generate a vector which can be inoculated onto soybean leaves without in vitro 
transcription, BPMV RNA2 was modified to fuse with genes of interest (GOI), GFP, GP5N-
GFP and GP5C-GFP and inserted into an expression cassette including 35S promoter and 
Nos terminator in pCass4-Nos. pGG7R2V (GFP), pGG7R2V (GP5N-GFP) and pGG7R2V 
(GP5C-GFP) were amplified by Phusion High-Fidelity DNA Polymerase (NEB) using 
primers BPMVR2-F and BPMVR2-XbaI-R. The resulting products will be digested with 
XbaI and integrated into the same digestion sites (StuI/XbaI) of pCass4-Nos to form the 
constructs of pBPR2(GFP), pBPR2(GP5N-GFP) and pBPR2(GP5C-GFP). These constructs 
were used for biolistic bombardment after the inserted genes were confirmed by restriction 
enzyme digestion and DNA Sanger sequencing. 
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RNA1 is required to be translated correctly for RNA2 replication (Zhang and Ghabrial 
2006). The 5’ untranslated region (UTR) of RNA2 is necessary for RNA2 accumulation (Lin 
et al. 2013). Therefore, the sequence of viral genome in each construct was carefully 
scanned and matched with the natural sequence of BPMV, especially in the 5’ and 3’ ends of 
RNA1 and RNA2.  
2.2.5 Bacterial transformation 
Chemically competent E.coli strains DH5 or JM101 (50 l) stored in a -80°C freezer were 
thawed on ice for 10 minutes (min). Plasmid or ligation reaction mixtures containing 
approximately 100 ng of DNA was added directly to competent cells in 1.5 ml tubes and 
mixed gently by stirring with a pipette tip. The tube was incubated on ice for 30 min. Cells 
were heat shocked at 42°C for 60 seconds (sec) and then immediately placed on ice for 2 
min. 200 l of SOC medium (Invitrogen) was added and the resulting mixture was kept at 
37°C for 1 hr in a shaking incubator (225 rpm) to maximize the transformation efficiency of 
E.coli (Hanahan 1983). An aliquot of each transformation (50 l) was spread on LB plates 
including appropriate antibiotics for selection. Plates were incubated overnight at 37°C and 
colonies were selected on the next day for PCR colony screening to confirm successful 
transformants. 
Agrobaterium transformation was performed using a MicroPulser Electroporation apparatus 
by following the manufacturer’s instructions (Bio-Rad). Competent cells of A. tumefaciens 
GV3101 (40 l) were thawed on ice for 10 min and gently mixed with approximately 100 ng 
of DNA plasmid. The mixture was transferred into a cold Gene Pulser cuvette (Bio-Rad), on 
ice, and then electroporated using the Bio-Rad E.coli Pulser (Bio-Rad) at 1.9 kV for 10 sec. 
Transformed cells immediately went through a short incubation with 200 l of SOC medium 
at 28°C for 2 hr in a shaking incubator (225 rpm). The cells were plated onto LB plates 
containing selection antibiotics and rifampicin, and then incubated at 28°C for 48 hr. A 
single colony was picked up for transformation analyses. Colonies with the correct insert 
sequence were cultured for agroinfiltration. 
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2.2.6 In vitro transcription 
The preparation for in vitro transcription was described previously (Kachroo and Ghabrial 
2012) with minor modifications. In brief, pGHoR1 and pGG7R2M were linearized by SalI 
and NotI or SalI, respectively. The fragments containing RNA1 (6 kb) and RNA2 (8 kb) were 
excised from agarose gel, and purified using the QIAprep Spin miniprep kit (QIAGEN). A 
part of purified fragments was tested by electrophoresis on 1.2% (w/v) agarose gel. When the 
sizes were confirmed, the rest was utilized as templates for in vitro transcription. In vitro 
synthesis of capped RNA was performed using mMESSAGE mMACHINER kit (Ambion 
Inc., Austin, TX, USA), according to the manufacturer s` protocol. To assess RNA yie ld and 
quality, 5 l of the in vitro transcription products was analyzed on 1.2% (w/v) agarose gels 
and the concentration of the products was measured by spectrophotometer (Nanodrop 1000, 
ABI). A mixture of RNA transcripts (including RNA1 and RNA2) was introduced into 
soybean leaf cells via biolistic bombardment during infectivity testing. 
2.2.7 Biolistic bombardment  
Since soybean cotyledons and leaves are recalcitrant to agroinfiltration, infectious clones of 
BPMV were introduced into the primary leaves of soybean at the vegetative cotyledon  stage 
(Zhang et al 2009), by biolistic bombardment using the Helios Gene Gun System (Bio-Rad, 
Hercules, CA, USA) according to the manufacturer’s instructions.  
To confirm the infectivity of the original infectious clones received from Dr. Ghabrial 
(Zhang and Ghabrial 2006), RNA transcripts of the templates, pGHoR1 and pGG7R2M, 
were bombarded into soybean plants. An equal amount of BPMV RNA1 (34 g) and BPMV 
RNA2 (34 g) was mixed with spermidine, CaCl2 and glycerol then followed by a 
precipitation onto 17 mg of 1.0 m gold particles (Bio-Rad), to produce an RNA loading 
ratio of 4 g RNA/shot following the manufacturer’s instruction. The suspension of gold and 
RNA was loaded into the Gold- Coat tubing (Bio-Rad) using the Tubing Prep Station (Bio-
Rad). Coated tubes were cut into 0.5 inch cartridges, which were installed in the cartridge 
holder of the Helios Gene Gun. Helium pressure was adjusted to 160 psi and three shots 
were distributed onto each primary leaf of the same plant. The leaves were supported by a 
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foam block to prevent them from being damaged during the bombardment procedure. Each 
plant was given five shots. For each plasmid mix, a total of six plants were bombarded per 
experiment. Leaf tissues of these plants were collected for detection of BPMV by double-
antibody sandwich enzyme-linked immunosorbent assays (DAS-ELISA) 15 days after 
biolistic bombardment. 
To test the infectivity of DNA-based BPMV infectious clones, DNA plasmids, pBPR1 and 
pBPR2 were introduced into soybean leaves via biolistic bombardment essentially as 
described above. The plants were also tested for the presence of BPMV by DAS-ELISA 20 
days after biolistic inoculation (Zhang et al. 2013). 
To transiently express different GOI in soybean, a mixture of pBPR1 and pBPR2(GOI) was 
introduced into soybean plants employing a similar method as mentioned in the infectivity 
test of DNA-based BPMV infectious clones. In addition, the pBPR2(GOI) construct 
included a GFP gene which can be transcribed, translated and exploited as an indicator of 
protein expression and virus accumulation. DAS-ELISA was performed 15 days after 
biolistic inoculation. When infection was confirmed, BPMV-infected plants were sampled 
for a time-course analysis, from days 20 downwards to 90 days post bombardment, to 
observe GFP using confocal microscopy or to quantify the level of protein expression by 
immunoblotting.  
Four to six soybean plants were inoculated with each construct. Following biolistic 
bombardment, plants were maintained in a growth chamber at 20°C and 70% RH, with a 
photoperiod of 16 hr.  
2.2.8 Electron microscopy 
To detect virions by transmission electron microscopy (TEM), 0.5 g of BPMV-infected leaf 
was ground in 2 ml of general extraction buffer (Agdia, Elkhart, IN, USA) with a mortar and 
a pestle. The resulting homogenate was centrifuged at 12 000 x g for 20 min at 4°C. The 
supernatant was removed to a new tube and subjected to a second centrifugation, under the 
same conditions, to help remove of plant debris. The resulting supernatant then was filtered 
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through a 45 m filter (VWR International, Mississauga, Ontario, Canada) to generate the 
working solution for TEM. Negative staining was performed using one drop of the working 
solution and 2% (w/v) potassium phosphor tungstate (PTA) as described (Kingsbury and 
Darlington 1968).  
2.2.9 Rub inoculation 
To test the stability of the BPMV expression vector, we performed serial mechanical 
infections. In this experiment, the infected materials from successful bombarded plants (the 
first passage) were employed to inoculate healthy plants. If these plants became infected, 
and showed symptoms, they were called the second passage. Tissue was then collected from 
these second passage plants to inoculate the new generation of plants. BPMV infected 
soybean leaves showing severe symptoms were chosen as the source of viral materials. 
Approximately 1 g of fresh leaf tissue was ground using a pestle in a mortar with 5 ml of 
0.01 M phosphate buffer  pH 8.0 (470 l of 1 M K2HPO4, 30 l of 1 M KH2PO4 plus 50 ml 
distilled water) (Sambrook and Russell 2001). The primary leaves of 10 day-old-soybean 
were dusted with fine 320-grit carborundum powder (Alfa Aesar, Lancaster, UK) and gently 
rubbed with inoculum. The carborundum and rubbing facilitated virus entry to infect leaf 
cells. At least six soybean plants were inoculated for each construct. 
2.2.10 Transient expression in N. benthamiana via agroinfiltration 
For transient expression in N. benthamiana, the GOI, including either GP5N-GFP or GP5C-
GFP, were recombined with either pCamGate-ER or pEAQ-HT and transformed into A. 
tumefaciens GV3101 via electroporation as described above.  
Agrobacterium cultures were grown in LB liquid medium with kanamycin (50 g/ml) and 
rifampicin (50 g/ml) at 28°C, to an optical density of 1.5-2.0 at 600 nm (OD600). Bacterial 
cells were harvested by centrifugation at 5 000 x g for 5 min. The pellet was resuspended in 
agroinfiltration buffer (10 mM MgCl2, 10 mM MES and 150 M 4ʹ-Hydroxy-3ʹ, 5ʹ-
dimethoxyacetophenone), incubated at room temperature for 2 hr and followed by a dilution 
with agroinfiltration buffer to a final OD600 of 1.0. The suspension was then infiltrated into 
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the abaxial leaf epidermis of 4-6 week old N. benthamiana with a 1 ml syringe (Kapila et al.  
1997). Plants were maintained in a growth chamber under normal conditions after 
infiltration. Five plants were infiltrated for each construct. Transient expression was then 
monitored by either UV lamp illumination or confocal microscopy.   
2.2.11 Double-antibody sandwich enzyme-linked immunosorbent assays (DAS-
ELISA) 
DAS-ELISA with  BPMV coat protein antibody (Agdia) was performed following the 
manufacturer’s instructions, at 15-30 days after bombardment (Zhang et al. 2013). Capture 
antibody was added to a 96 well plate during the coating step. Subsequently, several washes 
applied to remove  excess capture antibody. Coat proteins of BPMV were extracted from 
infected plants using the general extraction buffer, and then added to coated wells and bound 
to the capture antibody. Enzyme conjugated antibody was then used to bind the capture 
antibody-coat protein complex and form a “sandwich”. A p-Nitrophenyl phosphate (PNP) 
solution was then added to the wells. The colorless PNP solution  reacts with positive 
samples by developing a color change. To determine the absorbance value of color change, 
the plate was read using iMark Microplate Reader (Bio-Rad) at 415 nm. At least three 
biological replicates were performed for each construct. Only constructs that had ability to 
infect soybean plants were applied for further steps. 
2.2.12 Reverse transcription-polymerase chain reaction (RT-PCR) 
Three leaf discs (6 mm diameter) equivalent to approximately 100 mg of leaf tissue were 
added to 2 ml tubes with three 2.3 mm ceramic beads (Biospec, Fisher Scientific LTD, 
Ottawa, ON, Canada) and homogenized using a TissueLyser II (QIAGEN) at 30 Hz for 60 
sec. Tissue sample was immediately processed with 1 ml TRIzol Reagent (Invitrogen) 
following the manufacturer s` procedure for RNA isolation. The RNA pellet was re-
suspended in RNase-free water (Ambion Inc.). DNase I (Invitrogen) treatment was 
conducted to remove DNA contamination. The concentration and purification of total RNA 
was determined by measuring absorbance at 260 nm/280 nm and 230 nm/260 nm in a 
spectrophotometer (Nanodrop 1000, ABI). To conf irm the infectivity of infectious clones, 
58 
 
 
 
RT-PCR was performed using the RNA extract. 1 g of total RNA was reverse transcribed 
by Superscript III Reverse Transcriptase (Invitrogen) to synthesize first strand cDNAs. 1 l 
of cDNA was served as a template for a sequential PCR reaction using GoTaq FlexiDNA 
polymerase (Promega, Madison, WI, USA). GFP was amplified by the primers of GFP-F and 
GFP-R. 
2.2.13 Ultraviolet (UV) lamp 
A portable Blak-Ray B-100AP UV lamp (Blak-Ray, Upland, CA, USA) was used for the 
detection of green fluorescence in infiltrated plants with constructs containing the GFP gene. 
Plants were brought to a dark room where long wave ultraviolet light (~ 365 nm) was used to 
excite fluorescence within leaf tissues. Pictures were taken by Nikon COOLPIX P500 digital 
camera (Nikon Canada, Mississauga, ON, Canada) under polarizing light for visible light 
images and under UV illumination. 
2.2.14 Confocal microscopy 
2.2.14.1 N. benthamiana 
For fluorescence visualization in N. benthamiana leaves, a 5 mm x 7 mm section was excised 
and mounted for detection using a Leica TCS SP2 confocal laser scanning inverted 
microscopy (Leica Microsystems, Wetzlar, Germany) with 63X water immersion objective . 
Leaf samples were immersed in a drop of water between a glass slide and a cover glass. 
Another drop of water was also added onto the objective lenses.  For imaging GFP, a 488 nm 
argon laser was used for the excitation and emission fluorescence was detected at 500-525 
nm. 
Images from different color channels were collected simultaneously at a resolution of 512 x 
512 pixels and analyzed with the Leica Application Suite for Advanced Fluorescence (LAS 
AF, version 2.3.5) (Leica Microsystem, Germany). 
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2.2.14.2 Soybean 
For soybean plants, leaves from plants bombarded with constructs containing GFP and GFP 
fused with GOI were visualized for GFP signal.  Leaf samples were taken as 3 mm leaf discs 
at 20, 30, 45 and 90 days post inoculation (dpi). The abaxial leaf epidermis of each leaf disc 
was imaged with a Leica TCS SP2 confocal equipped with either a 10X dry or a 63X water 
immersion objectives. The procedure was essentially as described for N. benthamiana except 
that there was no water needed on the 10X dry objective. 
2.2.15 Fluorometry of GFP 
To quantify the concentration of GFP in N. benthamiana leaf extracts, a GFP quantification 
kit, Fluorometric (Cells Biolabs Inc., Burlington, ON, Canada), was used, following the 
manual provided by the supplier. 100 l of tissue lysate containing GFP in Lysate Buffer 
was transferred into a 96 well, black, flat bottom polystyrene, tissue culture-treated 
microplate (Corning, MA, USA). Fluorescence intensity was measured using excitation and 
emission wavelengths of 485 nm and 516 nm, respectively, in a Synergy
 
2 microplate reader 
(BioTek, VT, USA). To account for background fluorescence in the plant tissue, the extract 
of plants infiltrated with an empty vector was used to normalize the data. All sample 
dilutions were compared to a standard curve that was generated using purified GFP provided 
in the kit, between the ranges of 20-120 ng. Three biological replicates were measured for 
each construct. TSP was calculated using Bio-Rad Protein Assay Dye Reagent Concentrate 
(Bio-Rad) following the manufacturer’s protocol, using bovine serum albumin (BSA) as a 
standard, and an iMark Microplate Reader (Bio-Rad) at 595 nm. 
2.2.16 Immunoblotting  
Three leaf discs of 15 mm in diameter were collected from different leaves showing 
fluorescence from a total of five plants. The sample was ground in liquid nitrogen using a 
mortar and a pestle. Total protein extract was processed by adding urea-sodium dodecyl 
sulphate (urea-SDS) extraction buffer, containing 50 mM Tris-HCl pH 6.8, 4.5% (w/v) SDS, 
9 M urea, 1 mM EDTA and 7.5% (v/v) -mercaptoethanol to the ground leaves. Protein 
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extraction from either control plants infected with an empty BPMV vector or, a mock plant, 
was also performed as described. The total protein of each sample was semi-quantitated by 
dot blot technique and GelCode Blue stain reagent (Thermo Fisher Scientific, Rockford, IL, 
USA), following the manufacturer’s protocol, and compared using a co lorimetric method 
with a known concentration of BSA and TotalLab TL100 software (Nonlinear Dynamics, 
Durham, USA). 
For immunoblotting analysis, the extracted proteins were separated using 12% (w/v) sodium 
dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), and transferred to a 
polyvinylidene difluride (PVDF) membrane. The primary antibody, polyclonal anti-GFP 
antibody produced in rabbit (Sigma-Aldrich, Oakville, ON, Canada) was applied to the 
membrane for detection of GFP or GP5C-GFP, respectively. Horseradish peroxidase (HRP) 
conjugated anti-rabbit IgG produced in goat (Sigma-Aldrich) was used as the secondary 
antibody to be bound to the primary antibody. The filter was visualized using an ECL 
detection kit (GE Healthcare, Mississauga, ON, Canada) and autoradiography, as described 
by the manufacturer. The amount of GFP or GP5C-GFP expressed was compared to a 
standard of purified GFP, to estimate the level of expression. The expression level was 
determined at 20, 30, 45 and 90 days after bombardment. The level of protein expression 
was assessed based on GFP expression using TotalLab TL100 software (Nonlinear 
Dynamics) to analyze band intensity. 
2.3 Results  
2.3.1 Infectivity of RNA infectious clones 
To validate constructs and determine the parameters for biolistic bombardment, soybean 
plants were infected using RNA transcribed from pGHoR1 and pGG7R2M. Both the 
plasmids contained T7 promoter which was placed upstream of the sequences of BPMV 
RNA1 and RNA2, respectively, and plasmid linearization was achieved by digestion with the 
restriction enzymes NotI and SalI or SalI only (Figure 2.1A). The purified RNA1 in pGHoR1 
linearized by NotI and SalI had the approximate size of 6 kb, whereas pGG7R2M digested by 
SalI had a size of 8 kb (Figure 2.1B). To test the success of in vitro transcription, the 
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products were visualized by electrophoresis on an agarose gel. The results confirmed 
successful in vitro transcriptions (Figure 2.1C) and these transcripts were used for biolistic 
bombardment in soybean seedlings. 
The transcripts of BPMV RNA1 and RNA2 were combined in a mixture and introduced onto 
the primary leaves of 10-day-old soybean seedlings via biolistic bombardment (Figure 2.2A). 
Several parameters, including the RNA loading ratio (DLR), Microcarrier Loading Quantities 
(MLQ) and discharge pressure, were adjusted to get the highest rate of infectivity, as well as 
maintain plant vitality. Intriguingly, the bombarded plants began to show symptoms at 12 dpi 
with mosaic patterning and wrinkled leaves (Figure 2.2B), compared to healthy plants 
(Figure 2.2C). DAS-ELISA confirmed the presence of BPMV in all soybean plants 
bombarded with the transcripts. Overall, these data suggest that pGHoR1 and pGG7R2M are 
infectious and thus, can be exploited as templates for the construction of BPMV DNA 
infectious clones. 
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Figure 2.1  BPMV RNA infectious clones. A.  Schematic representation of BPMV RNA1 in 
pGHoR1 and BPMV RNA2 in pGG7R2M that were employed to produce infectious RNAs  
(not drawn to scale). The full length cDNA of BPMV RNA1 and RNA2 were placed 
downstream of T7 promoters. The names of mature proteins were designated above their 
respective coding regions. BPMV RNA1 encodes five proteins including protease cofactor 
(Co-pro), helicase (Hel), viral genome -linked protein (Vpg), RNA-dependent RNA 
polymerase (RdRp). BPMV RNA2 translates into four proteins; RNA2 replication cofactor 
(CR), movement protein (MP), large coat protein (L-CP) and small coat protein (S-CP).The 
vertical lines show restriction enzyme sites for plasmid linearization. pGHoR1 was digested 
by NotI and SalI, whereas, pGG7R2M was linearized by SalI only. B. Purified products from 
the digestion of pGHoR1 and pGG7R2M prior to in vitro transcription. The linearized 
templates of RNA1 in pGHoR1, and RNA2 in pGG7R2M were approximately 6 kb and 8 kb 
in length, respectively, as shown on a 1.2% (w/v) agarose gel. C. RNA transcripts of the 
linearized templates on a 1.2% (w/v) agarose gel. 
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Figure 2.2  Biolistic bombardment on soybean using RNA transcripts. A. A soybean 
seedling at 10 days old was infected by biolistic bombardment.   B. Infected soybean leaves, 
which showed mosaic and blistering symptoms.    C.  Healthy soybean leaves.  
  
A C B 
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2.3.2 Construction of the full- length cDNA infectious clones and expression 
vectors  
To directly use the vector for infection without in vitro transcription, I replaced the T7 
promoter with the Cauliflower mosaic virus 35S promoter (CaMV 35S) and introduced a 
nopaline synthase (Nos) terminator. The full-length cDNAs of RNA1 and RNA2 were 
amplified from pGHoR1 and pGG7R2M (Zhang and Ghabrial 2006), respectively, and 
cloned into pCass4-Nos vector (Figure 2.3A) to generate pBPR1 and pBPR2 (Figure 2.3B). 
The BPMV-based expression vectors were constructed based on pGG7R2V (Zhang and 
Ghabrial 2006) to generate pBPR2(GOI), which contains genes of interest such as GFP, 
GP5N-GFP, and GP5C-GFP (Figure 2.3C). The resulting plasmids were mixed and 
bombarded into primary leaves of soybean plants. Infected plants started to exhibit 
symptoms on young leaves 15 dpi. BPMV symptoms included stunted height and mosaic, 
blistered and mottled leaves, which were identical to soybean plants infected by wild-type 
virus or RNA transcripts. The symptoms were fully developed 20 days after bombardment 
when there were no symptoms on mock-treated plants (bombarded with pCass4-Nos) 
(Figure 2.4). DAS-ELISA confirmed the presence of BPMV in samples of infected leaves at 
20 dpi. The results indicated that the modified full-length cDNA clones of BPMV were 
infectious on soybean plants.  
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Figure 2.3 Construction of plant expression vectors (not drawn to scale). A. pCass4-Nos 
containing multi-cloning sites, hygromycin phosphotransferase gene (HPT) and double 
CaMV 35S, followed by cloning sites and a Nos terminator between LB (left border) and RB 
(right border). B. Constructs of cassettes in T-DNA plasmids harboring BPMV genomic 
RNAs. The transcription start site is designed right after a double 35S promoter and a Nos 
terminator is attached to the poly A tail of the virus genome to ensure replication of the virus 
genome and protein expression in each construct. C. Genes of interest (GOI) are fused 
between movement protein (MP) and large coat protein (L-CP) in RNA2 of BPMV and 
flanked by two cleavage sites of Glutamine -Methionine (QM). GOI includes GFP, and GP5C 
or GP5N fused with GFP. 
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Figure  2.4  Soybean plants infected by BPMV DNA infectious clones at 20 dpi. Red arrows 
show spots of biolistic bombardment. 
  
    Mock plant   Infected plants 
       Mock plant pBPR1 + pBPR2 
    Inoculation area 
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2.3.3 Exploiting BPMV-based vector for GFP expression in soybean 
To test whether the BPMV based expression vector is able to infect and produce proteins of 
interest in soybean plants, a mixture of pBPR2(GFP) and pBPR1 was introduced into 
soybean plants via biolistic bombardment. P lasmid pBPR2(GFP) contains a cassette of 
double 35S promoter::RNA2(GFP)::Nos terminator which can be transcribed into the RNA2-
GFP transcript to produce RNA2 proteins and GFP in plants (Figure 2.5A). The results 
showed that pBPR2(GFP) was infectious when co-bombarded with pBPR1. Inoculated 
soybean plants developed mosaic and mottling symptoms at 15 dpi, similar to the BPMV 
empty vector-infected plants. These symptoms were not evident in mock-treated plants which 
were bombarded with pCass4-Nos (Figure 2.5B). DAS-ELISA also indicated the infection of 
BPMV in bombarded soybean plants. 
Furthermore, I also proved that GFP were expressed on systemic leaves of GFP infected 
plants. Samples of systemic leaves showed green fluorescence under confocal microscopy 
starting at 20 days after bombardment. To characterize the GFP expression, green 
fluorescence was observed in newly infected leaves at 15, 20, 30, 45 and 90 days post 
bombardment. The signal began to show in a mosaic pattern on leaves at 20 dpi, increased 
remarkably at 30-45 dpi and subsequently decreased at 90 dpi (Figure 2.6A). RT-PCR 
analysis of RNA purified from upper non-bombarded leaves with primers covering GFP 
coding region amplified a cDNA fragment of approximately 720 base pairs (bp) which 
matched the GFP positive control (Figure 2.6B). Interestingly, none of these plants showed 
fluorescence when scanned by a hand-held UV lamp at mentioned time points, possibly due 
to the thick layer of epicuticular wax on leaf surface.  
To evaluate the GFP expression, leaf samples were subjected to western blot analysis. Total 
protein was extracted from leaves and showed green fluorescence using a urea-SDS 
extraction buffer. The protein extract was quantified by dot blot analysis with a polyclonal 
anti GFP-antibody, and GFP was measured using GFP fused with hydrophobin I (GFP-
HFBI) as a standard. The results indicated that GFP expression could reach 37.29 g/g of 
leaf fresh weight at 30-45 dpi, equivalent to 0.5% of total protein in soybean while the 
amount decreased dramatically, to 2.5 g/g of leaf fresh weight, at 90 dpi. The data of both 
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confocal microscopy and western blot were in agreement that GFP was produced in soybean 
leaves at highest level in 30-45 dpi (Figure 2.7A). Therefore, the best harvest time should be 
within 30-45 dpi. The size of GFP produced by the BPMV vector in soybean was slightly 
bigger than 25 kDa, the calculated molecular mass of GFP due to the addition of 27 amino 
acids (aa), derived from MP and L-CP of BPMV, in the expression construct (Figure 2.7B).  
Taken together, all data support that the BPMV based expression vector can be exploited to 
infect soybean plants and produce GFP in whole soybean plants. The GFP expression was 
37.29 g/g fresh weight of leaf tissue at 30-45 days after bombardment. Moreover, the fact 
that GFP could be transiently expressed in soybean leaves by employing these viral vectors 
encouraged us to investigate whether this system would be suitable for production of plant-
made vaccine against PRRSV. 
2.3.4 Exploiting BPMV-based vector for GP5 expression 
2.3.4.1   Characterization of GP5 and its expression in N. benthamiana 
The GP5 protein of PRRSV possesses four main regions including a signal peptide (aa 1-32), 
an ectodomain (aa 33-63), a transmembrane domain (aa 64-134) and an endodomain (aa 135-
200), (Music and Gagnon 2010; Peyret and Lomonossoff 2013; Thuenemann et al. 2013a). 
As indicated earlier, GP5 or its fusion GP5-CTB expression in transgenic plants was not  
detectable (Wang et al. 2011). To test if this can be improved by expression of partial GP5, 
GP5 was halved into two parts, the first 100 aa of GP5 (GP5N) and the remaining 100 aa of 
GP5 (GP5C), and each was tagged by GFP (Figure 2.8). GP5N-GFP and GP5C-GFP fusions 
were inserted into pCaMGate-ER via Gateway cloning (Figure 2.9A). pCaMGate-ER 
containing several components which enhances protein expression and accumulation in 
plants. The double CaMV 35S promoter and tCUP (Wu et al. 2001) translational enhancer 
from tobacco can promote the transcription and translation of GOI. PR1b, a secretory signal 
peptide from tobacco (Cutt et al. 1988) and KDEL, an endoplasmic reticulum (ER) retrieval 
tetra peptide, were used to retain the protein of interest to the ER. Elastin-like polypeptides 
(ELP), a pentapeptide repeat polymer (Val-Pro-Gly-Xaa-Gly), could allow the purification 
process based on its ability to form aggregates above its transition temperature. Moreover, 
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ELP has proved to increase the accumulation of recombinant proteins in planta (Conley et al.  
2009; Joensuu et al. 2010). Quantitation of GFP indicated that GP5N-GFP and GP5C-GFP 
expression levels were slightly different at 4 dpi, with the first producing less protein, 
0.023% of TSP, when compared to 0.031% of TSP, for GP5C-GFP.   
To further investigate the expression pattern of GP5 in two moieties GP5N and GP5C, pEAQ 
GP5N-GFP and pEAQ GP5C-GFP were created and infiltrated into N. benthamiana (Figure 
2.10A). The backbone vector is pEAQ-HT, a binary vector derived from Cowpea mosaic 
virus (CPMV). HT is in abbreviation for hypertranslation since this vector uses a modified 5’ 
UTR and 3’UTR of CPMV to enhance the translation of GOI, which are inserted between 
them. In order to suppress gene silencing, a cassette of p19, known as a viral gene silencing 
suppressor, is placed downstream of 3’UTR. None of the plants infiltrated with pEAQ 
GP5N-GFP or pEAQ GP5C-GFP exhibited fluorescence when illuminated by UV light. 
However, the plants infiltrated with pEAQ GFP as a positive control showed tremendous 
florescence in the same condition. Confocal microscopy was employed to observe green 
fluorescence in these plants. Interestingly, green fluorescence was evident in N. benthamiana 
leaves infiltrated with either GP5N-GFP or GP5C-GFP plasmids (Figure 2.10B). The level of 
GP5N-GFP was much higher than that of GP5C-GFP at 3 dpi (Figure 2.10C). N. 
benthamiana infiltrated with either GP5N-GFP or GP5C-GFP started to show necrosis at 3 
dpi and the infiltrated leaves were totally wilted and dead after 1 week, as shown in Figure 
2.11A and B, respectively. The plants infiltrated with either pEAQ GFP (Sainsbury et al.  
2009b), or buffer, developed normally (Figure 2.11A and B). Overall, the results confirm that 
there was a variance in the expression of GP5N and GP5C when fused with GFP in N. 
benthamiana and both could cause necrosis when expressed in N. benthamiana.   
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Figure 2.5 Construct of pBPR2(GFP) and its infectivity to soybean plants (not drawn to 
scale). A. Construct of the BPMV-based expression vector containing GFP which was placed 
between the left border (LB) and the right border (RB) in pBPR2(GFP).  B. Soybean plants 
bombarded with this construct at 20 dpi. The GFP plants showed mosaic and wrinkling 
symptoms in leaves when compared to mock inoculated plants. 
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Figure 2.6  GFP expression in soybean plant using pBPR2(GFP).   A. GFP observation by 
confocal microscopy at 30 dpi. Scale bar is 100 m.    B. RT-PCR results showed a 720 bp 
band of GFP in GFP expressing plants at 30 dpi. Lane M: 100 bp ladder. Lane 1: Empty 
vector infected plant. Lane 2: GFP expressing plant. Lane 3: Positive control with a plasmid 
containing GFP. 
Empty vector infected plant 
GFP expressing plant 
   Dark field                                     Overlay 
    
A. 
B. 
 720 bp 
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Figure 2.7  Western blot using anti-GFP antibody for GFP extracted from soybean leaves 
infected with BPMV expression vectors containing GFP.  A. Western blot of GFP in soybean 
leaves at 30 dpi. 50 g total protein of extract was loaded per well.  Lane 1: Extract from 
leaves infected with BPMV expression vector containing GFP. Lane 2: GFP-HFBI as a 
positive control. Lane 3: Extract from leaves infected with BPMV empty vector.               
Lane 4: Extract from mock inoculated plant.  B. A time course of GFP expression in soybean 
leaves. 70 g total protein of extract was loaded per well. Lane 1: Mock inoculated plant. 
Lane 2: Empty vector. Lane 3: 20 dpi. Lane 4: 30 dpi. Lane 5: 45 dpi. Lane 6- 8: 90 dpi.    
Lane 9: 50 ng GFP-HFBI as a standard for quantification of GFP.  
  
kDa    1        2             3         4           5         6          7         8          9
  
B. 
       kDa        1         2        3       4          
40- 
35- 
25- 
A.
75 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8  Characteristics of glycoprotein 5 (GP5) in PRRSV.  GP5 was halved into GP5N 
and GP5C shown by the brackets. The numbers under the bar indicate the position of amino 
acids in this protein relevant to the coding regions; signal peptide, ectodomain, 
transmembrane domain and endodomain. “N” and “C” are abbreviated for N -terminus and C-
terminus of GP5. The dashed line in red separates the protein into two halves. 
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Figure 2.9 The expression of GP5N-GFP and GP5C-GFP in N. benthamiana using 
pCamGate-ER at 4 dpi. A. Schematic representations of pCamGate GP5N-GFP and 
pCamGate GP5C-GFP (not drawn to scale). 2 x 35S - double CaMV 35S promoter; tCUP - 
tobacco translational enhancer; PR1b - Pathogenesis-Related-1b, a secretory signal peptide 
from tobacco; Xpress and cmyc - detection/purification tags; attB1 and attB2 - Gateway 
recombination sites; KDEL - an endoplasmic reticulum (ER) retrieval tetra                          
peptide; ELP - elastin-like polypeptides; Nos - nopaline synthase terminator.                                                
B.  Observation of fluorescence of these constructs by confocal microscopy. Scale bar is 40 
m.   C. The expression of each construct via GFP quantitation. Error bars represent the 
standard deviation of the mean (n=3). 
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Figure 2.10 The expression of GP5N-GFP and GP5C-GFP in N. benthamiana using       
pEAQ-HT at 3 dpi.  A. Schematic representations of pEAQ GP5N-GFP and pEAQ GP5C-
GFP (not drawn to scale).  RB - right border; 35S - CaMV 35S promoter; CPMV 5’UTR -  
translational enhancer sequences from Cowpea mosaic virus (CPMV); GP5N-GFP - GP5N 
fused with GFP; GP5C-GFP - GP5C fused with GFP; 3’UTR - translational enhancer 
sequences from CPMV; 6XHis - detection/purification tag; Nos - nopaline synthase 
terminator; p19 - expression cassette of p19 protein, a gene silencing suppressor from Tomato 
bushy stunt virus; NPTII - neomycin phosphotransferase II as a selective marker; LB - left 
border.  B. The observation of fluorescence of these constructs under visible light and UV 
light. The red arrow indicates the positive control pEAQ GFP construct. The grey arrows 
show the leaves infiltrated with the constructs labelled below each photo.  C. The observation 
of fluorescence of these constructs under confocal microscopy. Scale bar is 300 m. 
   
C. 
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Figure 2.11  Necrosis symptoms of plants infiltrated by pEAQ GP5N-GFP and pEAQ 
GP5C-GFP. A. Necrosis started in infiltrated leaves at 3 dpi.   B. Necrosis developed in the 
whole of infiltrated leaves, as the leaves became wilted and died, after one week while those 
leaves infiltrated with either pEAQ GFP, or buffer, did not show necrosis and grew ordinarily 
well. The red arrows point to infiltrated leaves. 
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2.3.4.2    Expression of GP5 in soybean using BPMV based vector 
To circumvent the necrosis phenomenon and the low expression of GP5N and GP5C in N. 
benthamiana, soybean was tested as an alternative plant for GP5 expression. The constructs 
of pBPR2(GP5N-GFP) and pBPR2(GP5C-GFP) were generated as expression vectors and 
introduced into soybean plants together with pBPR1 via biolistic bombardment (Figure 2.12). 
All plants were infected with the combination of pBPR1 and pBPR2(GP5C-GFP), whereas 
none of the plants inoculated with the constructs of pBPR1 and pBPR2(GP5N-GFP) showed 
symptoms of BPMV infection. The infected plants displayed symptoms with mosaic, 
wrinkling and mottling leaves, similar to the BPMV infection described. DAS-ELISA 
confirmed the infectivity of these clones in which, pBPR2(GP5C-GFP) was infectious and 
pBPR2(GP5N-GFP) was not. To further examine the presence of BPMV in infected plants 
with pBPR2(GP5C-GFP), extracts of leaves with severe symptoms was observed by TEM. 
The result revealed many icosahedral-like particles which had diameters of approximately 30 
nm perfectly matching with the predicted size of BPMV (Figure 2.13A). These results 
indicate that pBPR2(GP5C-GFP) can be co-bombarded into soybean plants to produce 
GP5C-GFP. 
Moreover, the data also demonstrate that GP5C-GFP was expressed in systemic leaves and 
the total amount of GP5C-GFP can be as high as 4.36 g/g fresh weight of leaf tissue. GFP 
in the fusion protein was observed by confocal microscopy in a time course of 15-20-30-45-
90 dpi. As expected, GP5C-GFP infected plants showed their high peak of fluorescence at 
30-45 dpi (Figure 2.13B), which was correlated with GFP expression in this study. Total 
protein was extracted from leaves which showed fluorescence under confocal microscopy at 
45 dpi and subjected to dot blot and western blot. Western blot results showed that GP5C-
GFP had the size of about 39 kDa, however, another band was detected at 27 kDa which was 
possibly GFP cleaved from the fusion protein (Figure 2.13B). Both bands were analyzed by 
TotalLab TL100 software and compared with the standard GFP. Assuming there was an 
equal amount of GP5C and GFP in the fusion protein GP5C-GFP, the total amount of GP5C-
GFP produced in soybean leaves could be as high as 4.36 g/g of fresh weight, equivalent to 
0.06% of total protein. 
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Figure 2.12  Construction of the T-DNA between the left border (LB) and the right border 
(RB) in BPMV expression vectors (not drawn to scale).     A. pBPR2(GP5N-GFP)               
B.  pBPR2(GP5C-GFP). 
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Figure 2.13 Analysis of GP5C-GFP expression in soybean plants infected by BPMV 
expression vectors. A. BPMV virions viewed by TEM. The virions of icosahedral shapes 
were indicated by black arrows, with their diameters which varied between 20-35 nm. Scale 
bar 100 nm.     B. Confocal microscopy of soybean leaves expressing GP5C-GFP at 45 dpi. 
Scale bar 100 m.   C. Western blot of GP5C-GFP expression using anti-GFP antibody, 50 
g total protein of GP5C-GFP extract was loaded on gel. Lane 1: GP5C-GFP plant.          
Lane 2: Empty vector.  Lane 3: Mock plant. Lane 4: 10 ng of GFP as a standard of 
quantification. 
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2.3.5 Stability of the foreign genes expressed by BPMV based vectors 
Since the production of heterologous proteins using this system relies on virus replication 
and translation, the stability of viral vectors plays a critical role during these stages, to ensure 
the functions, as well as, protein production. Many reports have indicated that heterologous 
genes were deleted from expression vectors, due to homologous recombination, resulting in 
reversion to the wild type of a modified virus (Zhang and Ghabrial 2006; Zhang et al. 2007; 
Zhang et al. 2009). To test the stability of these constructs, we employed the use of GFP and 
confocal microscopy. Leaf tissues were harvested from soybean plants infected with either 
BPMV-GFP or BPMV-GP5CGFP, as materials to mechanically inoculate new plants. When 
these new plants were infected, and produced proteins of interest, the leaves were used to 
infect a subsequent batch of soybean plants. The fluorescence of GFP could be detected by 
confocal microscopy up to 6 passages, with a similar intensity to that observed in the first 
passage.  
2.4 Discussion  
In the 1990s, a variety of BPMV isolates was collected from the fields of soybean in the 
United States which demonstrated the diversity of this virus in nature. To study this virus for 
disease management, the infectious clones of three different strains, K-G7, K-Ha1 and K-
Ho1 were constructed and their transcripts were inoculated in soybean plants (Gu and 
Ghabrial 2005). Later on, the infectious clone of RNA2, belonging to K-G7 isolate, was 
modified as a VIGS vector (Zhang and Ghabrial 2006). The full length cDNAs of BPMV 
RNAs were placed under the control of a T7 promoter in all of these infectious clones which 
required an extra step of in vitro transcription to produce RNA transcripts for mechanical 
infection. Recently, modifications were made by replacing the full length cDNAs of RNA1 
and RNA2, of the IA-D1 isolate, under the control of a CaMV 35S promoter and Nos 
terminator for both protein expression and gene silencing purposes (Zhang et al. 2010). In 
this study, I also used the same method to switch the T7 promoter of infectious clones, 
pGHoR1, pGG7R2M and pGG7R2V, to CaMV 35S promoter, and to add Nos terminator to 
eliminate the inconvenience of in vitro transcription and enhance the versatility of the 
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expression system. I further demonstrate here that the modified clones were infectious and 
successfully directed the expression of heterologous proteins, GFP and GP5C-GFP in 
soybean plants. To date, many different BPMV-based vectors have been developed and 
utilized as an effective tool for functional genomic studies via VIGS (Chen et al. 2016; Chen 
et al. 2015; Rao et al. 2014; Singh et al. 2011). Nevertheless, their application for 
heterologous protein expression is limited to several proteins, GFP, Bar, DsRed and silencing 
suppressors (Zhang et al. 2010). To my best knowledge, this is the first report on the 
application of BPMV-based expression vectors for vaccine production in soybean leaves. 
The concept of plant-made vaccines for oral administration has drawn a lot of interest 
recently since the therapeutic proteins produced in plants showed their efficiency in clinical 
trials and treatments. A remarkably successful story is that ZMapp, a mixture of three 
chimeric monoclonal antibodies produced in tobacco plants, was administered to seven 
patients and five of them were recovered during the 2014 Ebola outbreak (Budzianowski 
2015). The drugs are now produced rapidly in N. benthamiana via transient expression under 
on-going development for commercialization. The potentials of fast production in plants and 
versatile administration via oral routes without needles have made plant-based vaccines more 
appealing (Liew and Hair-Bejo 2015) as these help to reduce the administration costs when a 
large population is involved. Since the first plant-based vaccine, Hepatitis B virus surface 
antigen (HBsAg), was produced in transgenic tobacco (Mason et al. 1992), a variety of plants 
including Arabidopsis thaliana, alfalfa, spinach, potato, rice, bean, maize, tomato, strawberry 
and carrot have been used for vaccine production (Liew and Hair-Bejo 2015). In this study, 
soybean leaves were selected as a plant bioreactor to express an oral vaccine against PRRSV 
in pigs. When compared to tobacco plants, soybean plants contain a low amount of alkaloids 
and no nicotine, thus, is suitable for animal feeding without the concern of toxicity. 
Moreover, my results showed that the expression of GP5 using pCamGate and pEAQ-HT 
caused necrosis in N. benthamiana starting at early days post agroinfiltration resulting in a 
low yield of proteins of interest. It has been reported that GP5 is involved in the apoptosis 
phenomenon induced by PRRSV in animal cells and the first N-terminal 119 aa of GP5 has 
been mapped for apoptosis induction (Fernández et al. 2002; Suárez et al. 1996). 
Lomonossoff group also reported the necrosis of GP5 infiltrated leaves in N. benthamiana 
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(Thuenemann et al. 2013) and suggested that the protein need to be engineered to eliminate 
its toxicity to plants such as a removal of transmembrane domains. Here, I chose soybean 
plants which are considered physically more endurable and biolistic bombardment, instead of 
agroinfiltration, to alleviate this necrosis. Overall, soybean is a worldwide crop which can 
grow on almost every continent and supply high amount of proteins. Exploiting this BPMV 
based expression system to produce a ready-to-use vaccine in soybean leaves will increase 
the value of the plant and provide a low-cost medicine in developing countries. 
Transgenic plants have been employed for the production of recombinant proteins since 1986 
(Ma et al. 2003). Within three decades, transgenic plants became the most commonly used 
platform to express heterologous proteins,several of which are commercialized products.  
However, the procedure requires a long time investment, often 6 months to a year, and 
intensive labour to generate stable transgenic plants that produce proteins of interest.  It may 
also require several generations to obtain homozygous lines. Due to its time and labour 
consumption, this system is inappropriate for the timely production of vaccines against 
emerging viral epidemics. From past endemics, such as influenza, it has become clear that 
earlier action is taken, the easier it is to control and vaccines play a critical role in this earlier 
time point to prevent outbreaks. In addition, transgenes can be subjected to gene silencing in 
plant nuclear transformation and result in a low level of protein expression (Chan and Daniell 
2015; Yao et al. 2015). Here, I introduced a transient expression system together with a viral 
vector as an alternative method to traditional stable transformation, as it is less time 
demanding and produces higher expression yields. Furthermore, BPMV-based expression 
vectors can allow heterologous proteins to be expressed throughout the plant, with high 
accumulation in leaves and vascular systems during virus infection based on the movement 
ability of this virus. This is more efficient than regular agroinfiltration-mediated transient 
expression, in which proteins of interest accumulated only in the infiltrated areas. Although 
the GP5N-GFP could not be produced in soybean using this system, the expression of GP5C-
GFP was approximately 4.36 g/g fresh weight of leaf tissue , equivalent to 0.06% of total 
protein. Previously, it has been reported that GP5 was expressed at a lower level such as 110-
257 ng/g fresh weight of leaf tissue (0.011-0.037% TSP) in transgenic tobacco and transgenic 
banana (Chan et al. 2013; Chia et al. 2010; Chia et al. 2011). It is impossible to precisely 
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compare these expression systems since my system expressed the C-terminus of GP5, and 
theirs expressed the entire GP5. However, the results confirm that the BPMV-based 
expression system can be promisingly exploited for a higher level of protein production in 
soybean plants. 
In this study, the level of GFP expression was 0.5% of total protein, which is lower than the 
1% of total protein previously reported when RNA transcripts were used to inoculate in 
soybean (Zhang and Ghabrial 2006). I believe that the difference of expression level may be 
caused by the methods of inoculation. In my experiment, the DNA expression vectors were 
introduced into plants via biolistic bombardment and underwent transcription in the nucleus. 
This was followed by an export of RNA to the cytoplasm then virus replication happened and 
proteins of interest were translated along with viral proteins. The procedure in the nucleus 
and exporting process may increase negative impacts on the synthesis of mRNA and 
proteins, due to gene silencing and improper protein interactions (Marillonnet et al. 2005). In 
contrast, neither the nucleus nor exporting-to-cytoplasm procedure was necessary when 
plants were infected by RNA transcripts, thus, less exposure to gene silencing as well as 
inefficient interactions result in a higher level of GFP expression. On the other hand, I can 
use the infected tissue after biolistic bombardment for subsequent infections by mechanical 
inoculation. 
GFP has been employed as a marker for many experiments due to its ability to produce 
fluorescence excitation under UV light (Cui and Wang 2016; Oparka 1997; Saberianfar et al.  
2016; Sattarzadeh et al. 2015). In this study, GFP was used as a reporter to track virus 
accumulation and quantify the level of protein expression. One of virus characteristics is the 
mosaic pattern which can be explained by variations in virus accumulation distributed in 
different parts of plants. The use of GFP facilitated observation of virus movement as well as 
viral protein accumulation. Furthermore, GFP was fused with either GP5N or GP5C in order 
to increase the amount of protein expression, by adding a stabilizing protein domain (P iron et 
al. 2014) and keep track of protein distribution (Zhang and Ghabrial 2006). 
I also demonstrated that both BPMV-GFP and BPMV-GP5C-GFP vectors were stable after 
six serial passages in soybean. The green fluorescence was maintained throughout the 
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soybean plants, especially in leaves and vascular systems in each passage. These results 
suggest that mechanical inoculation by rubbing BPMV-infected leaf tissue onto new plants 
can become an alternative conventional method since soybean leaves are recalcitrant to 
agroinfiltration. I stored infected leaves at -80
o
C up to 6 months and used these materials to 
effectively infect healthy plants. The new plants showed a hundred percent rate of infection 
using this method. The stability of this expression system facilitates the production of 
recombinant proteins on a large scale with automatically mechanical inoculation. 
2.5 Conclusion 
In summary, my data suggest that BPMV-based expression vectors can be employed to 
produce heterologous proteins in soybean plants. The level of GFP expressed in soybean 
using this system was 37.29 g/g fresh weight of leaf tissue (0.5% of total protein) at 30-45 
dpi. In addition, the C-terminus of GP5 fused with GFP was produced up to 4. 36 g/g leaf 
fresh weight (0.06% of total protein) in soybean leaves. The possibility of this protein to be 
an oral vaccine for pigs against PRRSV, and whether the level of protein expression can be 
increased by employing several strategies, including co-expression with a silencing 
suppressor p19 (Liu and Kearney 2010; Sainsbury et al. 2009b), fusing the protein of interest 
with a stabilizing domain (Piron et al. 2014) or generating a BPMV RNA1 transgenic 
soybean, which is then bombarded with modified BPMV RNA2, will be interesting topics for 
future studies. Despite the fact that much research has been done to express GP5 in either 
transgenic plant system (Chan et al. 2013; Chen and Liu 2011; Chia et al. 2010; Chia et al.  
2011; P iron et al. 2014) or transient system (Uribe-Campero et al. 2015), this is the first 
report of using viral expression vectors to successfully produce the GP5C-GFP in soybean 
leaves for an oral vaccine in pigs. Moreover, since there are not many viral expression 
vectors which can infect legumes, the BPMV based expression vectors offers an opportunity 
to produce soybean-made vaccine for oral administration. 
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Table 2.1 Primers used to construct expression vectors. 
Name Sequence (5’-3’) 
BamHI-GFP-F ATCCGGATCCGTGAGCAAGGGCGAGGAGCTGTT 
MscI-GFP-R ACCTTGGCCACTTGTACAGCTCGTCCATGCCGAGAG 
BamHI-GP5N-F ATCCGGATCCTTGGGGAAATGCTTGACCGCG 
BamHI-GP5C-F ATCCGGATCCTATTACCATGGGCGGTATGTTTTG 
BPMVR1-F TATTAAAATTTTCATAAGATTTGAAATTTTGAT 
BPMVR1-BamHI-
R 
CGCGGATCCTTTTTTTTTTTTATATTTAAACAC 
BPMVR2-F TAATACGACTCACTATAGTATTAAAATTTTCATAAGATTTG 
BPMVR2-XbaI-R GCGTCTAGATTTTTTTTTTTTTTTTTTTTTTTTTTAAAAT 
Nos-BamHI-F TTAGGATCCAGCTCGAATTTCCCCGATCGT 
Nos-PmeI-R CGCGTTTAAACCGCCAATATATCCTGTC 
GFP-F GTGAGCAAGGGCGAGGAGCTGTT 
GFP-R CTTGTACAGCTCGTCCATGCCGAGAG 
GP5N-F 
GGGGacaagtttgtacaaaaaagcaggcttgATGTTGGGGAAATGCTTGAC
CGCG 
GP5C-F 
GGGGacaagtttgtacaaaaaagcaggcttgTATTACCATGGGCGGTATGT 
TTTG 
GP5N-GFPlink-F 
GATCACTGTGTCTGCCGCCGGAATGGTGAGCAAGGGCGAG 
GAGC 
GP5N-GFP link-R 
GCTCCTCGCCCTTGCTCACCATTCCGGCGGCAGACACAGTG
ATC 
GFPatt-R 
GGGGACCACTTTGTACAAGAAAGCTGGGTCCTTGTACAGCT
CGTCCATGCC 
GP5C-GFPlink-F 
CAGCGGAACAATGGGGTCGTCCTATGGTGAGCAAGGGCG 
AGGAGC 
GP5C-GFPlink-R 
GCTCCTCGCCCTTGCTCACCATAGGACGACCCCATTGTTCCG
CTG 
pCamGateSeq-F CCTCACCTCAAAACCCACCA 
pCamGateSeq-R CCACGCCAGGTACTCCTACT 
M13 foward GTAAAACGACGGCCAG 
M13 reverse CAGGAAACAGCTATGAC 
AgeI-GP5N-F ATCGGACCGGTATGTTGGGGAAATGCTTGACCGC 
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AgeI-GP5C-F ATCGGACCGGTATGTATTACCATGGGCGGTATGT 
*Letter in lower cases stand for Gateway compatible primers including attB1 sites. 
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3.1 Introduction 
Cucumber green mottle mosaic virus (CGMMV) is an economically important seed-borne 
virus which affects cucurbitaceous crops worldwide. The virus was first identified in England 
(Ainsworth 1935), and has subsequently been detected in many countries in Europe, Asia and 
the Middle East (Al-Shahwan and Abdalla 1992; Fletcher et al. 1969; Liu et al. 2009; Ugaki 
et al. 1991; Wijethunga et al. 2014; Yoon et al. 2008). In recent years, several reports have 
alerted the existence of this virus in Australia and North America, including United States 
and Canada (Li et al. 2015; Tesoriero et al. 2016; Tian et al. 2014) resulting in devastating 
economic losses in melon and greenhouse cucumber crops. CGMMV belongs to the 
subgroup II of the genus Tobamovirus in the family Virgaviridae. Like other members of this 
genus, CGMMV assembles rod shaped particles, which are approximately 300 nm x 18 nm 
in size and encapsidate a single-stranded, positive-sense RNA of 6423 nucleotides (nt) in 
length as its genome. The genomic RNA encodes a 126-kDa protein (small replicase 
subunit), a 186-kDa readthrough protein known as RNA-dependent RNA polymerase 
(RdRp), a 30-kDa movement protein (MP) and a 17-kDa coat protein (CP). The movement 
and coat proteins are translated from individual 3’ co-terminal subgenomic RNAs. The 
coding sequence for MP is overlapped with that of the 186-kDa protein and CP. The 3’ UTR 
of the RNA genome consists of approximately 174 nt and forms a tRNA like structure. 
Similar to Tobacco mosaic virus (TMV), which is in the same genus, CGMMV can easily 
infect its host plants and yields a large amount of viral particles within a short time of initial 
infection. The simple monopartite genome of CGMMV makes genetic engineering relatively 
easy for expression of exogenous proteins. Therefore, CGMMV has great potential for the 
development of a virus-based expression system. However, a CGMMV vector developed 
recently was unstable due to the recombination of repeating promoters. In this vector, GFP 
was placed in frame with MP and CP sequences and transcribed by a subgenomic promoter 
of CP. GFP was initially detected in new leaves of bottle gourd, but deletion of GFP also 
occurred (Zheng et al. 2015). Apparently, CGMMV is not suitable for expression of long 
polypeptides. Based on their naturally symmetrical nanostructures, virus particles have 
demonstrated a proficiency to carry and display small peptides attached to the outer part of 
their capsids. Such small peptides could be a component of an enzyme inhibitor (Hamamoto 
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et al. 1993) or, an antigen, which binds to antibodies in immune systems (Brennan et al.  
1999; Sugiyama et al. 1995). For example, Dalsgaard et al. have employed CPMV to deliver 
the neutralizing epitope of the VP2 capsid protein, from Mink enteritis virus (MEV), as a 
subunit vaccine for mink, dogs and cats. The virus particles of CPMV have an icosahedral 
shape, which is comprised of 60 copies each of large (L) and small (S) protein subunits. The 
viral epitope, which includes 17 amino acids, was inserted into the B-C loop of the S coat 
protein subunit and produces viable virus particles, each containing 60 copies of the epitope. 
Approximately 100 g, or 1 mg, of purified chimeric virus particles can protect mink from 
clinical disease, but only the 1 mg dose is able to prevent viral shedding (Dalsgaard et al.  
1997). This example supports the idea that chimeric virus particles could act as efficient 
carriers in the development of plant-based vaccines against animal diseases. CGMMV is 
distinguished from CPMV by its helical shape, which is characteristic of the Tobamovirus 
genus, which includes TMV, Odontoglossum ringspot virus (ORSV), Ribgrass mosaic virus 
(RMV) and Tobacco mild green mosaic virus (TMGMV). As evidenced when visualization 
with fibre diffraction methods, the topography of all viruses in this family, including 
CGMMV, share similar coat protein structures, with a four- helix coat protein core and the 
N-terminus and C-terminus exposed on the surface of virus particles (Lobert et al. 1987; 
Namba and Stubbs 1986). The amino acid sequence of the coat protein of CGMMV, 
however, is just 36% identical to that of TMV (Meshi et al. 1983). The origin-of-assembly 
(OAS) is located approximately 300 nt from the 3’ end of the CGMMV genome, whereas, it 
is located approximately 900 nt from the 3’ end of the TMV genome. These differences 
divided tobamoviruses into two categories, subgroup I and II, based on coat protein 
sequences and OAS. TMV belongs to subgroup I and CGMMV in subgroup II (Fukuda and 
Okada 1982; Fukuda et al. 1980). Despite this, several studies have shown that CGMMV is 
also capable of peptide expression on the surface of chimeric virus particles and could be 
utilized for vaccine development, similar to TMV (Ooi et al. 2006; Teoh et al. 2009). 
In this study, the full-length cDNA sequence of CGMMV-ON, derived from infected 
cucumber plants in an Ontario greenhouse, was cloned into a binary vector. The clone was 
delivered to plants through agroinfiltration. The clone successfully infected cucumbers, 
watermelons, cantaloupes and N. benthamiana in pathogenicity tests, with different levels of 
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virulence severity. The infectious clone was further modified to express chimeric CGMMV, 
bearing the neutralizing epitope (NE) of PRRSV, in cucumber plants. The NE, which induces 
the production of neutralizing antibodies against the disease in pigs, is a nine-amino-acid 
peptide (Ser
37
-Gln-Leu-Gln-Ser-Ile-Tyr-Asn-Leu
45
) of GP5, the major envelope protein of 
PRRSV. Here, I describe the construction of this expression vector and the expression of 
chimeric CGMMV, via a readthrough translational mechanism, in cucumber for a plant-made 
vaccine against PRRSV. 
3.2 Materials and methods 
3.2.1 Construction of agro-infectious CGMMV clone 
To produce CGMMV genomic cDNA, total RNA was extracted from CGMMV-ON infected 
cucumber leaves using TRIzol reagent (Invitrogen, Burlington, Ontario, Canada). First strand 
cDNA was synthesized using SuperScript III Reverse Transcriptase (Invitrogen) with 
Random Primers 6 (New England Biolabs, P ickering, Ontario, Canada), fo llowed by RNase 
H (Invitrogen) treatment at 37°C for 20 min. The full-length viral genome was amplified 
using the forward primer, CGMMV5UTR-F, and the reverse primer, CGMMV3UTR-R. PCR 
was performed using Phusion High-Fidelity DNA Polymerase (New England Biolabs) and 
the following cycle: (1) a pre-denaturation at 98°C for 3 min; (2) 25 cycles of denaturation at 
98°C for 30 sec, annealing at 50°C for 1 min and extension at 72°C for 7 min; and (3) an 
extra 5 min of extension at 72°C. The resulting PCR product, of 6.5 kb, was then gel 
separated and purified using GenepHlow Gel Extraction Kit (FroggaBio, Toronto, Ontario, 
Canada) and subsequently cloned into pCR-Blunt with a Zero Blunt PCR Cloning Kit 
(Invitrogen), to create pCR-Blunt CGMMV. Selected clones were confirmed by colony PCR 
using M13 reverse and CGMMVR3-R primers and by DNA sequencing with M13 reverse 
and M13 forward primers. 
The binary vector, pCB 301 (Xiang et al. 1999) was modified to contain a double 35S 
promoter and a ribozyme sequence at the 3’ end, right upstream of the terminator (Rz-T), and 
was used for construction of an infectious CGMMV clone. The double 35S promoter and Rz-
T fragments were amplified from pCass4-Rz (Annamalai and Rao 2005) using two primer 
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sets, SacI-35S-F and SpeI-StuI-35S-R, and BamHI-RzT1-F and KpnI-RzT1-R, respectively. 
The amplified PCR products were digested with SacI and SpeI (for the double 35S product) 
and BamHI-HF and KpnI (for the Rz-T product), and cloned into the corresponding sites 
(SacI/SpeI or BamHI/KpnI) of the pCB 301 vector. The resulting pCB-Rz vector was then 
introduced into Escherichia coli DH 5 (Invitrogen). The insert cDNAs were confirmed by 
DNA sequencing.  
The full-length cDNA sequence of the CGMMV genome was obtained in two steps using 
Phusion High-Fidelity DNA Polymerase (New England Biolabs). The first 1348 nt of the 
CGMMV cDNA were amplified by the forward primer , CGMMV5UTR-F and the reverse 
primer, BamHI-AgeI-R. PCR was performed using the following cycle: (1) a pre-
denaturation at 98°C for 3 min; (2) 25 cycles of denaturation at 98°C for 30 sec, annealing at 
55°C for 1 min and extension at 72°C for 1 min; and (3) an extra 5 min of extension at 72°C. 
The purified PCR product was digested with BamHI and ligated into the corresponding sites 
(StuI/BamHI) of pCB-Rz, such that the 5’ untranslated region (UTR) of the CGMMV 
genome was just downstream of the transcription start site of the double 35S promoter, to 
create pCB-CG-1. The remainder cDNA of the CGMMV genome was amplified using the 
forward primer, CGMMVAgeI-F, and the reverse primer, BamHI-3UTR-R, using the 
following PCR cycle, (1) a pre-denaturation at 98°C for 3 min; (2) 25 cycles of denaturation 
at 98°C for 30 sec, annealing at 55°C for 1 min and extension at 72°C for 4 min; and (3) an 
extra 5 min of extension at 72°C. The PCR product was purified, digested with AgeI/BamHI 
and cloned into pCB-CG-1 in order to generate the full-length cDNA clone of CGMMV, 
pCB-CG. pCB-CG was confirmed by PCR and DNA sequencing. 
All the primer sequences are described in Table 3.1. 
3.2.2 Construction of chimeric CGMMV presenting the NE of GP5 
My first attempt was made by introducing NE into the C-terminus of the CGMMV CP before 
the stop codon. The sequence of NE, encoding nine amino acids (Ser
37
-Gln-Leu-Gln-Ser-Ile-
Tyr-Asn-Leu
45
), was amplified together with the sequence of CGMMV CP, by fusion PCR, 
using pCB-CG as a template and primers, NheI-NE-F and BamHI-3UTR-R. The PCR 
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product was digested and ligated into pCB-CG to create pCG-NE. The construct was 
confirmed by DNA sequencing, transformed into agrobacteria (strain GV3101) and 
subsequently infiltrated into cucumber cotyledons. 
For production of NE-containing CP, another attempt was made using a readthrough strategy 
(Ooi et al. 2006; Teoh et al. 2009). The CGMMV clone was engineered to include the 
readthrough (RT) sequence, either “TCT-AAA-TAG-CAA-TTA” (RT1) or “TCC-AAA-TAG-
CAA-TTA” (RT2). First, a fragment of the CP coding region in pCB-CG was digested by 
MluI and BamHI and then ligated in to a MluI/BamHI-digested pCR-Blunt vector 
(Invitrogen) to generate pCR-CP. The RT1-NE-3’UTR was amplified from pCG using 
HindIII-AmberNE-F and BamHI-3UTR-R and then introduced into pCR-CP via 
HindIII/BamHI sites to create pCR-NE. The entire CP coding sequence and 3’ UTR of 
CGMMV were digested from pCR-NE and ligated into pCB-CG via MluI/BamHI sites to 
form pCG-RT1NE. Second, the RT2-NEcmyc-3’UTR was amplified using HindIII-
NEcmycC-F and BamHI-3UTR-R, and inserted into pCR-CP, via HindIII/BamHI, to form 
pCR-NEcmyc. The entire CP and 3’ UTR fragment was digested from pCR-NEcmyc and 
ligated into the MluI/BamHI sites of pCB-CG, to generate pCG-RT2NEcmyc. 
All the primer sequences are described in Table 3.1. 
3.2.3 Agroinfiltration of CGMMV infectious clone and chimeric CGMMV 
clones 
The CGMMV based constructs were agroinfiltrated into plants using Agrobacterium 
tumefaciens (strain GV3101). Agrobacterial cultures were grown in liquid LB medium with 
kanamycin (50 g/ml) and rifampicin (50 g/ml) at 28°C, to an optical density at 600 nm 
(OD600) of 1.5-2.0. Cells were harvested by centrifugation at 5000 x g for 5 min. The pellet 
was resuspended in agroinfiltration buffer (10 mM MgCl2, 10 mM MES and 150 M 4ʹ-
Hydroxy-3ʹ, 5ʹ-dimethoxyacetophenone) and incubated at room temperature for 2 hr.  This 
was followed by a further dilution with agroinfiltration buffer, to reach a final OD600 of 1.0. 
The suspension was then infiltrated into either the abaxial leaf epidermis of Nicotiana 
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species, or the cotyledons of cucumbers, watermelons and cantaloupes, with a 1 ml syringe 
(Kapila et al. 1997) 
 For the infectivity test of the CGMMV infectious clone, leaves of 3-week-old N. 
benthamiana and N. tabacum seedlings were agroinfiltrated with 1 ml of bacterial suspension 
(Yoon et al. 2011). For cucumbers (Cucumis sativus var. Straight 8), watermelons (Citrullus 
lanatus var. Greybelle) and cantaloupes (Cucumis melo var. Hami), fully expanded 
cotyledons of 10-day-old plants were agroinfiltrated (Cui et al. 2013).  For each variety, six 
seedlings (two leaves or cotyledons each) were used. Infectivity was identified by either 
double-antibody sandwich enzyme-linked immunosorbent assays (DAS-ELISA) or reverse 
transcription-polymerase chain reactions (RT-PCR). 
3.2.4 DAS-ELISA and RT-PCR 
CGMMV infection of agroinfiltrated plants was confirmed using either ELISA or RT-PCR. 
DAS-ELISA was performed using a CGMMV ELISA kit (catalog number SRA 45701; 
Agdia, Elkhart, IN, USA) and follow ing the manufacturer’s protocol. Three 4 mm leaf disks 
were sampled from systematic leaves and homogenized using a TissueLyser II (QUIAGEN), 
mixed well with 500 l of general extraction buffer (GEB) and then  l of the resulting 
mixture was added to a 96 well plate. Following the ELISA procedure, virus positive samples 
were detected by a significant color development in plate wells. To determine the absorbance 
value of the color change, plates were read using an iMark Microplate Reader (Biorad) at 415 
nm. Three biological replicates were performed for each treatment. ELISA values were 
compared between infected plants and mock-treated plants using the two-tailed Student’s t-
test. Statiscal analysis was performed using Microsoft Excel software.  A p-value of 0.05 or 
less indicates a significant difference. 
Total RNA was extracted from young leaves using TRIzol (Invitrogen) and treated with 
DNase I (Invitrogen), as described in 2.2.12. First-strand cDNA was generated by reverse-
transcription reactions with Random Primer 6 (New England Biolabs) and SuperScript III 
Reverse Transcriptase (Invitrogen). To test the infectivity of pCB-CG, RT-PCR was 
conducted to amplify the full length of the MP of CGMMV, using primers CGMMVMP-F 
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and CGMMVMP-R, at 15 dpi. To identify the infectivity of expression constructs including 
pCG-NE, pCG-RT1NE and pCG-RT2NEcmyc, RT-PCR was performed with primers of CP-
F and BamHI-3UTR-R, at 21 dpi. Similar primers were also used for RT-PCR and 
sequencing at 45 dpi to examine the stability of pCG-RT2NEcmyc. The resulting sequence 
was aligned with the insert and wild-type GGMMV sequences using the online T-coffee 
program (http://tcoffee.crg.cat). All PCR reactions were performed using 2X Taq Frogga 
Mix (FroggaBio, Toronto, ON, Canada) using the following cycle:  (1) a pre-denaturation at 
94°C for 3 min; (2) 32 cycles of denaturation at 94°C for 30 sec, annealing at 55°C for 1 min 
and extension at 72°C for 1 min; and (3) an extra 10 min of extension at 72°C. Internal 
control of RT-PCR for pCG-NE was performed using primers Actin-F and Actin-R. All the 
primer sequences are described in Table 3.1. 
3.2.5 Chimeric coat protein extraction and quantification 
To study the protein production of chimeric CGMMV in cucumber, western blot analysis 
was performed using systemic leaf tissue samples. Ten leaf discs (3 mm in diameter) were 
sampled for a time-course experiment, with collections at 21 and 50 dpi, and homogenized 
using a TissueLyser II (QUIAGEN). One ml of extraction buffer (50 mM Tris-HCl pH 7.5, 
150 mM NaCl, 10% (v/v) glycerol, 0.1% (v/v) TritonX-100, 5 mM dithiothreitol, 1.5X 
protease inhibitor) was then added to the ground leaves in order to obtain the total soluble 
protein (TSP). Protein extraction from buffer-only infiltrated plants and CGMMV infiltrated 
plants was also performed under the same conditions and used as negative and positive 
controls, respectively. Total soluble protein concentration levels were determined using a 
Bradford assay (Bradford 1976), with bovine serum albumin (BSA) as a standard, and using 
an iMark Microplate Reader (Biorad). Protein extracts were separated by electrophoresis in a 
15% (w/v) sodium dodecyl sulphate-polyacrylamide gel (SDS-PAGE) and transferred onto a 
polyvinylidene difluride (PVDF) membrane. To identify CP, primary anti-CGMMV CP 
monoclonal antibody, produced in mouse (Zheng et al. 2015), was incubated with the 
membrane and subsequently detected using horseradish peroxidase (HRP)-conjugated goat 
anti-mouse IgG antibody (Sigma-Aldrich, Oakville, ON, Canada). To determine levels of 
chimeric CP tagged with cmyc, the primary antibody was changed to mouse anti-cmyc 
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monoclonal antibody (Sigma- Aldrich). Western blots were visualised by the Immobilon 
Western (Millipore Corporation, Billerica, MA, USA), following the manufacturers’ 
protocol. The resulting images were analysed with TotalLab TL100 software (Nonlinear 
Dynamics, Durhan, USA) by comparing the densitometry of bands with known a mounts of a 
synthetic cellulose-binding domain (CBD) protein tagged with cmyc (GenScript, P iscataway, 
USA). Three biological replicates were performed for each time-course extraction. 
3.2.6 Characterization of the chimeric CGMMV displaying NE by transmission 
electron microscopy (TEM)  
30 l of the anti-cmyc agarose conjugate (Sigma-Aldrich) was washed 5 times with 1 ml 
washing buffer (20 mM Tris-HCl pH 7.5, 300 mM NaCl, 5 mM MgCl2, 0.5% (v/v) Triton X-
100). CGMMV particles were extracted following the procedure as described (Seo et al.  
2013). Chimeric CGMMV-infected leaf tissue (0.5 g) was ground with 1 ml of extraction 
buffer (20 mM Tris-HCl pH 7.5, 300 mM NaCl, 5 mM MgCl2, 5 mM dithiothreitol, 0.5% 
(v/v) Triton X-100) using a mortar and pestle. The extraction was centrifuged at 12 000 x g 
and 4°C for 10 min at and then filtered through a 45 m cell strainer (BD Biosciences, 
Franklin Lakes, NJ, USA) to eliminate cell debris. The resulting supernatant was added to the 
washed resin in a 1.5 ml Eppendorf tube and incubated for 2 hr on an orbital shaker at 4°C, 
following the manufacturers’ protocol. After incubation, the virus-resin complexes were then 
precipitated by centrifugation for 1 min at 8 000 x g and washed six times in 500 l of wash 
buffer to remove nonspecific bindings. The resin was resuspended in 100 l of wash buffer 
in the final step. Wild-type CGMMV-infected leaves were processed in the same procedure 
as a negative control. The resulting suspension was subjected to negative staining with 2% 
(w/v) uranyl acetate (pH 4.5) and visualization using TEM (Haschemeyer and Meyers 1973). 
3.3 Results  
3.3.1 Characteristics of CGMMV infectious clone for agroinfiltration 
The full-length cDNA of CGMMV was successfully cloned into plasmid pCB-Rz (Figure 
3.1A) between the double 35S promoter and the ribozyme sequence (Rz), to generate            
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pCB-CG. Since the 5’ UTR sequence is important for efficient replication and biological 
activities of the positive strand RNA virus (Boyer and Haenni 1994; Janda et al. 1987) , the 
transcription start site was designed precisely at the nucleotide “G” of the CGMMV genome 
to produce the authentic viral 5’ end. Transcription of the full-length CGMMV cDNA, 
followed by ribozyme self-processing would produce the entire viral genome with an 
additional 18 nt extension at the 3’ UTR (Figure 3.1B). 
A pathogenicity test of the CGMMV derived clone, pCB-CG, was conducted using its 
natural hosts including cucumbers, cantaloupes and watermelons, as well as experimental 
hosts, N. benthamiana and N. tabacum. Plants were observed for symptoms at 10-15 dpi. 
Cucurbit plants showed obvious mosaic, chlorosis, necrosis and crinkle symptoms on new 
emerging leaves at 10 dpi, identical to the symptoms of wild-type CGMMV-infected plants 
(Figure 3.2A, B, and C). Mild mottling and distortion appeared on the upper leaves of N. 
benthamiana at 15 dpi (Figure 3.2D). No typical symptom was displayed in N. tabacum. All 
mock plants treated with buffer infiltration did not exhibit any of these symptoms (Figure 
3.2). To further confirm the infectivity, samples of systemic leaves were collected and 
subjected to DAS-ELISA and RT-PCR. Both DAS-ELISA and RT-PCR detected CGMMV 
in cucumbers, watermelons, cantaloupes and N. benthamiana infiltrated with the pCB-CG 
clone, but not mock-treated control plants (Figure 3.3A, B and C). Although DAS-ELISA 
results showed a significant difference between pCB-CG-infiltrated N. tabacum and mock-
treated plants, RT-PCR did not show a strong band of interest. These data suggest that the 
full-length cDNA clone of CGMMV was infectious in cucumbers, watermelons, cantaloupes 
and N. benthamiana, but not in N. tabacum, and that symptoms were various, depending on 
the host family.  
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Figure 3.1  Construction of the CGMMV infectious clone. A. Schematic representation of T-
DNA vector, pCB-Rz, which was used to clone the cDNA of CGMMV genomic RNA 
between the left border (LB) and right border (RB) (not drawn to scale). The vector contains 
a double CaMV 35S promoter (35S), a ribozyme sequence (Rz) and a CaMV 35S terminator 
(T) derived from pCass4-Rz. Cloning region with three restriction sites, StuI, SpeI and 
BamHI was used to introduce cDNA of the CGMMV genome. B. Characteristics of T-DNA 
plasmid containing the CGMMV genome used for agroinfiltration. Single lines and open box 
represent noncoding and coding regions, respectively. Polycistronic CGMMV RNA encodes 
for a 186-kDa protein (186K), movement protein (MP) and coat protein (CP). The dashed 
line represents readthrough translation in the 186K coding sequence. The 3’ end of the double 
35S promoter is represented in lower case, whereas, the 5’ sequence of CGMMV cDNA was 
shown in uppercase. Transcription start site is shown with a bent arrow. The 3’ end of 
CGMMV cDNA is shown in uppercase and the non-viral sequence, following the ribozyme 
site, is in lowercase and italic. The self-cleavage site of ribozyme is indicated by a curved 
arrow.  
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Figure 3.2  Pathogenicity test on natural and experimental hosts with the CGMMV 
infectious clone. Symptoms in: A. Cantaloupe (Cucumis melo var. Hami) at 15 dpi with 
mosaic and crinkled leaves, B. Watermelon (Citrullus lanatus var. Greybelle) infiltrated with 
the infectious clone showed mosaic and clearing vein symptoms on leaves, C. Cucumber 
(Cucumis sativus var. Straight Eight) which was infected with CGMMV showed mosaic and 
crinkled leaves, and  D. N. benthamiana showed mild symptoms with crinkle and mosaic 
leaves at leaf edges, as indicated by the white arrow. 
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Figure 3.3  DAS-ELISA and RT-PCR results of infiltrated plants at 15 dpi. Error bars 
represent the standard deviation of the mean (n=3). Asterisks indicate significant differences 
from mock-treated plants (Student’s t-test, p<0.05). A. Infiltrated cantaloupes, watermelons 
and N. tabacum. B. Infiltrated cucumbers and N. benthamiana. C. RT-PCR results of 
infiltrated plants at 15 dpi, amplifying the coding sequence of the viral movement protein. 
Lane M: 100 bp DNA marker. Lane 1: CGMMV infected cucumber (greenhouse) as a 
positive control. Lane 2: Negative control mock plant infiltrated with buffer.                              
Lane 3: Infiltrated cucumber. Lane 4: Infiltrated watermelon. Lane 5: Infiltrated cantaloupe. 
Lane 6: Infiltrated N. benthamiana. 
  
C. 
114 
 
 
 
3.3.2 Infectivity of chimeric CGMMV 
3.3.2.1 Direct fusion downstream of CP 
Firstly, NE, which includes nine amino acids (Ser
37
-Gln-Leu-Gln-Ser-Ile-Tyr-Asn-Leu
45
) of 
the PRRSV GP5, was inserted right before the stop codon of CGMMV-CP, to generate the 
construct pCG-NE (Figure 3.4A). To test the infectivity of this construct in cucumber and N. 
benthamiana, the upper non-infiltrated leaves of plants infiltrated with pCG-NE was sampled 
at 21 dpi and total RNA purified from the samples was analyzed by RT-PCR. Viral RNA was 
hardly detected in cucumber and N. benthamiana infiltrated with pCG-NE (Figure 3.4B), 
unlike samples from pCB-CG infiltrated plants which served as a positive control. These 
results indicated that the direct fusion strategy did not work well.  
3.3.2.2 Readthrough stop codon  
The modified CGMMV constructs generated using the readthrough strategy were also tested 
for their infectivity. In contrast to the direct fusion mentioned above, both constructs 
displayed high infectivity in cucumber, but the infectivity was varied on N. benthamiana. 
The pCG-RT1NE clone could infect both cucumber and N. benthamiana, whereas the pCG-
RT2NEcmyc could only infect cucumber (Figure 3.5A and 3.6A). The severity of symptoms 
caused were varied, depending on construct and host plant combinations. N. benthamiana 
infected by pCG-RT1NE showed very mild symptoms, with clearing veins and blistering on 
leaf edges (Figure 3.5B bottom), and pCG-RT1NE-infected cucumber demonstrated 
wrinkled and mosaic leaves (Figure 3.5B top). In contrast, pCG-RT2NEcmyc-infected 
cucumber displayed blistering and cupped leaves (Figure 3.6B). Consistently, DAS-ELISA 
and RT-PCR confirmed the presence of chimeric CGMMV in all cucumber plants infiltrated 
with pCG-RT1NE and pCG-RT2NEcmyc, and in N. benthamiana infiltrated with pCG-
RT1NE (Figure 3.5C and 3.6C). 
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Figure 3.4  Construction of pCG-NE and its infectivity in N. benthamiana and cucumber.    
A. Schematic representation of pCG-NE in which 2 restriction sites of NheI and BamHI were 
employed to introduce NE upstream before the stop codon of CP (not drawn to scale).          
B. RT-PCR results of pCG-NE infiltrated plants at 21 dpi, amplifying sequences of coat 
protein (CP) and 3’ UTR, and actin.  Lane 1-3: pCG-NE infiltrated cucumbers. Lane M: 100 
bp DNA marker. Lane 4: pCG infiltrated cucumber as a positive control (663 bp).            
Lane 5-6: pCG-NE-infiltrated N. benthamiana. Lane 7: pCG infiltrated N. benthamiana as a 
positive control (663 bp). 
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Figure 3.5  Construction of pCG-RT1NE and its infectivity in N. benthamiana and 
cucumber. A. Schematic representation of pCG-RT1NE (not drawn to scale) .                         
B. Symptoms in cucumbers and N. benthamiana infiltrated with pCG-RT1NE at 21 dpi.       
C. RT-RCR results of pCG-RT1NE infiltrated plants at 21 dpi, amplifying the coding 
sequence of CGMMV CP fused with NE and 3’ UTR (711 bp). Lane 1: Negative control. 
Lane 2: Infiltrated N. benthamiana. Lane 3: Positive control of wild-type CGMMV-infected 
plant. Lane M: 100 bp DNA ladder.  Lane 4: Infiltrated cucumber. 
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Figure 3.6  Construction of pCG-RT2NEcmyc and its infectivity in N. benthamiana and 
cucumber.  A. Schematic representation of pCG-RT2NEcmyc (not drawn to scale) .              
B. Symptoms in cucumber infiltrated with pCG-RT2NEcmyc at 21 dpi.                                
C. RT-PCR results from samples of cucumbers and N. benthamiana infiltrated with pCG-
RT2NEcmyc at 21 dpi, amplifying the extended CP sequence (738 bp). Lane 1: Negative 
control. Lane M: 100 bp DNA ladder. Lane 2: Wild-type CGMMV-infected plant.              
Lane 3-5: pCG-RT2NEcmyc infiltrated cucumber. Lane 6-8: pCG-RT2NEcmyc -infiltrated N. 
benthamiana.  
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3.3.3 Peptide expression on the coat protein of chimeric CGMMV via 
readthrough translation 
Since the pCG-RT1NE could infect both cucumber and N. benthamiana, protein extracts 
from these plants were subjected to western blot analysis, using anti-CP antibody, to detect 
NE-containing CP. Unfortunately, none of these plants produced chimeric CP. The results of 
western blot analysis showed only one band, approximately 15 kDa in size, which matched 
with the predicted molecular mass for CGMMV CP (used as a negative control) (Figure 
3.7A) 
On the contrary, the chimeric CP containing NEcmyc (CP-NEcmyc), which has a size of 
approximately 20 kDa, was detected in cucumber infiltrated with pCG-RT2NEcmyc using 
both anti-CGMMV CP antibody (Figure 3.7B) and anti-cmyc antibody (Figure 3.7C). The 
expression level of CP-NEcmyc was estimated to be 35.84 g/g of fresh weight (0.067% of 
TSP) at 21 dpi, and decreased to 16.60 g/g of fresh weight (0.038% of TSP) at 50 dpi 
(Figure 3.7D and E). 
3.3.4 Presentation of the NE on the surface of chimeric CGMMV coat protein 
To determine whether the NE of PRRSV GP5 was displayed on the surface of CGMMV 
capsids, the chimeric virions extracted from pCG-RT2NEcmyc-infiltrated leaves underwent 
immunoprecipitation using anti-cmyc beads and were imaged using transmission electron 
microscopy, as described in Figure 3.8A. The amount of chimeric CGMMV bound to anti-
cmyc beads was remarkably more abundant when compared to wild-type CGMMV, as a 
negative control, at 19 000X magnification (Figure 3.8B top). Moreover, there were more 
beads unbound by wild-type CGMMV when compared to chimeric CGMMV in the same 
field. Each virion shape was an intact rod about 300 nm in length and 18 nm in width, which 
is distinct for CGMMV (Figure 3.8B bottom). The results demonstrated that the affinity of 
chimeric virions to anti-cmyc beads was much higher than that of the wild-type CGMMV 
virions, due to the immuno-attraction between cmyc antigen and the anti-cmyc beads. These 
data affirmed that NE, as well as cmyc, was successfully displayed on the surface of chimeric 
CGMMV capsids.      
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Figure 3.7  Western blot analysis of protein extracts from chimeric virus -infected leaves.       
A. Western blot analysis of pCG-RT1NE-infected leaves using anti-CP antibody.              
Lane 1: Chimeric virus-infected cucumber. Lane 2: Chimeric virus -infected N. benthamiana. 
Lane 3: Wild-type virus-infected N. benthamiana.   B. Western blot analysis of pCG-RT2NE-
infected leaves using anti-CP antibody. Lane 1-2: Chimeric virus-infected cucumber.        
Lane 3-6: Wild-type virus-infected N. benthamiana. Lane 7-8: Wild-type virus-infected 
cucumber.  C. pCG-RT2NE-infected plants displayed a chimeric CP (containing NEcmyc) 
band, at about 20 kDa on a western blot with anti-cmyc antibody. Lane 1: Non-infiltrated 
plant. Lane 2: Buffer infiltrated plant. Lane 3: Wild-type virus-infiltrated plant.                 
Lane 4-7: pCG-RT2NEcmyc-infiltrated cucumber.  D. Quantification of chimeric CP at 
different harvest time using western blot with anti-cmyc antibody. Lane 1-5: 1, 4, 8, 16, 32 ng 
of cellulose-binding domain (CBD) protein tagged with cmyc as a standard, respectively.  
Lane 6-8: pCG-RT2NEcmyc-infiltrated cucumber at 21 dpi. Lane 9-11: pCG-RT2NEcmyc-
infiltrated cucumber at 50 dpi.   E. Level of chimeric CP expression measured by g per g 
fresh weight of leaf tissue. Error bars represent the standard deviation of the mean (n=3). 
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Figure 3.8  The presentation of NEcmyc on the surface of chimeric CGMMV.                     
A. Flow chart of the immunoprecipitation procedure for detection of chimeric CGMMV.      
B. TEM results of chimeric CGMMV under different magnification, 19 000X and 64 000X. 
The number of chimeric virus particles bound to anti-cmyc beads was remarkable when 
compared to the wild-type viruses. At 64 000X magnification, these virus particles displayed 
the rod shapes which are characteristics for CGMMV.  
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3.3.5 The stability of the pCG-RT2NEcmyc 
To investigate the stability of pCG-RT2NEcmyc in cucumber, RT-PCR and DNA 
sequencing was conducted using newly emerging young leaves from infiltrated plants at 45 
dpi. The results from RT-PCR confirmed that the amplicon of chimeric CP and 3'UTR, 738 
bp, was preserved and larger than that of wild-type CP, which is 663 bp (Figure 3.9A). The 
NEcmyc sequence on the chimeric coat protein was also confirmed at 45 dpi (Figure 3.9B). 
Moreover, no wild-type CP was detected in plants infiltrated with the pCG-RT2NEcmyc  
construct. The results confirmed that the pCG-RT2NEcmyc was stable in infiltrated 
cucumber for at least 45 dpi.  
3.4 Discussion 
CGMMV is an important vial pathogen that impedes Cucurbita crop production in the world. 
In this study, I developed a full-length cDNA infectious clone based on CGMMV-ON, a 
CGMMV isolate from a greenhouse in Ontario, Canada and further modified it for 
expression of PRRSV GP5. In addition to being employed as expression vectors for 
biotechnological applications, such as the production of proteins of interest in plants (Lindbo 
2007b; Marillonnet et al. 2005), infectious clones also play an essential role in studies of 
RNA plant viruses such as replication and virus-host interactions (Ahlquist et al. 1984; 
Ahlquist et al. 2003; Cui et al. 2013; Cui and Wang 2016). This explains why the generation 
of infectious clones is often the initial step of virus investigations. Construction of infectious 
clones may encounter many technical difficulties in order to maintain the biological 
characteristics of wild-type viruses. For example, the addition of non-viral nucleotides at 
either the 5’ end or the 3’ end of transcripts has a deleterious impact on viral replication and 
infectivity (Annamalai and Rao 2005; Chapman 2008). The process of developing an 
infectious clone into a binary vector also involves the potential introduction of mutants, 
which can lead to infectivity failures (Boyer and Haenni 1994; Junqueira et al. 2014; Lai 
2000; Lindbo 2007a; Liu and Kearney 2010). Keeping these in mind, I minimized PCR 
cycles and subcloning steps to prevent mutations during construction of the CGMMV 
infectious clone. Moreover, the CGMMV genome was placed right downstream of a double 
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CaMV 35S promoter in order to eliminate any non-viral nucleotide between the transcription 
start and the 5’ end of virus genome, thus, ensured a successful in vivo transcription in plant 
(Turpen et al. 1993). The CGMMV vector developed in this study can be introduced into 
plants through agroinfiltration, a versatile method compared to biolistic bombardment or 
inoculation of RNA transcripts (Chapman 2008). 
CGMMV is a member of the genus Tobamovirus, which also includes TMV. Tobamoviruses 
are well-known for their stability and persistence for long periods on non-host surfaces, such 
as plant debris, soil and tools, which facilitates the transmission of these viruses by 
mechanical means (Broadbent 1976; Broadbent et al. 1965; Lanter et al. 1982). As a member 
of this genus, CGMMV employs these characteristics to spread among cucurbit crops 
worldwide (Ainsworth 1935; Al-Shahwan and Abdalla 1992; Fletcher et al. 1969; Liu et al.  
2009; Wijethunga et al. 2014; Yoon et al. 2008). Natural hosts of CGMMV are restricted to 
Cucurbitaceae, including cucumber, squash, melon, muskmelon, bottle gourd and 
watermelon (Lovisolo 1981). The infectious clone derived from CGMMV infected cucumber 
plants found in these greenhouses can infect not only natural hosts, such as cucumbers 
(Cucumis sativus var. Straight Eight), cantaloupes (Cucumis melo var. Hami) and 
watermelons (Citrullus lanatus var. Greybelle), but also an experimental host, N. 
benthamiana with disease symptoms ranging from latent to mild (Figure 3.2). In N. 
benthmiana, systemically infected leaves, although without obvious symptoms, did carry the 
virus (Figure 3.3B and C). The results suggested that there was a remarkable difference in 
host responses to CGMMV, and N. benthamiana may serve as a model plant for the studies 
of CGMMV pathogenesis and virus-host interactions. 
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Figure 3.9  Stability of chimeric construct pCG-RT2NEcmyc at 45 dpi.  A. RT-PCR results 
using primers for chimeric coat protein and 3’ UTR sequence. Lane 1: Negative control.    
Lane M: 100 bp ladder.  Lane 2: Wild-type CGMMV. Lane 3-7: Chimeric CGMMV.              
B. Sequence alignment of chimeric virus. The insert sequence of NEcmyc was detected in all 
of infiltrated cucumber plants at 45 dpi.  
B. 
738 bp 
A. 
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In this study, CGMMV was utilized as a viral expression system for peptide display on the 
surface of CGMMV capsids, by the readthrough strategy. Several previous studies have 
reported the decoration of CGMMV capsids with different peptides such as Hepatitis B virus 
surface antigen (HBsAg) (Ooi et al. 2006) and a truncated dengue virus envelope protein 
(Teoh et al. 2009) via readthrough translation. The infectious clones used in these studies had 
to be transcribed via in vitro transcription to obtain the viral RNA transcripts, which were 
then mechanically inoculated onto plants. In this study, I modified the full length cDNA of 
CGMMV-ON to express the NE of PRRSV GP5 in cucumber. In my study, in vitro 
transcription was eliminated and agroinfiltration was exploited as a one-step, low-cost 
inoculation method. The infectivity rate was 100% of infiltrated cucumber plants. These data 
suggests that this vector may be inoculated via agroinfiltration for scale-up production.  
Systemic movement in infected host plants is one of the key processes of viral pathogenesis 
and results in a large amount of viral proteins produced throughout the plant. Taking 
advantage of this property, a chimeric CGMMV, expressing PRRSV-NE was designed to 
preserve the ability of wild-type CGMMV to spread systemically in cucumber. In this study, 
the NE was initially fused directly upstream of the CP stop codon. However, this chimeric 
CGMMV demonstrated inefficient systemic movement in both cucumber and N. 
benthamiana (Figure 3.4), probably due to the incompetence of virus assembly. CGMMV 
long distance movement is through the xylem or phloem in the form of virus particles 
(Moreno et al. 2004; Simón-Buela and García-Arenal 1999) which requires an intact CP. 
Direct fusion of the nine-amino-acid NE to CP may impair CP structure and disrupt CP 
assembly, thus, leading to the failure of systemic infection as previously described with TMV 
(Dawson et al. 1989; Saito et al. 1990; Takamatsu et al. 1990). 
To maintain systemic virus movement and express NE on CP, I exploited ribosomal 
readthrough translation in my second approach. Several families of plant viruses including 
tobamoviruses, luteoviruses, benyviruses and tombusviruses have been reported to use the 
stop codon readthrough strategy to regulate gene expression (Harrell et al. 2002). For 
example, a 126-kDa protein was translated from the first open reading frame in the sequence 
of TMV, and a 183-kDa protein was encoded by an extension of the first open reading frame 
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through an in-frame UAG stop codon. By using this readthrough translation, TMV controlled 
the ratio of 126-kDa and 183-kDa synthesis, which plays a critical role as helicase and RdRp 
in viral replication, at a relative level of approximately 20 to 1 (Skuzeski et al. 1991). 
CGMMV also possesses this mechanism for RdRp synthesis. However, the essential 
sequence required for readthrough of CGMMV, “AAA-UAG-CAA-UUA”, was distinct from 
that of TMV, “CAA-UAG-CAA-UUA”, and using the TMV readthrough sequence could not 
produce readthrough translation of CGMMV in musk melon (Teoh et al. 2009). In this study, 
two sequences named RT1 and RT2, were used to express NE and NEcmyc, respectively. 
Both sequences met the minimal context required for CGMMV readthrough translation and 
only differed in one nucleotide (upstream of the minimal context) which did not alter the 
amino acid sequence. Interestingly, RT1, “TCT-AAA-TAG-CAA-TTA”, failed to direct 
readthrough translation in cucumber, in contrast RT2, “TCC-AAA-TAG-CAA-TTA” 
successfully led to expression of the readthrough protein CP-NEcmyc (Figure 3.7A, B and 
C). Moreover, the construct pCG-RT1NE could establish systemic infection in both 
cucumbers and N. benthamiana (Figure 3.5), whereas pCG-RT2NEcmyc could infect 
cucumber only (Figure 3.6). These results suggest that the minimal context of leaky stop 
codon in CGMMV should be extended to “UCC-AAA-UAG-CAA-UUA” for an efficient 
readthrough translation, and that the infectivity of chimeric virus is dependent on the foreign 
peptides introduced on CGMMV CP, especially their sizes.  
Despite the intense research on peptide-displaying TMV, there are limited reports on the 
exploitation of CGMMV for antigen presentation. In previous studies, the level of chimeric 
CGMMV containing a HBsAg or a truncated dengue virus type 2 envelope protein binding 
region (EB4), was estimated at 50% of the total virus particles produced in musk melon at 14 
dpi (Ooi et al. 2006; Teoh et al. 2009). In this study, the chimeric CP containing NEcmyc 
was measured at 35.84 g/g of fresh weight (0.067% of TSP) in cucumber at 21 dpi, and the 
ratio of chimeric CP to wild-type CP was approximately 1:20 (Figure 3.7B). In the case of 
TMV, the amount of TMV CP with ACEI, a 12 amino acid peptide which has anti-
hypertensive effects in humans, was 100 g/g fresh weight of leaf tissue in tobacco and 
tomato, with a readthrough efficiency of 5% (Hamamoto et al. 1993). The readthrough 
efficiency of TMV in tobacco has been reported at 5-10% (Skuzeski et al. 1991; Sugiyama et 
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al. 1995). Therefore, translation via a leaky stop codon of CGMMV in cucumber occurred at 
a similar rate to TMV as described previously, and that the expression of chimeric CGMMV 
in musk melon may be higher than in cucumber, since readthrough mechanism is host-
dependent (Ooi et al. 2006). The stability of a virus-based expression vector also plays a 
critical role in yield determination. Because viruses have a significant rate of mutation and 
recombination via replication, a foreign gene is usually deleted from the virus genome and, 
as a result, chimeric viruses will revert back to the wild type. Chimeric CGMMV, which 
displayed 45 amino acids of EB4 on its surface, was found to lose the EB4 gene after 21 dpi 
(Teoh et al. 2009). In this study, no deletion was found in cucumber after 45 dpi, as shown by 
RT-PCR, DNA sequencing and western blot analysis (Figure 3.7D and Figure 3.9). These 
results indicate that the CGMMV-based vector is stable and can be used to express PRRSV-
NE in cucumber for at least 6 weeks. 
Viruses are a highly promising platform for antigen display. CGMMV possesses a 
symmetrical helical structure composed of about 2100 molecules of coat protein along its rod 
shape. Ideally, if each of these molecules is fused with one molecule of PRRSV-NE, each 
virion could carry approximately 2100 copies of PRRSV-NE on its surface. To further test if 
these chimeric virus particles displayed NE on their surfaces, as antigen carriers, 
immunoprecipitation and TEM were performed. The results confirmed that NEcmyc 
protruded outward from the CGMMV virion, together with the C-terminal portion of coat 
protein and was able to bind to anti-cmyc beads, leading to the formation of immune 
complexes, as shown in Figure 3.8. These results are consistent with other reports on TMV or 
CGMMV (Ooi et al. 2006; Sugiyama et al. 1995; Turpen et al. 1995). The multivalent 
presentation of surface PRRSV-NE on chimeric CGMMV has the potential to enhance 
immune response and, simultaneously, enable exceptionally high payload capacities. Indeed, 
chimeric CGMMV expressing HBsAg was able to stimulate specific antibody production by 
lymphocytes in vitro (Ooi et al. 2006). Virus-like particles displaying NE and other T-
epitopes of PRRSV were reported to be capable of neutralizing viruses in MARC 145 cells 
(Murthy et al. 2015). Further in vivo experiments are needed to examine the ability of the 
chimeric CGMMV-NEcmyc as an effective vaccine against PRRSV. 
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3.5 Conclusion 
In summary, the infectious clone of CGMMV-ON was successfully generated and modified 
to express PRRSV-NE on the surface of chimeric CGMMV. The infectious clone, itself, was 
able to infect several cucurbit crop species, such as cucumbers, watermelons and cantaloupes 
and the experimental host N. benthamiana. However, the expression clone could only 
produce the fusion protein in its natural host, cucumber, via readthrough translation. 
Chimeric CGMMV presenting NEcmyc on CP surface was quantified to be 35.84 g/g fresh 
weight of leaf tissue (0.067% of TSP) at 21 dpi. The foreign gene and peptide were detected 
in cucumber until 50 dpi. These data demonstrate that the CGMMV vector holds great 
promise to expression an edible vaccine against PRRSV in pigs.  
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Table 3.1 Primers used to construct the CGMMV infectious clone and CGMMV-based 
expression vectors 
Name Sequence (5’-3’) 
CGMMV5UTR-F GTTTTAATTTTATAATTAAACAAACAAC 
CGMMV3UTR-R TGGGCCCCTACCCGGGGAAA 
M13 reverse CAGGAAACAGCTATGAC 
M13 forward GTTTTCCCAGTCACGAC 
CGMMVR3-R CCTCTCTCGAATGGTCCCAGTGTA  
SacI-35S-F                ATACGAGCTCAAGCTTGCATGCCTGCAGGT 
SpeI-StuI-35S-R       ATACACTAGTAGGCCTCTCCAAATGAAATG 
BamHI-RzT1-F          ATCCGGATCCTAGAGGATCCGATACCCTGT 
KpnI-RzT1-R              ATACGGTACCTACGCCAGCTGGCGAAAGGG  
BamHI-AgeI-R ATCCGGATCCTCGACCAGGGCCCCTTTA 
CGMMVAgeI-F AACGTACCGGTTGATCAGCT 
BamHI-3UTR-R     ATCCGGATCCTGGGCCCCTACCCGGGG 
CGMMVMP-F ATGTCTCTAAGTAAGGTGTC 
CGMMVMP-R CTAGGTGTGATCGGATTGTA 
NheI-NE-F 
CGCCGCTAGCTCACAACTCCAGAGTATCTACAATCTGT
AGCTTCGAGGGTCTTCTGATGG 
HindIII-AmberNE-F 
TCGAAAGCTTCTAAATAGCAATTATCACAACTCCAGA
GTATCTACAATCTGCAACCATAGCTTCGAGGGTCTTCT
GATGG 
HindIII-NEcmycC-F 
CCAAGCTTCCAAATAGCAATTAATGTCACAACTCCAG
AGTATCTACAATCTGGAACAAAAGTTGATCTCTGAGG
AAGACCTCTAGCTTCGAGGGTCTTCTGATGG 
Actin-F GGGATGTGAAGGAGAAGTTGGC 
Actin-R ATCAGCAATGCCCGGGAACA 
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4.1 Introduction 
Pepino mosaic virus (PepMV) is a member of the genus Potexvirus in the family 
Alphaflexiviridae. It was first isolated from field pepino (Solanum muricatum) in 1974 in 
Peru (Jones et al. 1980). Since then, it has been found in Europe (Cotillon et al. 2002; 
Hasiow-Jaroszewska et al. 2009; Pagan et al. 2006; Roggero et al. 2001; van der Vlugt et al 
2000), North and South America (Ling et al. 2008; Ling 2007; Maroon-Lango et al. 2005), 
South Africa (Carmichael et al. 2011), and Asia (Ge et al. 2013). In Canada, the virus was 
first detected in tomatoes (Solanum lycopersicum) in southern Ontario greenhouse during the  
winter of 2000 (French et al. 2000). Phylogenetic analysis revealed five genotypes of 
PepMV, i.e. European (EU), Peruvian (LP), southern Peruvian (PES), American (US1) and 
Chilean 2 (CH2), that differ each other in the genomic sequence and host range (Hanssen and 
Thomma 2010; Minicka et al. 2016; Moreno-Perez et al. 2014). The virus has a filamentous 
shaped virion of approximately 508 nm in length (Jones et al. 1980). The genome of PepMV 
consists of a positive, single-strand RNA of approximately 6.4 kb and contains five open 
reading frames (ORFs), which encode a 164-kDa RNA-dependent RNA polymerase (RdRp), 
triple gene block proteins (TGB) of 26, 14, and 9 kDa (TGBp1, 2, and 3 in abbreviation, 
respectively) and a 25-kDa coat protein (CP) (Aguilar et al. 2002). RdRp is the only viral 
protein required for virus replication. All TGB as well as the CP are involved in viral 
movement and the development of symptoms. In addition, TGB1 also functions as an RNA 
silencing suppressor and RNA helicase. Like other potexviruses, RdRp is expressed from the 
genomic RNA, while TGB and CP are translated from subgenomic RNAs. In general, the 
host range of PepMV is restricted to plants in the family Solanaceae, e.g. tomato, potato, 
eggplant and Nicotiana benthamiana (Blystad et al. 2015; Minicka et al. 2016). When 
entering host cells, the virus can replicate rapidly, resulting in a high level of viral proteins 
within its host (Minicka et al. 2015). This outstanding expression ability makes PepMV a 
promising candidate to be a virus-based expression system in solanaceous plants, particularly 
N. benthamiana.  
Transient expression systems are a versatile platform, using A. tumefaciens to deliver genes 
of interest into plant leaves in order to produce recombinant proteins within a few days. 
140 
 
 
 
Currently, this system has been a popular and powerful tool, with the ability of upgrading to 
large scale production of desired proteins when applied in N. benthamiana (Hefferon 2013; 
Lomonossoff and D'Aoust 2016). N. benthamiana belongs to the genus Nicotiana, in the 
family Solanaceae. The plant was first identified and collected in Australia about 160 years 
ago. However, interest in this species has just recently accelerated in both research and 
application fields (Goodin et al. 2008). N. benthamiana, a widely used laboratory model 
plant, has become one of a few most popular plant species in molecular farming, due to 
several factors. Firstly, it is very susceptible to agroinfiltration, which facilitates conventional 
transient expression. Secondly, the plant is easily grown either in controlled growth 
chambers, for research, or in greenhouses, for industrial purposes. It is also a common host of 
many pathogens such as viruses including PepMV, bacteria and fungus. Moreover, many 
reports have shown that N. benthamiana is able to produce protein bodies and increase the 
level of recombinant proteins within a short time, when exploited for transient expression 
with viral vectors (Goodin et al. 2008; Peyret and Lomonossoff 2015; Twyman et al. 2003). 
Given these advantages, N. benthamiana was chosen as a bioreactor for protein expression in 
this study. 
Polyprotein or proteolytic processing is a crucial expression strategy for many viruses, in 
order to produce different functional proteins from a polycistronic genome. The viral 
polyprotein is cleaved by viral proteinase(s) to create individual mature proteins. The 2A 
protein derived from Foot-and-mouth disease virus (FMDV-2A or F2A), consisting of 18 
amino acids (-LLNFDLLKLAGDVESNPG-), is an autonomous element that mediates a co-
translational self-cleavage at its own C-terminus (Donnelly et al. 2001; Ryan et al. 1991). 
This cleavage site is located between the last glycine of the F2A and the first proline of the 
downstream F2B protein. Due to this autonomous self-cleaving ability, F2A has been widely 
employed to perform an artificial “self-cleavage” and, hence, to release co-expressed 
multiple proteins encoded by the same expression cassette in plant cells (Luke et al. 2015).  
In this work, a PepMV-based vector was constructed using an Ontario PepMV isolate 
(PepMV-ON) and was used for transient expression of recombinant proteins in N. 
benthamiana. A reporter gene, the green fluorescent protein (GFP) and an ectodomain of 
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PRRSV GP5-fused with GFP (designated as GP5e-GFP) were tested using this viral vector. 
Since PRRSV infects pigs worldwide and causes tremendous losses in the swine industry, my 
goal was to produce GP5e-GFP as a plant-made subunit vaccine against PRRSV. 
4.2 Materials and methods 
4.2.1 Construction of PepMV-based expression clones 
The full-length cDNA of a PepMV isolate (PepMV-ON), obtained from infected tomatoes in 
an Ontario greenhouse, was amplified by RT-PCR and inserted into a binary vector, pGR 107 
(Jones et al. 1999), to generate the full-length cDNA clone, pGR-PepMV-ON-3. All the 
PepMV-based vectors were constructed using standard restriction enzyme digestion and 
fusion PCR methods. First, a fragment, which included 36 nucleotides (nt) of CP sequence 
and the multi-cloning sites ScaI, XhoI, XmaI and SmaI, was amplified by primers of SfoI-
XmaI-CP36R and BbvCI-TGB2-F using pGR-PepMV-ON-3 as a template. The resulting 
amplicon was digested with SfoI and BbvCI and then introduced into digested pGR-PepMV-
ON-3, via the same restriction enzyme sites, to create pGR-Pep-36CP. To generate pGR-Pep-
F2A, the resulting amplicon following fusion PCR with primers XmaI-F2A-CP-F and SfoI-
TDNA, was inserted into pGR-Pep-36CP via XmaI and SfoI. The primer XmaI-F2A-CP-F 
contains the sequence of the 2A self-cleaving peptide of FMDV. To construct pGR-Pep-GFP, 
the GFP was amplified using primers ScaI-GFP-F and XmaI-cmyc-R, with pCaMGateER-
GP5ectoGFP (kindly provided by Hong Zhu from Dr. Rima Menassa’s lab) as a template, 
and then introduced into digested pGR-Pep-F2A via ScaI and XmaI sites. GFP is the 
enhanced GFP, which was described previously (GenBank: U55762.1) (Cormack et al.  
1995). GP5e-GFP was amplified using primers ScaI-GP5e-F and XmaI-cmyc-R and inserted 
into digested pGR-Pep-F2A by the same method, to create pGR-Pep-GP5e-GFP. PCR was 
performed using Phusion High-Fidelity DNA Polymerase (New England Biolabs, Pickering, 
Ontario, Canada) and the following cycle: (1) a pre-denaturation at 98°C for 3 min; (2) 25 
cycles of denaturation at 98°C for 30 sec, annealing at 55°C for 1 min and extension at 72°C 
for 90 sec; and (3) an extra 5 min of extension at 72°C. All the primer sequences are listed in 
Table 4.1. The resulting constructs were confirmed by PCR and DNA sequencing. 
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4.2.2 Agroinfiltration of N. benthamiana with PepMV-ON-derived clones 
Agrobacterium transformation was performed, as described in 2.2.5. Agroinfiltration was 
carried out on two expanded leaves of N. benthamiana, as previously described in 2.2.10. 
However, the bacterial strain used was A. tumefaciens GV3101 containing the pSoup plasmid 
(Hellens et al. 2000). Transformed bacteria were selected and cultured in LB medium with 
kanamycin (50 g/ml), rifampicin (50 g/ml) and tetracycline (10 g/ml) at 28°C. Following 
transformation, bacteria recovered in a 28°C incubator for 2 hr, before being plated on 
selection media. 
For infectivity testing of the PepMV infectious clone, young seedlings of N. benthamiana 
were agroinfiltrated with 1 ml of suspension into two leaves at 3-4 weeks of age (Yoon et al.  
2011). A total of six seedlings were used. Infectivity was identified by either DAS-ELISA or 
RT-PCR at 15 dpi, using systemically infected leaves. 
For protein expression, plant materials, agroinfiltration and detection were essentially as 
described above. For co-infiltration of p19 (Silhavy et al. 2002) and pGR-Pep-GP5e-GFP, 
suspensions of agrobacteria containing each construct were adjusted using agroinfiltration 
buffer to obtain a final density of OD600 and then mixed together in a 1 to 1 ratio. The 
resulting suspension was infiltrated into N. benthamiana leaves, as described above. 
4.2.3 RT-PCR 
Total RNAs were extracted from young leaves using TRIzol (Invitrogen, Burlington, 
Ontario, Canada) and treated with DNase I (Invitrogen). First-strand cDNA was generated by 
reverse-transcription reactions using Oligo dT and SuperScript III Reverse Transcriptase 
(Invitrogen). To determine the infectivity of pGR-PepMV-ON-3, RT-PCR was conducted to 
amplify the sequence of PepMV TGB and CP, using coupled primers Pep5-F and Pep6-R. 
Internal control with actin was carried out using Actin-F and Actin-R. To determine the 
infectivity of expression constructs, including pGR-Pep-GFP and pGR-Pep-GP5e-GFP, RT-
PCR was performed using primers TGB3-F and GFP-R and systemically infected leaves 
collected at 15 dpi. PCR was performed using 2X Taq FroggaMix (FroggaBio, Toronto, ON, 
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Canada) with the following cycles: (1) a pre-denaturation at 94°C for 3 min; (2) 32 cycles of 
denaturation at 94°C for 30 sec, annealing at 55°C for 1 min and extension at 72°C for 90 
sec; and (3) an extra 10 min of extension at 72°C. All the primer sequences are described in 
Table 4.1. 
4.2.4 Visualization of green fluorescence with a UV lamp 
A handheld UV lamp was used to detect green fluorescence in plants infiltrated with 
constructs containing GFP in a dark room, as previously described in 2.2.13. 
4.2.5 Confocal microscopy 
To visualize fluorescence at the cellular level, confocal laser scanning inverted microscopy 
was employed as describe in 2.2.14.1. 
4.2.6 Protein extraction and quantification 
To analyze protein production in N. benthamiana, western blot analysis was performed using 
infiltrated leaves. Three leaf discs (3 mm in diameter) were sampled for a time-course 
experiment set at 3 to 9 dpi, and homogenized in liquid nitrogen using 2.3 mm ceramic beads 
(BioSpec Inc., Bartlesville, USA) and a TissueLyser II (Qiagen). Extraction buffer (50 mM 
Tris-HCl pH 7.5, 150 mM NaCl, 10% (v/v) glycerol, 0.1% (v/v) TritonX-100, 5 mM 
dithiothreitol, protease inhibitor) of 250 l was added to the homogenized leaf tissue to 
obtain the total soluble protein (TSP) from ground leaves. Protein extraction using a p19 
infiltrated plant and a PepMV infiltrated plant was also performed under the same conditions, 
as negative controls. Tota l soluble protein concentration was determined by Bradford assay 
(Bradford, 1976), with bovine serum albumin as a standard, using an iMark Microplate 
Reader (Biorad). Protein extract was separated by electrophoresis in a 12% (w/v) sodium 
dodecyl sulphate-polyacrylamide gel (SDS-PAGE) and transferred onto a polyvinylidene 
difluride (PVDF) membrane (Biorad, Hercules, USA). The primary antibody, either anti-GFP 
monoclonal antibody produced in mouse (Sigma-Aldrich Oakville, ON, Canada) or anti-
PepMV CP polyclonal antibody produced in rabbit (Agdia, Elkhart, IN, USA), was incubated 
with the membrane. The membrane, with the primary antibody produced in mouse, was 
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incubated with horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG antibody 
(Sigma-Aldrich), whereas, the membrane with primary antibody produced in rabbit was 
incubated with HRP-conjugated goat anti-rabbit IgG antibody (Sigma-Aldrich). Western 
blots were visualised using Immobilon Western (Millipore Corporation, Billerica, MA, 
USA), following the manufacturers’ protocol. The resulting images were analysed with Total 
Lab TL100 software (Nonlinear Dynamics, Durhan, USA) by comparing the densitometry of 
bands with known amounts of a standard GFP fused with hydrophobin-I (GFP-HFBI). Three 
biological replicates were performed for each time-course extraction. 
4.3 Results 
4.3.1 Infectivity of infectious clone 
The full-length PepMV cDNA clone pGR-PepMV-ON-3 (GenBank accession number: 
KY031324), was constructed using a Canadian PepMV isolated from infected tomatoes in 
Ontario greenhouses (Figure 4.1A). This isolate showed approximately 99% similarity to the 
American genotype US1 and the clone pGR-PepMV-ON-3 was infectious and induced 
similar symptoms on tomato as its virus (Wu and Wang unpublished data). The natural host 
range of PepMV is limited within the family of Solanaceae (Minicka et al. 2016). To test if 
this isolate can infect N. benthamiana, the infectious clone was introduced into N. 
benthamiana leaves via agroinfiltration. RT-PCR was performed to amplify TGB of PepMV. 
Results confirmed that the clone was infectious, with a 100% infection rate (Figure 4.1B). 
Viral symptoms began to appear at 7-8 dpi. Infected plants showed mild mosaic, leaf 
blistering and yellow spots in newly emerged leaves (Figure 4.1C). With the ability to induce 
fast infection, this clone was an eligible candidate for the construction of a transient 
expression vector in N. benthamiana. 
4.3.2 Construction of PepMV-based expression vectors  
To construct a PepMV-based expression vector, the 2A self-cleaving peptide of FMDV 
(F2A) (Kim et al. 2011), NFDLLKLAGDVESNPGP, was inserted after the putative sub-
genomic promoter of CP (Sempere et al. 2011). Together with F2A, a multi-cloning site  
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(MCS) including ScaI, XhoI, XmaI and SmaI was also fused to the N-terminal of F2A to 
generate pGR-Pep-F2A. In order to maintain the integrity of CP, the first 36 nucleotides of 
the CP gene was repeated immediately after the MCS (Figure 4.2A). GFP was inserted via 
ScaI and XmaI restriction sites into pGR-Pep-F2A to construct pGR-Pep-GFP (Figure 4.2B). 
When this vector is introduced into plant cells, GFP would be translated as a 12aaCP-GFP-
F2A-CP fusion which simultaneously undergoes auto-proteolysis by F2A to produce two 
proteins, GFP-F2A with 12 amino acids of the N-terminal CP (12aaCP-GFP-F2A) and CP. 
The chimeric gene GP5e-GFP was also inserted into pGR-Pep-F2A, via ScaI and XmaI in 
the MCS, to create pGR-Pep-GP5e-GFP (Figure 4.2C). The expected translation product for 
this viral expression vector would be processed into GP5e-GFP-F2A with 12 amino acids of 
the N-terminal CP (12aaCP-GFP5e-GFP-F2A) and CP.  
4.3.3 Agroinfiltration of N. benthamiana with pGR-Pep-GFP 
pGR-Pep-GFP was transformed into A. tumefaciens GV3101 via electroporation and 
delivered in 4-week-old N. benthamiana. Following agroinfiltration, infiltrated leaves 
showed mild green fluorescence, when illuminated by a handheld UV lamp, at 2 dpi (Figure 
4.3A). Intense green fluorescence was visualized in the infiltrated leaves at 4 dpi (Figure 
4.3A). At 8 dpi, green fluorescence appeared strongly in newly emerging leaves, as a result 
of viral systemic movement (Figure 4.3A). Symptoms caused by PepMV infection arose in 
these infiltrated plants with mild mosaic and bubbling leaves at 8 dpi. No symptoms and no 
green fluorescence were detected in the plants infiltrated with buffer during the observation 
period (Figure 4.3A). 
To further confirm GFP expression in the upper newly emerging leaves of the agroinfiltrated 
plants, RT-PCR and confocal laser scanning microscopy were performed. RT-PCR detected 
a 1059-bp band of TGB3 and GFP in the upper leaves at 15 dpi (Figure 4.3B) Confocal 
images showed intense green fluorescence in these leaves at 9 dpi (Figure 4.3C). Taken 
together, these results affirmed the ability of the recombinant virus derived from pGR-Pep-
GFP to move long-distance and establish systemic infection (Figure 4.3B and C). 
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Figure 4.1  Schematic representation of the PepMV infectious clone, pGR -PepMV-ON-3 
(not drawn to scale).  A. Characteristics of the T-DNA plasmid harboring the PepMV 
genome used for agroinfiltration. Single lines and open box represents noncoding and coding 
regions, respectively. Polycistronic PepMV RNA encodes for a 164-kDa protein (164K), 
triple gene block (26K, 14K and 9K) and a 25-kDa coat protein (25K). At the 5’ end, the 
nucleotide sequence of the double CaMV 35S promoter (35S) is indicated with an orange 
box, whereas, the 3’ poly A tail is indicated with An. The nopaline synthase terminator (Nos) 
is presented by a brown box at the downstream end of the 3’ tail. The LB stands for left 
border and RB for right border.  B. RT-PCR results from PepMV infected N. benthamiana at 
15 dpi. The bands of TGB3-CP, and actin are 1566 bp, and 300 bp, respectively.                
Lane 1-4: pGR-PepMV-ON-3-infiltrated plants. Lane 5: Buffer infiltrated plant.              
Lane 6-9: Actin control from pGR-PepMV-ON-3 infiltrated plants. Lane 10: Actin control 
from buffer infiltrated plants. Lane M: 100 bp DNA marker. Lane 11: Positive control from 
PepMV-infected plant. C. Symptoms of infected plants at 15 dpi. 
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Figure 4.2  Schematic representation of expression vectors containing the 2A peptide of 
Foot-and-mouth disease virus (F2A) (not drawn to scale). F2A peptide has amino acid 
sequence as LLNFDLLKLAGDVESNPG.  A. pGR-Pep-F2A contains a multi-cloning site 
(ScaI/XhoI/XmaI/SmaI) and F2A which are inserted between the putative subgenomic 
promoter (SGP) of coat protein (CP) and CP (25K). F2A is represented by an orange box.  
The cleavage site is located between glycine (G) and proline (P), and designated by a red 
arrow.   B. Green fluorescent protein gene (GFP) was inserted between the SGP and F2A, by 
restriction enzyme digestion (ScaI and XmaI) and ligation to generate pGR-Pep-GFP.           
C. The sequence containing the neutralizing epitope of glycoprotein 5 (GP5e) was fused with 
GFP to create GP5e-GFP.  Subsequently, GP5e-GFP was placed between the SGP and F2A 
using the same method as pGR-Pep-GFP, to create pGR-Pep-GP5e-GFP.  
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Figure 4.3  N. benthamiana infiltrated with pGR-Pep-GFP.  A.  A time-course observation of 
pGR-Pep-GFP infiltrated plants under visible and UV light at 2, 4, 8 dpi, respectively , and 
buffer infiltrated plant as a negative control.  B. RT-PCR results from pGR-Pep-GFP 
infiltrated plants at 15 dpi. The band of TGB3-GFP is 1059 bp. Lane 1: Negative control 
using buffer infiltrated leaf.  Lane 2-3: pGR-Pep-GFP infiltrated plants. Lane M: 100 bp 
DNA marker. Lane 4: Positive control using pGR -Pep-GFP. C. Observation of fluorescence 
in newly emerged leaves by confocal microscopy. Scale bar 68 m. 
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4.3.4 Agroinfiltration of pGR-Pep-GP5e-GFP 
4.3.4.1 No expression without p19 co-infiltration 
Encouraged by the GFP expression results, I decided to use the same method to express the 
GP5 epitope fused with GFP (GP5e-GFP) in N. benthamiana. The pGR-Pep-GP5e-GFP was 
introduced into Agrobacterium and infiltrated into N. benthamiana leaves. Unexpectedly, 
green fluorescence was hardly observed in both the infiltrated or systemic leaves up to 9 dpi, 
using either a handheld UV lamp or confocal laser scanning microscopy (Figure 4.4A and B). 
Furthermore, necrosis appeared early, at 4-5 dpi, in the infiltrated areas and had spread to the 
whole leaf at 7 dpi in plants agroinfiltrated with pGR-Pep-GP5e-GFP (Figure 4.4C). On the 
other hand, no necrosis was observed in mock-infiltrated plants (with buffer only) (Figure 
4.3A).  
4.3.4.2 Positive GFP signals observed in plants co-infiltrated with pGR-Pep-
GP5e-GFP and p19 
Previous studies reported that co-expression of a suppressor of post-translational gene 
silencing (PTGS) could increase the accumulation levels of exogenous proteins (Conley et al.  
2009; Liu and Kearney 2010). Thus, a binary vector, harboring the silencing suppressor, p19 
of Cymbidium ringspot tombusvirus (CymRSV) (Silhavy et al. 2002), was agro-infiltrated 
with pGR-Pep-GP5e-GFP into N. benthamiana. Mild green fluorescence was observed at 2 
dpi and increased at 4 dpi (Figure 4.5A). Necrosis appeared at 8 dpi, which was similar to 
pGR-Pep-GFP on the infiltrated leaves. To further investigate the influence of p19 on GP5e-
GFP expression, infiltrated and the upper new leaves were examined under a confocal laser 
scanning microscope. The results revealed an abundance of N. benthamiana cells expressing 
GFP in infiltrated leaves (Figure 4.5B). However, only very week GFP signals were detected 
in the upper leaves (Figure 4.5C). These data suggest that the silencing suppressor, p19, 
could increase the expression of GP5e-GFP in infiltrated leaves only and that GP5e-GFP was 
toxic to the plants which could result in necrosis. 
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Figure 4.4 Expression of GP5e-GFP without p19 co-infiltration. A. Fluorescence observation 
at 6 dpi under visible light and a handheld UV lamp. B. Fluorescence observation at 9 dpi 
using confocal microscopy. Scale bar 68 m. C. Necrosis in pGR-Pep-GP5e-GFP infiltrated 
leaves at 5-7 dpi. The white arrows point to necrosis leaves. 
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Figure 4.5  N. benthamiana infiltrated with a mixture of pGR-Pep-Gp5e-GFP and p19.            
A.  Fluorescence observed in infiltrated plants at 2 and 4 dpi under visible light and a 
handheld UV lamp. B. Fluorescence observed in infiltrated leaves at 6 dpi by confocal 
microscopy. Scale bar 68 m.  C. Fluorescence detected in the secondary upper leaves at 9 
dpi by confocal microscopy. Scale bar 68 m. 
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4.3.5 Immunoblotting analysis of GFP and GP5e-GFP 
To detect the presence of GFP and GP5e-GFP in infiltrated leaves, western blot analysis was 
carried out using anti-GFP antibody and anti-PepMV CP antibody at 4 dpi. 12aaCP-GFP-
F2A or 12aaCP-GP5e-GFP-F2A was expected to be released from 12aaCP-GFP-F2A-CP and 
12aaCP-GP5e-F2A-CP expressed in plants agroinfiltrated with pGR-Pep-GFP and pGR-Pep-
GP5e-GFP, respectively. As shown in Figure 4.6A, a 25-kDa band of PepMV CP and an 
approximately 55-kDa band, which was possibly a processed product containing GFP-F2A-
CP, were detected in both GP5e-GFP and GFP plants by the anti-PepMV CP antibody. Aside 
from this similarity, the patterns of GP5e-GFP and GFP expression were distinguished in the 
same blot. For pGR-Pep-GFP, the blot showed bands of 12aaCP-GFP-F2A-CP (~58 kDa) 
and 12aaCP-GFP-F2A (33 kDa). Meanwhile, a band of 12aaCP-GP5e-GFP-F2A-CP (~66 
kDa) was shown for pGR-Pep-GP5e-GFP (Figure 4.6A). On the other hand, another blot 
probed by anti-GFP antibody revealed 12aaCP-GP5e-GFP-F2A (41 kDa) and 12aaCP-GP5e-
GFP-F2A-CP (~66 kDa) in plants agroinfiltrated with pGR-Pep-GP5e-GFP, whereas, 
12aaCP-GFP-F2A (33 kDa), and 12aaCP-GFP-F2A-CP (~58 kDa) appeared in pGR-Pep-
GFP-infiltrated samples (Figure 4.6B). These detected proteins were not detected in p19-
infiltrated plants (Figure 4.6A and B) or in pGR-PepMV-ON-3 infiltrated plants. Results 
indicate that fusion proteins were efficiently processed by the F2A protein to produce GP5e-
GFP and GFP, despite a small amount of unprocessed fusions. 
A time-course protein quantification from 3-9 dpi revealed that the accumulation of proteins 
of interest was optimal at 4-6 dpi. The level of GFP recombinant proteins including GFP-
F2A fused with 12 amino acids from the N-terminus of CP (12aaCP-GFP-F2A) and 12aaCP-
GFP-F2A fused with the entire CP (12aaCP-GFP-F2A-CP) was as high as 2.03 mg/g of fresh 
weight in pGR-Pep-GFP-infiltrated leaf tissue at 5 dpi. Specifically, 12aaCP-GFP-F2A and 
12aaCP-GFP-F2A-CP accounted for 1.30 mg/g and 0.73 mg/g fresh weight of leaf tissue, 
respectively (Figure 4.7A). In contrast, GP5e-GFP recombinant proteins were estimated to be 
0.036 mg/g of fresh weight in pGR-Pep-GP5e-GFP-infiltrated leaf tissue (Figure 4.7B), 
where the levels of 12aaCP-GP5e-GFP-F2A and 12aaCP-GP5e-GFP-F2A-CP were 
approximately 0.014 and 0.022 mg/g of fresh weight, respectively (Figure 4.7B). These 
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results confirmed that the PepMV-based expression vector could be used for protein 
expression within a short time period (5 days) in N. benthamiana. However, more 
refinements need to be made to enhance GP5e expression. 
4.4 Discussion 
In this study, an infectious clone was developed based on an Ontario greenhouse-tomato 
isolate of PepMV, pGR-PepMV-ON-3, and further modified to expression recombinant 
proteins in N. benthamiana. PepMV has diverse strains that significantly differ in host range 
and disease symptoms (Blystad et al. 2015; Duff-Farrier et al. 2015; Hasiow-Jaroszewska et 
al. 2011; Hasiow-Jaroszewska et al. 2010; Minicka et al. 2016; Sempere et al. 2016). Thus, 
pGR-PepMV-ON-3 was first examined and observed for the development of symptoms in N. 
benthamiana. Plants exhibited a 100% infection rate following agroinfiltration into young 
leaves. Compared to the European strain, PepMV-ON-3 caused moderate blistering and 
mosaic leaf symptoms in N. benthamiana at 7-8 dpi. These symptoms are easily observed 
and may serve as an indicator of infection. PepMV-ON-3 does not induce any local or 
systemic necrosis as a hypersensitive response of plants that may restrict viral spread and 
significantly reduce the yield of protein production (Aguilar et al. 2015; Dickman et al. 2001; 
Love et al. 2005). For instance, the Polish necrotic isolate of PepMV not only induce 
systemic necrosis on tomato but also on N. benthamiana (Minicka et al. 2015; Sempere et al.  
2016). Thus, pGR-PepMV-ON-3 is a powerful viral vector for the development of a transient 
expression system in N. benthamiana. 
To circumvent homologous recombination, a problem often associated with subgenomic 
promoter duplication which is needed for expression of the heterologous protein in viral 
vectors (Dawson et al. 1989; Donson et al. 1991; Zheng et al. 2015), I fused GFP or GP5e 
with a F2A peptide and inserted the chimeric gene in frame into the N-terminus CP to avoid 
addition of another copy of the CP promoter. F2A’s co-translational self-cleavage could free 
CP from the fusion protein, which is needed for virion assembly and viral long distance 
movement. The F2A which I used in this study was from FMDV, belonging to the family 
Picornaviridae. Other 2A peptides, such as Equine rhinitis A virus 2A (E2A), Porcine 
teschovirus-1 2A (P2A), Thosea asigna virus 2A (T2A), Cytoplasmic polyhedrosis virus 2A 
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(BmCPV 2A), and Flacherie virus (BmIFV 2A), have also been characterized and applied in 
biological research (Kim et al. 2011; Wang et al. 2015). Cleavage efficiency of these 
peptides has been well-studied in different cell lines. In human cell lines, zebrafish embryos 
and mouse liver cells, P2A showed higher cleavage efficiency, when compared to F2A, E2A, 
and T2A (Kim et al. 2011). This was also the case in silkworm (Bombyx mori) where P2A 
carried a glycine-serine-glycine spacer (GSG), when compared to F2A, E2A, T2A, BmCPV 
2A and BmIFV 2A (Wang et al. 2015). Nevertheless, a number of studies have demonstrated 
that F2A can efficiently process for multiprotein expression in plants (Sempere et al. 2011; 
Zhang et al. 2010). In this study, the F2A sequence was flanked by the first 36 nt sequence of 
CP and the entire CP sequence (without the start codon) in order to maintain optimal activity 
of  the CP subgenomic promoter (Sempere et al. 2011). Western blot analysis showed that 
F2A functioned efficiently to process fusion proteins to release 12aaCP-GFP-F2A or 
12aaCP-GP5e-GFP (Figure 4.6B), and viral CP (Figure 4.6A). Although a small amount of 
fusions (either 12aaCP-GFP-F2A-CP or 12aa-GP5e-GFP-F2A-CP) were detected, the 
systemic movement of the modified PepMV was preserved, as shown by GFP expression in 
newly emerged leaves (Figure 4.6A and Figure 4.3A). The level of GFP expression in 
infiltrated leaves was approximately 1.30 mg/g fresh weight in the form of 12aaCP-GFP-
F2A, and 0.73 mg/g fresh weight of 12aaCP-GFP-F2A-CP at 5 dpi (Figure 4.7A), which is 
comparable to the pEAQ-HT expression system (Sainsbury et al. 2009). The results show 
that F2A works efficiently at protein cleavage in order to concurrently acquire a high level of 
GFP expression and maintain viral movement and that pGR-Pep-F2A can be exploited as a 
virus-based expression vector to produce recombinant proteins in N. benthamiana. 
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Figure 4.6  Western blot of infiltrated leaves at 4 dpi. A. Western blot with anti-PepMV CP 
antibody. Lane 1: p19 infiltrated leaves. Lanes 2-5: pGR-Pep-GP5e-GFP-F2A infiltrated 
leaves. Lanes 6-9: pGR-Pep-GFP-F2A infiltrated leaves.  B. Western blot with anti-GFP 
antibody. Lane 1: p19 infiltrated leaves. Lanes 2-5: pGR-Pep-GP5e-GFP-F2A infiltrated 
leaves.  Lanes 6-7: pGR-Pep-GFP-F2A infiltrated leaves. 
 
  
 B. 
 A. 
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Figure 4.7 Quantification of protein expression during a time course of 4-6 dpi. Error bars 
indicate the standard deviation of the mean (n=3). A. Expression of green fluorescent protein 
(GFP) in N. benthamiana.  B. Expression of glycoprotein 5 (GP5) containing epitope and 
fused with GFP (GP5e-GFP) in N. benthamiana.  
 B. 
 A. 
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Since the results from the GFP construct were promising, I sought to determine if the viral 
vector, pGR-Pep-F2A, could be used to express a subunit vaccine against PRRSV in N. 
benthamiana. The GP5e sequence is the first 180 nucleotides of the GP5, which was codon 
optimized for plants and had the transmembrane domain removed. This sequence contains 
the neutralizing epitope (NE) of GP5, which induces neutralizing antibodies against PRRSV 
in pigs (Music and Gagnon 2010). In contrast to pGR-Pep-GFP, GFP was not detected, by 
either a handheld UV lamp or confocal microscopy, in a time course of 9 dpi when N. 
benthamiana was infiltrated with pGR-Pep-GP5e-GFP. Moreover, infiltrated leaves turned 
brownish quickly, a sign of necrosis, at 5-7 dpi, possibly due to the toxicity of GP5e. To help 
overcome the difficulties involved in GP5e-GFP expression, a silencing suppressor, p19, 
from CymRSV (Silhavy et al. 2002) was co-infiltrated with pGR-Pep-GP5e-GFP. Many 
studies have reported that the production of heterologous proteins could be enhanced by co-
infiltration with a silencing suppressor (Lindbo 2007; Sainsbury et al. 2009; Saxena et al.  
2011). Liu and Kearney showed that co-inoculation of p19, derived from Tomato bushy stunt 
virus (TBSV), and pSHEC/GFP could significant ly increase the GFP expression in 
inoculated leaves (Liu and Kearney 2010). Consistently with these observations, GFP was 
detected in leaves co-infiltrated with p19 at 4 dpi. However, the level of GFP expression, 
which also reflected GP5e-GFP expression when using pGR-Pep-GP5e-GFP combined with 
p19, was much lower than using pGR-Pep-GFP alone (Figure 4.5A and B, upper panel).  
Furthermore, necrosis started in pGR-Pep-GFP infiltrated leaves at 7 dpi, which was 2 days 
later, when compared to pGR-Pep-GP5e-GFP-inoculated leaves. Also, the constructs 
containing GP5e-GFP showed a reduction in virus movement, as only a limited area of 
secondary upper leaves expressed GFP, when compared to the infiltrated leaves (Figure 
4.5B, lower panel and Figure 4.5C). These results suggest that p19 can enhance the 
expression of GP5e-GFP by suppressing RNA silencing in infiltrated leaves. Nevertheless, 
without p19 the toxicity of GP5e probably caused cell death and silencing suppression in 
leaves and, as a result, viruses were not able to replicate and spread efficiently. 
As GFP was remarkably observed in pGR-Pep-GFP infiltrated leaves at 4 dpi (Figure 4.3A), 
I conduct a time-course assay of protein expression for both pGR-Pep-GFP and pGR-Pep-
GP5e-GFP from 3 to 9 dpi. Western blot analyses revealed that high levels of GFP or GP5e-
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GFP could be acquired within 4-6 dpi. As mentioned above, GP5e-GFP infiltrated leaves 
exhibited necrosis at 7 dpi, while GFP infiltrated plants showed systemic infection 
throughout the plant at 8 dpi. This may explain the lower yield of proteins of interest in 
infiltrated leaves from 7-9 dpi. It was estimated that the yield of GP5e-GFP was 20 times 
lower than that of GFP as shown in protein quantification by immunoblotting. In addition, 
free GP5e-GFP exhibited increased instability, as evidenced by the increase in degraded 
proteins shown by western blotting, during time-course assays, when compared to GP5e-GFP 
fused with CP (Figure 4.7B). However, the expression of GP5e-GFP, in both free form and 
fusions, was approximately 0.036 mg/g fresh weight (Figure 4.7B), which is 100 times 
higher than previously documented levels of GP5 expressed in transgenic banana or tobacco 
(Chan et al. 2013; Chia et al. 2010). This demonstrates that this viral vector is able to express 
GP5e in the form of fusion with GFP within a short time frame (seven-day period). Fusion of 
GP5e with stabilizing protein domains, such as “fragment crystallizable chain” of 
immunoglobulins (Fc), hydrophobin I (HFBI) or elastin-like peptide (ELP) (Conley et al.  
2009; Conley et al. 2011; Joensuu et al. 2010; P iron et al. 2014), may reduce its toxicity to 
host plants and enhance the stability of GP5e, which in turn enhance protein accumulation in 
plant systems. Moreover, the stabilizing proteins could also assist in maintaining the 
immunogenicity of GP5 and improving the delivery efficiency into animal systems for 
induction of immune response. 
Despite the unexpectedly low levels of GP5e-GFP expression, the PepMV-based expression 
vector is a promising candidate for further refinements in order to acquire a high level of 
proteins of interest via virus replication. For instance, CP may be replaced by a heterologous 
protein, which will diminish the threat of unwanted dissemination of the virus, in terms of 
biosafety concerns. The CP may be provided in trans (i.e., via genetic transformation) to 
restore cell-to-cell movement (Sempere et al. 2011). This expression strategy has been 
proven to be highly successful for TMV-derived MagnICON vectors (Gleba et al. 2005; 
Marillonnet et al. 2004; Marillonnet et al. 2005). Vacuum infiltration may also be applied to 
deliver the viral vector to entire N. benthamiana plants, upgrading the system to large scale 
capacity. Moreover, p19, the silencing suppressor gene, may be introduced into this viral 
vector to help maximize the expression of heterologous proteins. To facilitate the cloning 
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process, pGR-Pep-F2A may be modified to include the entry sites for the Gateway cloning 
system. To enhance the cleavage efficiency of 2A, a short spacer such as glycine-serine-
glycine (GSG), may be placed upstream of the F2A peptide (Wang et al. 2015). Through 
these optimizations, the PepMV vector will likely become an efficient, powerful expression 
system as a protein expression vector in N. benthamiana.  
4.5 Conclusion 
In summary, I have described the construction of a versatile expression system, pGR-Pep-
F2A, based on Ontario PepMV. This vector was used to express GFP and a potential subunit 
vaccine, e.g. GP5e, in N. benthamiana to control PRRSV. The yield of GFP has reached up 
to 2.03 mg/g fresh weight of leaf tissue at 5 dpi, whereas, the level of GP5e-GFP was much 
less at 0.036 mg/g fresh weight likely due to the specific toxicity of this protein in plant cells. 
The pGR-Pep-F2A vector has potential not only for protein expression, but also for 
pathogenic studies to expand the knowledge of PepMV. Further experimentation is required 
in order to optimize this viral vector and improve the expression of GP5 as a plant-made 
vaccine. 
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Table 4.1 Primers used to construct the PepMV-based expression vectors 
Name Sequence (5’-3’) 
SfoI-XmaI-CP36R  
TATAGGCGCCCTTCCCCCGGGCTCGAGAGTAC 
TGGAACCAGAAGTAGCAGC 
BbvCI-TGB2-F TTTCCTCAGCAACAATCATAC 
XmaI-F2A-CP-F 
TTCCCCCGGGGGAAGCGGAAATTTTGACCTTC 
TCAAGTTGGCGGGAGACGTGGAGTCCAACCCT 
GGGCCTGCTGACAATACCCCAGTT  
SfoI-TDNA CAGGCGCCATTCGCCATTCAGGC 
ScaI-GFP-F  CATTAAGTACTATGGTGAGCAAGGGCGAGGAGCT 
XmaI-cmyc-R CTGACCCGGGGAGGTCTTCCTCAGAGATCAA 
ScaI-GP5e-F CATTAAGTACTATGCTTGGCAAATGCTTAACAGC 
Pep6-R CACGTAGTTAACGCATGTACCACA 
Pep5-F CACACTACACTTCCTTCAGGACGC 
TGB3-F  GTTCTAAAAGCAATCAACTT 
GFP-R CTTGTACAGCTCGTCCATGCCGAG 
Actin-F GGGATGTGAAGGAGAAGTTGGC 
Actin-R ATCAGCAATGCCCGGGAACA 
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Chapter 5: General discussion and conclusion 
It has been over thirty years since the first biopharmaceutical, human growth hormone, was 
produced in sunflower (Helianthus annus) and tobacco (Nicotiana tabacum var. petit Havana 
SR1) plants (Barta et al. 1986). Scientists, especially molecular biologists, have put an 
endless amount of dedication into molecular farming. The success story of ZMapp, an 
experimental drug produced in plants, is one of the fruits borne of this dedication. ZMapp is a 
combination of three monoclonal antibodies against Ebola virus and showed a significant 
100% rescue rate when applied to infected Rhesus macaques (Qiu et al. 2014). With Ebola 
outbreaks in 2015, the United States Food and Drug Administration (FDA) approved ZMapp 
for use in new clinical drug trials in Liberia. ZMapp was produced in N. benthamiana by 
transient expression under the collaboration of Kentucky BioProcessing (Kentucky, USA), 
Mapp Biopharmaceutical Inc. and LeafBio (San Diego, USA), Defyrus Inc. (Toronto, 
Canada), the US government and the Public Health Agency of Canada (PHAC). Although 
ZMapp is still in clinical trials, it gives hope in the fight against the Ebola virus disease. The 
United States Department of Agriculture (USDA) gave approval to Dow Agro Sciences for 
the first plant-made vaccine, against Newcastle disease virus (NDV), in 2006. This vaccine 
was produced in tobacco suspension cells and is able to efficiently protect poultry from NDV 
virus (Vermij and Waltz 2006). These stories are not only milestones for molecular farming, 
but also demonstrate the competence of plants as bioreactors for plant-made vaccines against 
human and animal diseases. 
PRRS is a devastating and recurring epidemic which affects the worldwide pork industry 
(Lunney et al. 2010; Topp et al. 2016). PRRS causes the death of pigs at all ages and reduces 
breeding herds by infection with porcine respiratory disease complex (PRDC) and/or 
reproductive failures (Lunney et al. 2016). Under farm conditions, PRRSV can co-infect with 
various bacteria and viruses, leading to severe and highly complex illnesses in pigs. Thus, 
antibiotics are often applied to infected pigs in PRRS outbreaks (Glass-Kaastra et al. 2013). 
In addition, this is an air-borne and very infectious disease, resulting in outbreaks within a 
short time frame (Cutler et al. 2011; Hermann et al. 2009; Tian et al. 2007). At present, no 
therapy exists. Vaccines, combined with other farming practices, play a critical role in the 
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fight against PRRS. Plant-made vaccines against PRRSV have become an attractive idea, as 
they provide the option of edible vaccines and lessen needle use and cold-chain requirements. 
Cold chain is the maintenance of optimal conditions during transport, storage and handling of 
vaccines. This not only reduces manufacturing and administration costs, but also eliminates 
the chance of PRRSV transmission via needles (Baker et al. 2012; Otake et al. 2002). As new 
health initiatives intend to decrease antibiotic use in livestock, in hopes of preventing 
antibiotic resistance in bacteria, the development of an effective plant-made vaccine will also 
help to fulfill this requirement (Topp et al. 2016).  
Transient expression using viral vectors has been widely exploited to improve the levels of 
protein expression in molecular farming (Arntzen 2015; Lico et al. 2008; Lomonossoff and 
D'Aoust 2016). As opposed to stable transformation, this method is an alternative which can 
speed up the start-to-finish manufacture and optimization of vaccines produced in plants for 
quick responses to emerging infectious diseases. In this thesis, I investigated the potential of 
three viruses as viral vectors for the production of GP5-based subunit vaccines in plants. The 
three viruses are BPMV, CGMMV, and PepMV, which belong to the different genera, 
Comovirus, Tobamovirus and Potexvirus, respectively. The main purpose of this study is to 
develop a viral expression system for plant-made vaccines against PRRSV. These plant-made 
vaccines could be delivered to pigs by oral administration.  
5.1 Discussion 
5.1.1 Can one viral system fit all desired requirements? 
In this thesis, I have worked with three different viruses which belong to distinct genera and 
families. It may be questioned as to whether one viral system among these virus-based 
expression systems can satisfy all the requirements, including protein yield, peptide 
presentation, oral administration, etc. 
The protein yield of each virus-based expression system was affected by a variety of factors, 
such as plant virus type, host species, delivery method, and the characteristics of the protein 
of interest. As described in Chapter 2, an expression vector was developed, based on BPMV, 
which is distinguished from the other two vector candidate viruses, CGMMV and PepMV, 
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by its bipartite genome. BPMV also possesses a narrow host range within the legume family 
thus, soybean was chosen as a specific host for protein expression in this study. Soybean is a 
popular and widely grown crop in many countries, e.g. USA and Canada (Liu et al. 2016; 
Rao et al. 2014). The plant contains a high level of nutrients, beneficial isoflavonoids, and no 
nicotine, which, unlike tobacco species, is appropriate for direct feeding to pigs, without 
extra purification steps. Moreover, soybean plants also provide a high level of biomass, either 
in the field or in the greenhouse. However, soybean plants are recalcitrant to agroinfiltration. 
The only methods to deliver virus amplicons are mechanical inoculation using RNA 
transcripts or biolistic bombardment of DNA plasmids. The latter method was selected for 
this study, in order to facilitate the inoculation steps, without in vitro transcription. Soybean 
leaves were particle bombarded with viral DNA amplicons to produce BPMV, and these 
viruses subsequently spread throughout the plant via systemic virus movement. Infected plant 
materials were collected to inoculate the next passage of soybean plants, via mechanical 
inoculation. The results showed that GP5C-GFP was successfully expressed in soybean 
leaves at 30-45 dpi. The overall goal is to develop a low-cost BPMV-based expression 
vectors for oral vaccine production in soybean leaves. 
As described in Chapter 3, the neutralizing epitope (NE) of GP5 was exposed on the outer 
surface of the viral particles of CGMMV in cucumber. To achieve this, a CGMMV peptide 
display vector was generated using a readthrough stop codon context. Viruses have been 
widely employed as nanocarriers for peptide display, which enhances the efficiency of 
subunit vaccines (Lico et al. 2008). A prerequisite using this strategy is the availability of 
knowledge of virus structure and topology. Since the CP of CGMMV is well characterized, 
the NE was inserted downstream of a readthrough context in the C-terminus of CP. This 
would display NE on the surface of chimeric virions, and maintain virus systemic movement 
in cucumber plants. Indeed, the results showed that the systemic leaves of CGMMV NE 
display vector-infiltrated cucumber contained NE-presenting virions. 
In Chapter 4, a PepMV-based expression vector was established to produce GP5e-GFP in N. 
benthamiana, using the transient expression method. GP5e, the ectodomain of GP5, was 
codon optimized for expression in plants. In addition, co-agroinfiltration with p19, a 
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silencing suppressor, was also employed to enhance GP5e expression in plants. As a result, 
GP5e-GFP was successfully transiently expressed in N. benthamiana at 5 dpi.  
As summarized above, three viruses were attempted for the development of a virus-based 
expression system to express a subunit vaccine in different plants. Each viral system is 
distinct to others in many ways. Virus type and host range are the first two main factors 
which must be carefully considered during viral vector development. These factors also have 
an influence on the method of infection. For example, soybean plants are a host of BPMV. 
The BPMV-based expression vectors could be delivered directly into plants by biolistic 
bombardment to initiate virus infection, and subsequent systemic virus movement is required 
to spread throughout infected plants. Therefore, construction of a BPMV-based expression 
vector should preserve correct virion assembly to ensure systemic virus movement. CGMMV 
and PepMV-based expression vectors are unable to infect soybean plants, as soybean is not a 
natural host. CGMMV was chosen to develop a peptide display system because its genomic 
organization and CP structure have been extensively studied and the viral vector is relatively 
easy to be modified for the insertion of short peptides (Ooi et al. 2006; Teoh et al. 2009; 
Zheng et al. 2015). In summary, there is no one viral system that can fit all purposes. Each 
system has its pros and cons which fit to specific requirements, such as the host plant, the 
peptide/protein of interest and the method of delivery. Therefore, we should select the right 
strategy and virus to maximize the beneficial characteristics of the virus for vaccine 
production in plants. 
5.1.2 The viral vectors can compensate for the toxicity of GP5 to increase the 
yield of GP5-based production via transient expression in planta 
Intensive research has been carried out on the expression of GP5 and other major structural 
proteins of PRRSV in planta. Other systems such as bacteria, insect cells, and mammalian 
cells have been also investigated for production of these proteins. The accumulation of 
PRRSV membrane protein (M) and nucleocapsid protein (N) in transgenic plants has been 
reported to reach as high as 5.1 g/g of fresh corn callus and 2.62 mg/g of ground soybean 
seed (Hu et al. 2012; Vimolmangkang et al. 2012) , respectively. In contrast, the expression of 
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PRRSV-GP5 in transgenic plants has usually been quite low (Piron et al. 2014). 
Accumulation of GP5 of PRRSV type 2 (NA) ranged from 110-267 ng/g of fresh weight leaf 
tissue in both transgenic tobacco and banana plants (Chan et al. 2013; Chia et al. 2010; Chia 
et al. 2011). There have been only two publications which showed higher accumulation 
levels of GP5. The first study demonstrated that GP5 (PRRSV type 2) was expressed at 2.5-
4.7 g/g fresh weight of leaf tissue and 0.8-1.2 g/g fresh weight of tuber in transgenic 
potato plants (Chen and Liu 2011). The second study showed that expression of GP5 from 
PRRSV type 1 (EU) fused with stabilizing protein domain “Fc” was estimated to be 2.3 mg/g 
fresh weight in transgenic Arabidopsis seeds (Piron et al. 2014). As mentioned earlier in this 
thesis, transient expression has an advantage over stable transgenic plants given its flexibility 
and versatility in large scale-up operations and the quick manufacture of vaccines for 
emergency responses to infectious diseases. More recently, viral expression systems have 
been used for the transient expression of GP5 in plants. Uribe-Campero et al. reported  the 
use of MagnICON vectors to transiently express GP5-M and GP5-T virus-like particles 
(VLPs) in N. silvestris, but did not disclose the expression yields (Uribe-Campero et al.  
2015). The Lomonossoff group employed the pEAQ-HT vectors to express a codon-
optimized GP5 ectodomain, without the transmembrane region and signal peptide, called 
GP5synt, in N. benthamiana. The product was insoluble at 5 mg/kg of infiltrated plant fresh 
weight (CORDIS  2015).  
One of the bottlenecks that possibly impede GP5 expression in planta is the toxicity of GP5. 
PRRSV is known as a causal agent of apoptosis both in vitro and in vivo (Kim et al. 2002; 
Labarque et al. 2003; Miller and Fox 2004; Suárez et al. 1996). GP5 protein was shown to 
induce apoptosis when expressed in mammalian cells (Gagnon et al. 2003; Suárez et al.  
1996). The N-terminal of GP5, which included the first 119 residues, has been mapped for 
apoptosis induction (Fernández et al. 2002). While the mechanism of GP5-inducing 
apoptosis remains unknown, this phenomenon has resulted in the low yield of GP5 
expression in these cells (Gagnon et al. 2003). Similar results were also observed when GP5 
was produced in planta (Peyret and Lomonossoff 2015; Thuenemann et al. 2013). 
Hydrophobicity of the GP5 transmembrane domain is believed to be the causal agent of the 
observed necrosis. Nevertheless, the expression of GP5oi, in which the signal peptide and 
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transmembrane region were deleted and only the ectodomain was kept, showed the 
expression at low levels when using pEAQ-HT (CORDIS 2015). Both GP5 and GP5-Tm 
(which has a deleted transmembrane region) were expressed at the same low level of 0.09% 
of TSP in transgenic Arabidopsis seeds (Piron et al. 2014). These data indicate that deletion 
of the transmembrane domain of GP5 did not affect expression levels of GP5 in planta. To 
overcome this challenge, many alternatives have been suggested, such as fusion to stabilizing 
proteins and compartment targeting (P iron et al. 2014), and/or plant codon optimization and 
silencing suppression (CORDIS 2015). 
In Chapter 2 of this thesis, GP5 was halved into two main parts, the N- and C- termini, and 
expressed in a fusion with a stabilizing protein, such as GFP, in soybean leaf using BPMV-
based vectors. Interestingly, only GP5C-GFP could be detected in the leaf extract, whereas, 
the GP5N-GFP-bombarded plants were not infected, although this experiment was repeated 
five times. I have speculated that the high toxicity of GP5N might interfere with BPMV 
replication and movement. Upon introduction of the modified BPMV vector into soybean 
leaf cells via biolistic bombardment, the recombinant virus must replicate in the bombarded 
cells, move intercellularly into neighboring cells and further spread systemically from the 
local leaf to the whole plant. GP5N toxicity causes plant cell death, i.e., necrosis and thus, 
prevents virus propagation throughout the whole plant, as was also reported in GP5-
expressing mammalian cells (Gagnon 2003).  
In Chapter 4, necrosis appeared at 5 dpi in infiltrated N. benthamiana when using pGR-Pep-
GP5e-GFP alone. GP5e is a truncated GP5, which is codon optimized and includes the signal 
peptide and ectodomain only. No green fluorescent signals from GP5e-GFP were detectable 
in infiltrated leaves following infiltration, suggesting GP5e might also be toxic. PepMV 
infection was somehow rescued by co-infiltration of pGR-Pep-GP5e-GFP with p19, a 
silencing suppressor of CymRSV (Silhavy et al. 2002). As a result, green fluorescent signals 
from GP5e-GFP were visualized under a UV lamp or a confocal microscope, and the fusion 
protein was detected by western blot analysis. However, GP5e-GFP was mainly present in 
local agro-infiltrated leaves.  GP5e-GFP PepMV could undergo systemic movement with p19 
with a very weak expression of GP5e-GFP.  
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Taken together, these results indicate that the N-terminus of GP5 can cause toxicity in plant 
cells, leading to necrosis and silencing induction. Furthermore, viral vectors based on 
CGMMV or PepMV can overcome this obstacle to successfully increase the levels of 
peptide/protein of interest in plants by transient expression alone or with p19, respectively. 
Particularly, chimeric CGMMV presenting the GP5 NE accumulated to the level of 35.84 
mg/kg fresh weight of leaf tissue in cucumber and GP5e-GFP was expressed at 
approximately 36.53 mg/kg fresh weight of leaf tissue in N. benthamiana. These expression 
levels are approximately 7 times higher than those previously reported using pEAQ-HT 
(CORDIS 2015). 
5.1.3 pGR-Pep-F2A is a robust and versatile system which can function both 
for protein production and peptide/protein display  
F2A-mediated cleavage allows for multiple proteins to be expressed in frame fused with viral 
CP as F2A can process the recombinant polyprotein into various products. In this study, free 
GFP was produced in N. benthamiana infiltrated with pGR-Pep-GFP (in which GFP-F2A 
was in frame fused with CP at the N-terminus in the pGR-Pep-F2A vector) at high levels of 
2.03 g/kg fresh weight of leaf tissue, which was approximately 14% of TSP, at 5 dpi. This 
result suggests that pGR-Pep-F2A is a successful protein expression vector. 
As mentioned in the introduction of Chapter 4, both PepMV and PVX belong to the genus 
Potexvirus. Although no crystallographic data for PepMV are available, the structure of 
PepMV is expected to be similar to PVX, where the N- and C- termini of CP are exposed on 
the surface of virions. As GFP was designed to insert into PepMV CP at the N-terminus, it 
was reasonable to expect that this protein would be displayed on the virus surface. As viral 
systemic movement was not affected and viral infect ion spread throughout the plants at 8 dpi, 
apparently GFP could be decorated on the surface of chimeric PepMV. However, I could not 
exclude the possibility that the free PepMV CP and the fused form of CP probably assembled 
together to form a chimeric PepMV, which displayed a protein of interest without steric 
hindrance, similar to the PVX ”OVERCOAT” system (Santa Cruz et al. 1998).  
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In addition, a quantification of the expression levels of GP5e-GFP in the free form or its 
fusion with PepMV CP revealed that the latter form was more stable during a time course of 
infection. This also suggests that PepMV-CP can help to stabilize a protein of interest, 
especially GP5e, which is easily degraded in a cytoplasmic environment. In general, the 
PepMV-based vector provides a versatile system for multiple purposes of protein expression 
in N. benthamiana. 
5.2 Conclusion 
In conclusion, viral vectors have contributed immensely to the development of molecular 
pharming. In this study, I generated a variety of viral vectors based on BPMV, CGMMV and 
PepMV for the expression of GP5 or its truncated proteins and short peptides. Using these 
vectors, I have successfully produced these proteins/peptides in different plants using 
transient expression. GP5C-GFP, CGMMV-NEcmyc, and GP5e-GFP were expressed at 4.36, 
35.84 and 36.53 mg/kg of leaf fresh weight in soybean, cucumber, and N. benthiamiana, 
respectively, using BPMV, CGMMV, PepMV-based expression vectors, respectively. The 
CGMMV-NEcmyc and GP5e-GFP products are promising as plant-made, oral vaccines for 
pigs against PRRSV. Although the GP5C-GFP does not contain the ectodomain of GP5, it 
can still act as an adjuvant for vaccine delivery, as GP5C is known for its high 
immunogenicity. The construction of these virus-based expression vectors provides robust 
and versatile tools for the multi-purpose expression of recombinant proteins in plants, as oral 
vaccines or therapeutics. I believe that these viral vectors, especially the pGR-Pep-F2A, have 
the potential to serve as useful over-expression systems not only for research, but also for 
molecular farming industry, in the future. 
5.3 Future prospects 
The low expression of GP5 in planta has raised questions about its toxicity to plants. To 
answer this question, the potential mechanisms behind this phenomenon need to be 
investigated and elucidated. Also, the natural characteristics of GP5 domains, as well as its 
roles in PRRSV pathogenesis and host immunity, are unknown (Lunney et al. 2016; Prather 
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et al. 2013; Van Breedam et al. 2010). To accomplish high production levels of a plant-made 
vaccine based on GP5, it is necessary to understand all of these aspects. 
Despite poor knowledge about PRRSV GP5 in plants, it is possible to improve the expression 
of GP5 in planta using multiple modifications (Piron et al. 2014). The GP5 of PRRSV type 1 
had the transmembrane region removed and was fused with a stabilizing domain, pFc, to 
create GP5-Tm:pFc. The sequence of GP5-Tm:pFc was codon optimized as an Arabidopsis 
seed storage protein. The protein of interest was expressed and targeted to the ER in 
Arabidopsis seeds at up to 0.83% of TSP, when using a high speed expression vector for 
transgenic plants. The results demonstrated that GP5 could be engineered to increase the 
level of expression in plants. This study suggests that GP5e expression may be enhanced by 
fusion with other PRRSV structural proteins, such as the membrane protein (M), the 
nucleocapsid protein (N), minor glycoproteins (GP) as GP4 and GP3 proteins or stabilizing 
proteins, such as elastin-like polypeptides (ELP), hydrophobin I (HFBI), and pFc, and then 
targeted to the ER using a PepMV-based expression vector. This will allow multi-protein 
expression for PRRSV vaccines, as well as a reduction of GP5 degradation in plants, to 
achieve biobetter products. 
The question of immunogenicity of these plant-made products as vaccines against PRRSV 
using BPMV, CGMMV or PepMV vectors must also be addressed. Thus, an immunization 
test should be conducted to assess whether these products are able to induce an immune 
responses in mouse or pig models. This test would also provide other necessary information, 
e.g. dosage, time, efficacy of oral administration, etc., for further applications. Since PRRSV 
pathogenesis is established through the mucosal surface in respiratory and reproductive 
tracts, it will be interesting to determine whether the plant-made vaccine can effectively 
trigger a strong immune response against PRRSV, when delivered by the oral route. 
Peptide display is an attractive system which exploits viral vectors to produce nanocarriers 
for drug delivery and nanotechnology applications (Gleba et al. 2014; Lico et al. 2015; 
Steinmetz et al. 2009). Both the CGMMV-based and PepMV-based expression systems can 
be investigated for their competence in these novel research fields. More strikingly, 
CGMMV- and PepMV-based systems can also be combined to establish a hybrid system, 
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with benefits from both genera, Tobamovirus and Potexvirus, for synchronous expression of 
virus particles or specific recombinant proteins such as immunoglobulins. This will provide a 
powerful tool for both virus and interdisciplinary research, similar to the hybrid system of 
TMV and PVX (Dickmeis et al. 2015; Giritch et al. 2006). 
Last but not least, biosafety concerns regarding the use of these viral vectors must be 
addressed. Since these viral vectors can replicate and release the virus into the environment, 
this may lead to the infection of healthy, non-target plants. There are two approaches to solve 
this issue: (1) physical barriers, and (2) biotechnology. In the first approach, containment can 
be maintained by the establishment of good manufacturing practices (GMPs) in molecular 
farming (Gleba et al. 2014; Holtz et al. 2015). Facilities would include a variety of 
containment level greenhouses and chambers which prevent the release of viruses into the 
natural environment. In the latter approach, virus vectors can be modified into deconstructed 
or inducible vectors, which eliminate some of the risk of contamination. It is practical to 
establish both methods as a part of a program to maintain biosafety. 
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